ABL1	2	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	1.000	0_HALLMARK_ALLOGRAFT_REJECTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1.000	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_LEISHMANIA_INFECTION	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	1.000	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	1.000	1_KEGG_VIRAL_MYOCARDITIS	1.000	2_IMMUNE_SYSTEM_PROCESS	1.000	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_INFLAMMATORY_RESPONSE	0.500	0_HALLMARK_ANGIOGENESIS	0.500	0_HALLMARK_KRAS_SIGNALING_UP	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	
ACAN	4	0_HALLMARK_G2M_CHECKPOINT	0.750	0_HALLMARK_E2F_TARGETS	0.750	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_P53_SIGNALING_PATHWAY	0.750	2_CELL_CYCLE_GO_0007049	0.750	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_MELANOMA	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_DNA_METABOLIC_PROCESS	0.500	2_MITOTIC_CELL_CYCLE	0.500	2_CELL_CYCLE_PHASE	0.500	2_REGULATION_OF_CELL_CYCLE	0.500	0_HALLMARK_APICAL_JUNCTION	0.250	0_HALLMARK_MYC_TARGETS_V1	0.250	1_KEGG_DNA_REPLICATION	0.250	1_KEGG_OOCYTE_MEIOSIS	0.250	1_KEGG_ECM_RECEPTOR_INTERACTION	0.250	1_KEGG_GLIOMA	0.250	1_KEGG_BLADDER_CANCER	0.250	1_KEGG_SMALL_CELL_LUNG_CANCER	0.250	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.250	2_CELL_MATRIX_JUNCTION	0.250	2_EXTRACELLULAR_MATRIX	0.250	
ACTB	4	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	2_CELL_CYCLE_GO_0007049	1.000	0_HALLMARK_MYC_TARGETS_V1	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	2_CELL_CYCLE_PROCESS	0.750	2_DNA_REPLICATION	0.750	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.500	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.500	1_KEGG_VIRAL_MYOCARDITIS	0.500	2_ORGANELLE_PART	0.500	2_MICROTUBULE_CYTOSKELETON	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	
ACTN1	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_CELL_CYCLE_GO_0007049	1.000	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_BLADDER_CANCER	0.500	1_KEGG_ASTHMA	0.500	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.500	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.500	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.500	1_KEGG_VIRAL_MYOCARDITIS	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	
ACVRL1	1	
ADAM12	7	0_HALLMARK_E2F_TARGETS	0.857	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.857	1_KEGG_CELL_CYCLE	0.857	1_KEGG_P53_SIGNALING_PATHWAY	0.857	1_KEGG_FOCAL_ADHESION	0.857	1_KEGG_PATHWAYS_IN_CANCER	0.714	2_NON_MEMBRANE_BOUND_ORGANELLE	0.714	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.714	2_CELL_CYCLE_GO_0007049	0.714	2_REGULATION_OF_CELL_CYCLE	0.714	0_HALLMARK_G2M_CHECKPOINT	0.571	1_KEGG_ECM_RECEPTOR_INTERACTION	0.571	1_KEGG_MELANOMA	0.571	1_KEGG_BLADDER_CANCER	0.571	2_CHROMOSOMAL_PART	0.571	2_CHROMOSOME	0.571	2_M_PHASE	0.571	2_CELL_CYCLE_PROCESS	0.571	2_MITOTIC_CELL_CYCLE	0.571	2_CELL_CYCLE_PHASE	0.571	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.571	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.571	2_CELL_PROLIFERATION_GO_0008283	0.571	2_MITOSIS	0.571	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	0.571	
ADCY2	2	
ADCY5	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_COMPLEMENT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_COLLAGEN	0.500	2_CELL_PROLIFERATION_GO_0008283	0.500	2_CELL_CYCLE_GO_0007049	0.500	
ADCY6	1	
ADCY8	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_REGION_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_COLLAGEN	1.000	2_REGULATION_OF_PHOSPHORYLATION	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
ADCY9	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_COMPLEMENT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_COAGULATION	0.500	1_KEGG_CALCIUM_SIGNALING_PATHWAY	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_ASTHMA	0.500	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.500	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.500	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.500	1_KEGG_VIRAL_MYOCARDITIS	0.500	2_EXTRACELLULAR_REGION	0.500	2_EXTRACELLULAR_REGION_PART	0.500	
ADCYAP1R1	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	2_AXON	1.000	2_MICROTUBULE_CYTOSKELETON	1.000	2_NEURON_PROJECTION	1.000	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_REGULATION_OF_CELL_CYCLE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_ESTROGEN_RESPONSE_LATE	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	2_ORGANELLE_PART	0.500	2_INTERMEDIATE_FILAMENT_CYTOSKELETON	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_CYTOSKELETAL_PART	0.500	2_NUCLEUS	0.500	2_SPINDLE	0.500	2_CYTOSKELETON	0.500	2_INTERMEDIATE_FILAMENT	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	
AHR	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_COLLAGEN	0.500	2_REGULATION_OF_PHOSPHORYLATION	0.500	2_CELL_CYCLE_GO_0007049	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	
AKAP6	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_ECM_RECEPTOR_INTERACTION	0.333	2_CELL_CELL_SIGNALING	0.333	2_SYNAPTIC_TRANSMISSION	0.333	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.333	2_TRANSMISSION_OF_NERVE_IMPULSE	0.333	2_GLUTAMATE_RECEPTOR_ACTIVITY	0.333	2_GABA_RECEPTOR_ACTIVITY	0.333	2_IONOTROPIC_GLUTAMATE_RECEPTOR_ACTIVITY	0.333	
AKAP9	8	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_CELL_CYCLE	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.375	1_KEGG_FOCAL_ADHESION	0.375	1_KEGG_ECM_RECEPTOR_INTERACTION	0.375	2_CELL_CYCLE_GO_0007049	0.375	2_GABA_RECEPTOR_ACTIVITY	0.375	0_HALLMARK_APOPTOSIS	0.250	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.250	0_HALLMARK_COMPLEMENT	0.250	0_HALLMARK_UV_RESPONSE_DN	0.250	0_HALLMARK_ANGIOGENESIS	0.250	1_KEGG_DNA_REPLICATION	0.250	1_KEGG_P53_SIGNALING_PATHWAY	0.250	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.250	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.250	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.250	1_KEGG_PATHWAYS_IN_CANCER	0.250	1_KEGG_MELANOMA	0.250	1_KEGG_SMALL_CELL_LUNG_CANCER	0.250	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.250	1_KEGG_ALLOGRAFT_REJECTION	0.250	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.250	1_KEGG_VIRAL_MYOCARDITIS	0.250	
AKT1	4	1_KEGG_MELANOMA	0.750	2_CELL_CELL_SIGNALING	0.750	2_SYNAPTIC_TRANSMISSION	0.750	2_TRANSMISSION_OF_NERVE_IMPULSE	0.750	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	2_COLLAGEN	0.500	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.250	0_HALLMARK_E2F_TARGETS	0.250	0_HALLMARK_ANGIOGENESIS	0.250	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.250	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.250	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.250	1_KEGG_PATHWAYS_IN_CANCER	0.250	1_KEGG_BLADDER_CANCER	0.250	1_KEGG_SMALL_CELL_LUNG_CANCER	0.250	1_KEGG_ASTHMA	0.250	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.250	1_KEGG_ALLOGRAFT_REJECTION	0.250	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.250	1_KEGG_VIRAL_MYOCARDITIS	0.250	
AKT3	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_CELL_CELL_SIGNALING	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APICAL_JUNCTION	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_GLIOMA	0.500	1_KEGG_MELANOMA	0.500	2_CHROMOSOMAL_PART	0.500	2_COLLAGEN	0.500	2_CHROMOSOME	0.500	2_DNA_REPLICATION	0.500	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.500	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.500	2_CELL_CYCLE_GO_0007049	0.500	2_TRANSMISSION_OF_NERVE_IMPULSE	0.500	2_REGULATION_OF_CELL_CYCLE	0.500	
AMPH	7	0_HALLMARK_E2F_TARGETS	0.714	1_KEGG_CELL_CYCLE	0.714	0_HALLMARK_G2M_CHECKPOINT	0.571	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.571	2_CELL_CYCLE_GO_0007049	0.571	2_REGULATION_OF_CELL_CYCLE	0.571	2_GABA_RECEPTOR_ACTIVITY	0.571	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.429	0_HALLMARK_MYC_TARGETS_V1	0.429	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.429	1_KEGG_P53_SIGNALING_PATHWAY	0.429	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.429	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.429	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.429	1_KEGG_ALLOGRAFT_REJECTION	0.429	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.429	1_KEGG_VIRAL_MYOCARDITIS	0.429	2_AXON	0.429	2_MICROTUBULE_CYTOSKELETON	0.429	2_NON_MEMBRANE_BOUND_ORGANELLE	0.429	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.429	2_NEURON_PROJECTION	0.429	0_HALLMARK_APOPTOSIS	0.286	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.286	0_HALLMARK_ALLOGRAFT_REJECTION	0.286	
ANAPC1	2	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.500	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_COLLAGEN	0.500	2_CELL_CYCLE_PROCESS	0.500	2_REGULATION_OF_PHOSPHORYLATION	0.500	2_CELL_CELL_SIGNALING	0.500	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.500	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.500	2_SYNAPTIC_TRANSMISSION	0.500	2_CELL_CYCLE_GO_0007049	0.500	
ANAPC7	1	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	1.000	1_KEGG_OOCYTE_MEIOSIS	1.000	2_CELL_CELL_SIGNALING	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	2_RECEPTOR_ACTIVITY	1.000	
ANK1	8	2_GABA_RECEPTOR_ACTIVITY	0.375	0_HALLMARK_G2M_CHECKPOINT	0.250	0_HALLMARK_APOPTOSIS	0.250	0_HALLMARK_COMPLEMENT	0.250	0_HALLMARK_E2F_TARGETS	0.250	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.250	0_HALLMARK_UV_RESPONSE_DN	0.250	0_HALLMARK_COAGULATION	0.250	1_KEGG_CELL_CYCLE	0.250	1_KEGG_P53_SIGNALING_PATHWAY	0.250	1_KEGG_ECM_RECEPTOR_INTERACTION	0.250	1_KEGG_GLIOMA	0.250	2_CALCIUM_ION_BINDING	0.250	0_HALLMARK_HYPOXIA	0.125	0_HALLMARK_ESTROGEN_RESPONSE_LATE	0.125	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.125	1_KEGG_FOCAL_ADHESION	0.125	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.125	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	0.125	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.125	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.125	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.125	1_KEGG_LEISHMANIA_INFECTION	0.125	1_KEGG_PATHWAYS_IN_CANCER	0.125	1_KEGG_PANCREATIC_CANCER	0.125	
ANK2	10	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.800	1_KEGG_FOCAL_ADHESION	0.800	1_KEGG_ECM_RECEPTOR_INTERACTION	0.800	2_EXTRACELLULAR_MATRIX_PART	0.700	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.600	2_EXTRACELLULAR_MATRIX	0.600	2_COLLAGEN	0.600	2_GABA_RECEPTOR_ACTIVITY	0.600	0_HALLMARK_UV_RESPONSE_DN	0.500	1_KEGG_CELL_CYCLE	0.500	2_CELL_CELL_SIGNALING	0.500	2_SYNAPTIC_TRANSMISSION	0.500	2_TRANSMISSION_OF_NERVE_IMPULSE	0.500	0_HALLMARK_G2M_CHECKPOINT	0.400	0_HALLMARK_E2F_TARGETS	0.400	0_HALLMARK_ANGIOGENESIS	0.400	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.400	1_KEGG_P53_SIGNALING_PATHWAY	0.300	1_KEGG_MELANOMA	0.300	0_HALLMARK_APICAL_JUNCTION	0.200	0_HALLMARK_COMPLEMENT	0.200	0_HALLMARK_COAGULATION	0.200	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	0.200	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.200	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.200	
ANK3	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_OOCYTE_MEIOSIS	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_GLIOMA	0.500	1_KEGG_PROSTATE_CANCER	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_BLADDER_CANCER	0.500	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	2_MICROTUBULE_CYTOSKELETON	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_SPINDLE	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_CHROMOSOMAL_PART	0.500	2_CHROMOSOME	0.500	2_M_PHASE	0.500	2_INTERPHASE	0.500	2_CELL_CYCLE_PROCESS	0.500	2_MITOTIC_CELL_CYCLE	0.500	
APEX2	3	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_CELL_CYCLE	0.667	2_CELL_CYCLE_GO_0007049	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_BASE_EXCISION_REPAIR	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_ECM_RECEPTOR_INTERACTION	0.333	1_KEGG_GLIOMA	0.333	1_KEGG_MELANOMA	0.333	2_NON_MEMBRANE_BOUND_ORGANELLE	0.333	2_REPLICATION_FORK	0.333	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.333	2_CHROMOSOMAL_PART	0.333	2_CONDENSED_CHROMOSOME	0.333	2_CHROMOSOME	0.333	2_DNA_METABOLIC_PROCESS	0.333	2_REGULATION_OF_MOLECULAR_FUNCTION	0.333	2_INTERPHASE	0.333	2_CELL_CYCLE_PROCESS	0.333	2_MITOTIC_CELL_CYCLE	0.333	2_CELL_CYCLE_PHASE	0.333	
APOB	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.750	2_EXTRACELLULAR_MATRIX_PART	0.750	2_EXTRACELLULAR_MATRIX	0.750	2_COLLAGEN	0.750	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	0.500	1_KEGG_MELANOMA	0.500	2_AXON	0.500	2_EXTRACELLULAR_REGION	0.500	2_EXTRACELLULAR_REGION_PART	0.500	2_NEURON_PROJECTION	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.250	0_HALLMARK_HYPOXIA	0.250	0_HALLMARK_G2M_CHECKPOINT	0.250	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.250	0_HALLMARK_COMPLEMENT	0.250	0_HALLMARK_E2F_TARGETS	0.250	0_HALLMARK_COAGULATION	0.250	1_KEGG_CELL_CYCLE	0.250	1_KEGG_P53_SIGNALING_PATHWAY	0.250	
ASPM	4	0_HALLMARK_E2F_TARGETS	0.750	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_P53_SIGNALING_PATHWAY	0.750	2_NON_MEMBRANE_BOUND_ORGANELLE	0.750	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.750	2_CELL_CYCLE_GO_0007049	0.750	0_HALLMARK_G2M_CHECKPOINT	0.500	1_KEGG_MELANOMA	0.500	2_REPLICATION_FORK	0.500	2_DNA_REPLICATION	0.500	2_REGULATION_OF_CELL_CYCLE	0.500	0_HALLMARK_APOPTOSIS	0.250	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.250	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.250	0_HALLMARK_MYC_TARGETS_V1	0.250	0_HALLMARK_UV_RESPONSE_DN	0.250	0_HALLMARK_ALLOGRAFT_REJECTION	0.250	1_KEGG_DNA_REPLICATION	0.250	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.250	1_KEGG_MISMATCH_REPAIR	0.250	1_KEGG_FOCAL_ADHESION	0.250	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.250	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.250	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	0.250	
ATM	6	0_HALLMARK_E2F_TARGETS	0.833	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.833	1_KEGG_CELL_CYCLE	0.833	1_KEGG_P53_SIGNALING_PATHWAY	0.833	1_KEGG_FOCAL_ADHESION	0.833	2_CELL_CYCLE_GO_0007049	0.833	2_REGULATION_OF_CELL_CYCLE	0.833	0_HALLMARK_G2M_CHECKPOINT	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_UV_RESPONSE_DN	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_BLADDER_CANCER	0.500	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.500	0_HALLMARK_ANGIOGENESIS	0.333	1_KEGG_PATHWAYS_IN_CANCER	0.333	1_KEGG_SMALL_CELL_LUNG_CANCER	0.333	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.333	2_EXTRACELLULAR_MATRIX_PART	0.333	2_NON_MEMBRANE_BOUND_ORGANELLE	0.333	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.333	2_EXTRACELLULAR_MATRIX	0.333	2_COLLAGEN	0.333	2_DNA_METABOLIC_PROCESS	0.333	2_REGULATION_OF_PHOSPHORYLATION	0.333	
ATN1	4	0_HALLMARK_E2F_TARGETS	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.750	2_GABA_RECEPTOR_ACTIVITY	0.750	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	1_KEGG_BLADDER_CANCER	0.500	1_KEGG_ASTHMA	0.500	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.500	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.500	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.500	1_KEGG_VIRAL_MYOCARDITIS	0.500	2_CELL_CELL_SIGNALING	0.500	2_SYNAPTIC_TRANSMISSION	0.500	2_TRANSMISSION_OF_NERVE_IMPULSE	0.500	1_KEGG_DNA_REPLICATION	0.250	1_KEGG_FOCAL_ADHESION	0.250	1_KEGG_MELANOMA	0.250	
ATR	6	0_HALLMARK_E2F_TARGETS	0.833	1_KEGG_CELL_CYCLE	0.833	0_HALLMARK_G2M_CHECKPOINT	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	2_CELL_CYCLE_GO_0007049	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_MELANOMA	0.500	2_REGULATION_OF_PHOSPHORYLATION	0.500	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.500	0_HALLMARK_UV_RESPONSE_DN	0.333	1_KEGG_ECM_RECEPTOR_INTERACTION	0.333	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.333	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	1_KEGG_BLADDER_CANCER	0.333	1_KEGG_ALLOGRAFT_REJECTION	0.333	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.333	2_NON_MEMBRANE_BOUND_ORGANELLE	0.333	2_REPLICATION_FORK	0.333	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.333	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.333	2_SYNAPTIC_TRANSMISSION	0.333	2_DNA_REPLICATION	0.333	2_REGULATION_OF_CELL_CYCLE	0.333	
ATRX	12	0_HALLMARK_E2F_TARGETS	0.833	1_KEGG_CELL_CYCLE	0.833	0_HALLMARK_G2M_CHECKPOINT	0.750	1_KEGG_P53_SIGNALING_PATHWAY	0.750	2_CELL_CYCLE_GO_0007049	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.583	2_CHROMOSOME	0.583	2_CELL_CYCLE_PROCESS	0.583	2_MITOTIC_CELL_CYCLE	0.583	2_CELL_CYCLE_PHASE	0.583	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.583	2_REGULATION_OF_CELL_CYCLE	0.583	2_INTERPHASE	0.500	2_CELL_PROLIFERATION_GO_0008283	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.417	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.417	2_DNA_METABOLIC_PROCESS	0.417	0_HALLMARK_MYC_TARGETS_V1	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_PATHWAYS_IN_CANCER	0.333	1_KEGG_SMALL_CELL_LUNG_CANCER	0.333	2_NUCLEUS	0.333	2_CHROMOSOMAL_PART	0.333	2_REGULATION_OF_PHOSPHORYLATION	0.333	
B2M	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_LEISHMANIA_INFECTION	1.000	1_KEGG_ASTHMA	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_REPLICATION_FORK	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_CHROMOSOMAL_PART	1.000	2_CHROMOSOME	1.000	2_DNA_METABOLIC_PROCESS	1.000	2_CELL_CYCLE_CHECKPOINT_GO_0000075	1.000	2_DNA_REPLICATION	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_REGULATION_OF_CELL_CYCLE	1.000	
BARD1	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_REGULATION_OF_PHOSPHORYLATION	1.000	0_HALLMARK_MITOTIC_SPINDLE	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_COMPLEMENT	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	0_HALLMARK_COAGULATION	0.500	0_HALLMARK_KRAS_SIGNALING_UP	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	1_KEGG_ASTHMA	0.500	
BCAR1	3	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_REGULATION_OF_CELL_CYCLE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_UV_RESPONSE_DN	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_BLADDER_CANCER	0.667	1_KEGG_SMALL_CELL_LUNG_CANCER	0.667	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.667	2_EXTRACELLULAR_MATRIX_PART	0.667	2_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_EXTRACELLULAR_MATRIX	0.667	2_COLLAGEN	0.667	2_SYNAPTIC_TRANSMISSION	0.667	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.667	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	0.667	0_HALLMARK_MITOTIC_SPINDLE	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	
BCLAF1	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_COMPLEMENT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	0_HALLMARK_KRAS_SIGNALING_UP	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	1_KEGG_ASTHMA	0.500	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.500	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.500	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.500	1_KEGG_VIRAL_MYOCARDITIS	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	
BCR	3	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_BLADDER_CANCER	1.000	1_KEGG_GLIOMA	0.667	1_KEGG_MELANOMA	0.667	2_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_CELL_CYCLE_GO_0007049	0.667	0_HALLMARK_UV_RESPONSE_DN	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_OOCYTE_MEIOSIS	0.333	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	0.333	1_KEGG_PROSTATE_CANCER	0.333	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	0.333	1_KEGG_SMALL_CELL_LUNG_CANCER	0.333	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.333	2_EXTRACELLULAR_MATRIX_PART	0.333	2_MICROTUBULE_CYTOSKELETON	0.333	2_EXTRACELLULAR_REGION	0.333	
BLM	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	1.000	
BMPR1B	1	
BRCA1	4	0_HALLMARK_E2F_TARGETS	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_FOCAL_ADHESION	0.750	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.500	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_CHROMOSOME	0.500	2_DNA_METABOLIC_PROCESS	0.500	2_INTERPHASE	0.500	2_CELL_CYCLE_PROCESS	0.500	2_MITOTIC_CELL_CYCLE	0.500	2_CELL_CYCLE_PHASE	0.500	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.500	2_CELL_PROLIFERATION_GO_0008283	0.500	2_CELL_CYCLE_GO_0007049	0.500	2_REGULATION_OF_CELL_CYCLE	0.500	0_HALLMARK_APOPTOSIS	0.250	0_HALLMARK_MYC_TARGETS_V1	0.250	
BSG	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	1_KEGG_P53_SIGNALING_PATHWAY	0.500	2_MICROTUBULE_ASSOCIATED_COMPLEX	0.500	2_MICROTUBULE_CYTOSKELETON	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_CONDENSED_CHROMOSOME	0.500	2_COLLAGEN	0.500	2_CHROMOSOME	0.500	2_M_PHASE	0.500	2_CELL_CYCLE_PROCESS	0.500	2_CELL_CYCLE_PHASE	0.500	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.500	2_CELL_CYCLE_GO_0007049	0.500	2_REGULATION_OF_CELL_CYCLE	0.500	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	
BTRC	5	0_HALLMARK_G2M_CHECKPOINT	0.800	0_HALLMARK_E2F_TARGETS	0.800	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.800	1_KEGG_CELL_CYCLE	0.800	1_KEGG_P53_SIGNALING_PATHWAY	0.800	1_KEGG_FOCAL_ADHESION	0.800	1_KEGG_ECM_RECEPTOR_INTERACTION	0.800	1_KEGG_PATHWAYS_IN_CANCER	0.800	1_KEGG_BLADDER_CANCER	0.800	2_CELL_CYCLE_GO_0007049	0.800	1_KEGG_GLIOMA	0.600	1_KEGG_MELANOMA	0.600	1_KEGG_SMALL_CELL_LUNG_CANCER	0.600	2_MICROTUBULE_CYTOSKELETON	0.600	2_NON_MEMBRANE_BOUND_ORGANELLE	0.600	2_SPINDLE	0.600	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.600	2_CHROMOSOMAL_PART	0.600	2_CHROMOSOME	0.600	2_M_PHASE	0.600	2_CELL_CYCLE_PROCESS	0.600	2_MITOTIC_CELL_CYCLE	0.600	2_CELL_CYCLE_PHASE	0.600	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.600	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.600	
BUB3	7	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	0_HALLMARK_G2M_CHECKPOINT	0.857	1_KEGG_P53_SIGNALING_PATHWAY	0.857	1_KEGG_FOCAL_ADHESION	0.857	1_KEGG_ECM_RECEPTOR_INTERACTION	0.714	1_KEGG_PATHWAYS_IN_CANCER	0.714	2_NON_MEMBRANE_BOUND_ORGANELLE	0.714	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.714	2_CELL_CYCLE_GO_0007049	0.714	1_KEGG_MELANOMA	0.571	1_KEGG_BLADDER_CANCER	0.571	2_MICROTUBULE_CYTOSKELETON	0.571	2_CHROMOSOMAL_PART	0.571	2_CHROMOSOME	0.571	2_M_PHASE	0.571	2_CELL_CYCLE_PROCESS	0.571	2_MITOTIC_CELL_CYCLE	0.571	2_CELL_CYCLE_PHASE	0.571	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.571	2_CELL_PROLIFERATION_GO_0008283	0.571	2_MITOSIS	0.571	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	0.571	2_REGULATION_OF_CELL_CYCLE	0.571	
CACNA1B	5	1_KEGG_CALCIUM_SIGNALING_PATHWAY	0.400	2_CALCIUM_CHANNEL_ACTIVITY	0.400	0_HALLMARK_G2M_CHECKPOINT	0.200	0_HALLMARK_E2F_TARGETS	0.200	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.200	0_HALLMARK_UV_RESPONSE_DN	0.200	0_HALLMARK_ANGIOGENESIS	0.200	1_KEGG_CELL_CYCLE	0.200	1_KEGG_P53_SIGNALING_PATHWAY	0.200	1_KEGG_FOCAL_ADHESION	0.200	1_KEGG_ECM_RECEPTOR_INTERACTION	0.200	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.200	2_EXTRACELLULAR_MATRIX_PART	0.200	2_VOLTAGE_GATED_CALCIUM_CHANNEL_COMPLEX	0.200	2_EXTRACELLULAR_MATRIX	0.200	2_COLLAGEN	0.200	2_REGULATION_OF_PHOSPHORYLATION	0.200	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.200	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.200	2_SYNAPTIC_TRANSMISSION	0.200	2_CELL_CYCLE_GO_0007049	0.200	2_REGULATION_OF_CELL_CYCLE	0.200	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	0.200	2_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	0.200	2_CATION_CHANNEL_ACTIVITY	0.200	
CACNA1C	4	1_KEGG_CALCIUM_SIGNALING_PATHWAY	0.500	2_CALCIUM_CHANNEL_ACTIVITY	0.500	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.250	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.250	0_HALLMARK_UV_RESPONSE_DN	0.250	0_HALLMARK_ANGIOGENESIS	0.250	1_KEGG_FOCAL_ADHESION	0.250	1_KEGG_ECM_RECEPTOR_INTERACTION	0.250	1_KEGG_TYPE_II_DIABETES_MELLITUS	0.250	1_KEGG_PANCREATIC_CANCER	0.250	1_KEGG_MELANOMA	0.250	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.250	2_EXTRACELLULAR_MATRIX_PART	0.250	2_EXTRACELLULAR_MATRIX	0.250	2_PLASMA_MEMBRANE	0.250	2_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	0.250	2_CATION_CHANNEL_ACTIVITY	0.250	2_GATED_CHANNEL_ACTIVITY	0.250	2_SUBSTRATE_SPECIFIC_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	0.250	2_SUBSTRATE_SPECIFIC_CHANNEL_ACTIVITY	0.250	2_SUBSTRATE_SPECIFIC_TRANSPORTER_ACTIVITY	0.250	2_GABA_RECEPTOR_ACTIVITY	0.250	2_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	0.250	2_ION_CHANNEL_ACTIVITY	0.250	2_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	0.250	
CACNA1E	5	2_CALCIUM_CHANNEL_ACTIVITY	0.800	1_KEGG_CALCIUM_SIGNALING_PATHWAY	0.400	2_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	0.400	2_CATION_CHANNEL_ACTIVITY	0.400	2_GATED_CHANNEL_ACTIVITY	0.400	2_SUBSTRATE_SPECIFIC_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	0.400	2_SUBSTRATE_SPECIFIC_CHANNEL_ACTIVITY	0.400	2_SUBSTRATE_SPECIFIC_TRANSPORTER_ACTIVITY	0.400	2_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	0.400	2_ION_CHANNEL_ACTIVITY	0.400	2_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	0.400	2_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	0.400	0_HALLMARK_G2M_CHECKPOINT	0.200	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.200	0_HALLMARK_E2F_TARGETS	0.200	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.200	0_HALLMARK_UV_RESPONSE_DN	0.200	1_KEGG_CELL_CYCLE	0.200	1_KEGG_P53_SIGNALING_PATHWAY	0.200	1_KEGG_ECM_RECEPTOR_INTERACTION	0.200	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	0.200	1_KEGG_TYPE_II_DIABETES_MELLITUS	0.200	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.200	2_EXTRACELLULAR_MATRIX_PART	0.200	2_AXON	0.200	
CACNA1G	1	1_KEGG_CALCIUM_SIGNALING_PATHWAY	1.000	2_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	1.000	2_CATION_CHANNEL_ACTIVITY	1.000	2_GATED_CHANNEL_ACTIVITY	1.000	2_SUBSTRATE_SPECIFIC_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	1.000	2_SUBSTRATE_SPECIFIC_CHANNEL_ACTIVITY	1.000	2_SUBSTRATE_SPECIFIC_TRANSPORTER_ACTIVITY	1.000	2_CALCIUM_CHANNEL_ACTIVITY	1.000	2_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	1.000	2_ION_CHANNEL_ACTIVITY	1.000	2_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	1.000	2_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	1.000	
CACNA1H	9	2_REGULATION_OF_HEART_CONTRACTION	0.778	2_CALCIUM_CHANNEL_ACTIVITY	0.444	1_KEGG_CALCIUM_SIGNALING_PATHWAY	0.333	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.111	0_HALLMARK_COMPLEMENT	0.111	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.111	0_HALLMARK_UV_RESPONSE_DN	0.111	1_KEGG_FOCAL_ADHESION	0.111	1_KEGG_ECM_RECEPTOR_INTERACTION	0.111	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.111	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.111	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.111	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.111	1_KEGG_LEISHMANIA_INFECTION	0.111	1_KEGG_ASTHMA	0.111	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.111	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.111	1_KEGG_ALLOGRAFT_REJECTION	0.111	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.111	1_KEGG_VIRAL_MYOCARDITIS	0.111	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.111	2_EXTRACELLULAR_MATRIX_PART	0.111	2_EXTRACELLULAR_REGION_PART	0.111	2_EXTRACELLULAR_MATRIX	0.111	2_COLLAGEN	0.111	
CACNA1I	4	2_CELL_CELL_SIGNALING	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	1_KEGG_CALCIUM_SIGNALING_PATHWAY	0.250	1_KEGG_CELL_CYCLE	0.250	1_KEGG_PATHWAYS_IN_CANCER	0.250	1_KEGG_MELANOMA	0.250	2_REGULATION_OF_PHOSPHORYLATION	0.250	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.250	2_SYNAPTIC_TRANSMISSION	0.250	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.250	2_TRANSMISSION_OF_NERVE_IMPULSE	0.250	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	0.250	2_RECEPTOR_BINDING	0.250	2_GROWTH_FACTOR_ACTIVITY	0.250	
CACNA1S	7	0_HALLMARK_E2F_TARGETS	0.429	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.429	1_KEGG_CELL_CYCLE	0.429	1_KEGG_FOCAL_ADHESION	0.429	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.429	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.429	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.429	1_KEGG_ASTHMA	0.429	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.429	1_KEGG_ALLOGRAFT_REJECTION	0.429	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.429	2_GABA_RECEPTOR_ACTIVITY	0.429	1_KEGG_P53_SIGNALING_PATHWAY	0.286	1_KEGG_ECM_RECEPTOR_INTERACTION	0.286	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.286	1_KEGG_LEISHMANIA_INFECTION	0.286	1_KEGG_MELANOMA	0.286	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.286	1_KEGG_VIRAL_MYOCARDITIS	0.286	2_CELL_CELL_SIGNALING	0.286	2_SYNAPTIC_TRANSMISSION	0.286	2_TRANSMISSION_OF_NERVE_IMPULSE	0.286	0_HALLMARK_G2M_CHECKPOINT	0.143	0_HALLMARK_APOPTOSIS	0.143	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.143	
CACNB3	1	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	1.000	0_HALLMARK_HYPOXIA	1.000	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	1.000	0_HALLMARK_COMPLEMENT	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_INFLAMMATORY_RESPONSE	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ANGIOGENESIS	1.000	0_HALLMARK_COAGULATION	1.000	0_HALLMARK_ALLOGRAFT_REJECTION	1.000	0_HALLMARK_KRAS_SIGNALING_UP	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	1.000	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1.000	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_LEISHMANIA_INFECTION	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	1.000	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	1.000	
CALM1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	1.000	
CALML5	5	0_HALLMARK_G2M_CHECKPOINT	0.400	0_HALLMARK_E2F_TARGETS	0.400	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.400	1_KEGG_CALCIUM_SIGNALING_PATHWAY	0.400	1_KEGG_CELL_CYCLE	0.400	1_KEGG_OOCYTE_MEIOSIS	0.400	1_KEGG_P53_SIGNALING_PATHWAY	0.400	1_KEGG_FOCAL_ADHESION	0.400	1_KEGG_ECM_RECEPTOR_INTERACTION	0.400	1_KEGG_PATHWAYS_IN_CANCER	0.400	1_KEGG_GLIOMA	0.400	1_KEGG_MELANOMA	0.400	1_KEGG_BLADDER_CANCER	0.400	1_KEGG_SMALL_CELL_LUNG_CANCER	0.400	2_MICROTUBULE_CYTOSKELETON	0.400	2_NON_MEMBRANE_BOUND_ORGANELLE	0.400	2_SPINDLE	0.400	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.400	2_CHROMOSOMAL_PART	0.400	2_CHROMOSOME	0.400	2_M_PHASE	0.400	2_CELL_CYCLE_PROCESS	0.400	2_MITOTIC_CELL_CYCLE	0.400	2_CELL_CYCLE_PHASE	0.400	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.400	
CBL	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	0.500	1_KEGG_GLIOMA	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_BLADDER_CANCER	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_CYTOSKELETON	0.500	2_EXTRACELLULAR_REGION_PART	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_COLLAGEN	0.500	2_REGULATION_OF_PHOSPHORYLATION	0.500	2_CELL_CELL_SIGNALING	0.500	
CBLB	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_COLLAGEN	1.000	2_REGULATION_OF_PHOSPHORYLATION	1.000	2_CELL_CYCLE_PHASE	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	1.000	
CCL3L1	1	0_HALLMARK_COMPLEMENT	1.000	0_HALLMARK_COAGULATION	1.000	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	1.000	2_INFLAMMATORY_RESPONSE	1.000	2_RESPONSE_TO_STRESS	1.000	2_RESPONSE_TO_EXTERNAL_STIMULUS	1.000	2_RESPONSE_TO_WOUNDING	1.000	
CCNF	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	
CCT2	8	0_HALLMARK_E2F_TARGETS	0.375	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.375	1_KEGG_CELL_CYCLE	0.375	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.375	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.375	1_KEGG_LEISHMANIA_INFECTION	0.375	1_KEGG_ASTHMA	0.375	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.375	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.375	1_KEGG_ALLOGRAFT_REJECTION	0.375	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.375	1_KEGG_VIRAL_MYOCARDITIS	0.375	2_KINESIN_COMPLEX	0.375	0_HALLMARK_APOPTOSIS	0.250	0_HALLMARK_UV_RESPONSE_DN	0.250	0_HALLMARK_ANGIOGENESIS	0.250	1_KEGG_P53_SIGNALING_PATHWAY	0.250	1_KEGG_ECM_RECEPTOR_INTERACTION	0.250	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.250	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	0.250	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.250	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.250	2_EXTRACELLULAR_MATRIX_PART	0.250	2_AXON	0.250	2_EXTRACELLULAR_REGION	0.250	
CCT6A	19	2_KINESIN_COMPLEX	0.263	0_HALLMARK_G2M_CHECKPOINT	0.211	0_HALLMARK_E2F_TARGETS	0.211	1_KEGG_CELL_CYCLE	0.211	2_CELL_CYCLE_GO_0007049	0.211	2_GABA_RECEPTOR_ACTIVITY	0.211	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.158	2_MICROTUBULE_CYTOSKELETON	0.158	2_CELL_CELL_SIGNALING	0.158	2_REGULATION_OF_CELL_CYCLE	0.158	1_KEGG_P53_SIGNALING_PATHWAY	0.105	1_KEGG_FOCAL_ADHESION	0.105	1_KEGG_ECM_RECEPTOR_INTERACTION	0.105	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.105	1_KEGG_MELANOMA	0.105	2_MICROTUBULE_ASSOCIATED_COMPLEX	0.105	2_NON_MEMBRANE_BOUND_ORGANELLE	0.105	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.105	2_INTERPHASE	0.105	2_CELL_CYCLE_PROCESS	0.105	2_MITOTIC_CELL_CYCLE	0.105	2_REGULATION_OF_PHOSPHORYLATION	0.105	2_CELL_CYCLE_PHASE	0.105	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.105	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.105	
CD1D	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_ALLOGRAFT_REJECTION	1.000	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1.000	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_LEISHMANIA_INFECTION	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	1.000	1_KEGG_VIRAL_MYOCARDITIS	1.000	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_COMPLEMENT	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_KRAS_SIGNALING_UP	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.500	2_REGULATION_OF_BIOLOGICAL_QUALITY	0.500	2_CELL_CELL_SIGNALING	0.500	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	0.500	2_TRANSMISSION_OF_NERVE_IMPULSE	0.500	
CD3E	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_BLADDER_CANCER	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_NUCLEUS	0.500	2_EXTRACELLULAR_REGION_PART	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_COLLAGEN	0.500	2_CHROMOSOME	0.500	
CD3G	9	1_KEGG_CELL_CYCLE	0.556	1_KEGG_ECM_RECEPTOR_INTERACTION	0.556	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.556	2_GABA_RECEPTOR_ACTIVITY	0.556	0_HALLMARK_G2M_CHECKPOINT	0.444	0_HALLMARK_E2F_TARGETS	0.444	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.444	1_KEGG_FOCAL_ADHESION	0.444	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.444	1_KEGG_ALLOGRAFT_REJECTION	0.444	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.444	0_HALLMARK_APOPTOSIS	0.333	0_HALLMARK_ANGIOGENESIS	0.333	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.333	1_KEGG_PATHWAYS_IN_CANCER	0.333	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.333	1_KEGG_VIRAL_MYOCARDITIS	0.333	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.333	2_EXTRACELLULAR_MATRIX_PART	0.333	2_EXTRACELLULAR_REGION	0.333	2_EXTRACELLULAR_REGION_PART	0.333	2_EXTRACELLULAR_MATRIX	0.333	2_COLLAGEN	0.333	2_TRANSMISSION_OF_NERVE_IMPULSE	0.333	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.222	
CD79B	1	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1.000	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_LEISHMANIA_INFECTION	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	1.000	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	1.000	1_KEGG_VIRAL_MYOCARDITIS	1.000	
CD97	1	
CDC2	3	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_BLADDER_CANCER	1.000	2_MICROTUBULE_CYTOSKELETON	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_SPINDLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_CHROMOSOMAL_PART	1.000	2_CHROMOSOME	1.000	2_M_PHASE	1.000	2_CELL_CYCLE_PROCESS	1.000	2_MITOTIC_CELL_CYCLE	1.000	2_CELL_CYCLE_PHASE	1.000	2_CELL_CYCLE_CHECKPOINT_GO_0000075	1.000	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	1.000	2_CELL_PROLIFERATION_GO_0008283	1.000	2_MITOSIS	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	1.000	
CDC23	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
CDC27	5	0_HALLMARK_G2M_CHECKPOINT	0.800	0_HALLMARK_E2F_TARGETS	0.800	1_KEGG_CELL_CYCLE	0.800	2_NON_MEMBRANE_BOUND_ORGANELLE	0.600	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.600	1_KEGG_DNA_REPLICATION	0.400	1_KEGG_P53_SIGNALING_PATHWAY	0.400	2_MICROTUBULE_CYTOSKELETON	0.400	2_SPINDLE	0.400	2_CYTOSKELETON	0.400	2_REGULATION_OF_PHOSPHORYLATION	0.400	2_CELL_CYCLE_GO_0007049	0.400	0_HALLMARK_MITOTIC_SPINDLE	0.200	0_HALLMARK_MYC_TARGETS_V1	0.200	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.200	0_HALLMARK_UV_RESPONSE_DN	0.200	1_KEGG_OOCYTE_MEIOSIS	0.200	1_KEGG_FOCAL_ADHESION	0.200	1_KEGG_ECM_RECEPTOR_INTERACTION	0.200	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.200	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.200	1_KEGG_ALLOGRAFT_REJECTION	0.200	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.200	2_ORGANELLE_PART	0.200	2_REPLICATION_FORK	0.200	
CDH15	2	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_COMPLEMENT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	2_AXON	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_REPLICATION_FORK	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_CHROMOSOMAL_PART	0.500	2_NEURON_PROJECTION	0.500	2_CHROMOSOME	0.500	2_PROTEIN_HOMODIMERIZATION_ACTIVITY	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	
CDH17	1	
CDH18	7	
CDH19	2	
CDH20	1	
CDH22	1	
CDH23	10	2_MICROVILLUS	0.300	2_PHOTORECEPTOR_CELL_MAINTENANCE	0.300	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.200	0_HALLMARK_UV_RESPONSE_DN	0.200	1_KEGG_FOCAL_ADHESION	0.200	1_KEGG_ECM_RECEPTOR_INTERACTION	0.200	2_GABA_RECEPTOR_ACTIVITY	0.200	0_HALLMARK_G2M_CHECKPOINT	0.100	0_HALLMARK_E2F_TARGETS	0.100	0_HALLMARK_ANGIOGENESIS	0.100	1_KEGG_CELL_CYCLE	0.100	1_KEGG_P53_SIGNALING_PATHWAY	0.100	1_KEGG_MELANOMA	0.100	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.100	2_EXTRACELLULAR_MATRIX_PART	0.100	2_EXTRACELLULAR_MATRIX	0.100	2_COLLAGEN	0.100	2_REGULATION_OF_PHOSPHORYLATION	0.100	2_CELL_CELL_SIGNALING	0.100	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.100	2_SYNAPTIC_TRANSMISSION	0.100	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.100	2_TRANSMISSION_OF_NERVE_IMPULSE	0.100	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	0.100	2_ENZYME_INHIBITOR_ACTIVITY	0.100	
CDH5	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_CHROMOSOME	1.000	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.500	0_HALLMARK_COMPLEMENT	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_BLADDER_CANCER	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_AXON	0.500	2_NUCLEUS	0.500	
CDH8	2	
CDH9	7	
CDK4	37	0_HALLMARK_E2F_TARGETS	0.919	1_KEGG_CELL_CYCLE	0.919	0_HALLMARK_G2M_CHECKPOINT	0.784	2_CELL_CYCLE_GO_0007049	0.730	1_KEGG_P53_SIGNALING_PATHWAY	0.703	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.676	2_NON_MEMBRANE_BOUND_ORGANELLE	0.595	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.595	1_KEGG_ECM_RECEPTOR_INTERACTION	0.541	2_REGULATION_OF_CELL_CYCLE	0.541	1_KEGG_FOCAL_ADHESION	0.486	2_GABA_RECEPTOR_ACTIVITY	0.486	1_KEGG_BLADDER_CANCER	0.459	2_CELL_CYCLE_PHASE	0.459	2_CHROMOSOME	0.432	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.432	2_CELL_PROLIFERATION_GO_0008283	0.432	1_KEGG_DNA_REPLICATION	0.405	1_KEGG_PATHWAYS_IN_CANCER	0.405	2_MITOTIC_CELL_CYCLE	0.405	2_CELL_CYCLE_PROCESS	0.378	2_CHROMOSOMAL_PART	0.351	2_INTERPHASE	0.351	1_KEGG_MELANOMA	0.324	1_KEGG_SMALL_CELL_LUNG_CANCER	0.324	
CDK5RAP2	1	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	2_CELL_CELL_SIGNALING	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
CDK6	6	1_KEGG_CELL_CYCLE	1.000	2_CELL_PROLIFERATION_GO_0008283	1.000	0_HALLMARK_G2M_CHECKPOINT	0.833	0_HALLMARK_E2F_TARGETS	0.833	1_KEGG_PATHWAYS_IN_CANCER	0.833	1_KEGG_MELANOMA	0.833	2_CELL_CYCLE_GO_0007049	0.833	1_KEGG_P53_SIGNALING_PATHWAY	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_GLIOMA	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	2_INTERPHASE	0.500	2_CELL_CYCLE_PROCESS	0.500	2_MITOTIC_CELL_CYCLE	0.500	2_CELL_CYCLE_PHASE	0.500	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	0.500	0_HALLMARK_APOPTOSIS	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	0_HALLMARK_ANGIOGENESIS	0.333	1_KEGG_PANCREATIC_CANCER	0.333	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	0.333	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.333	2_EXTRACELLULAR_MATRIX_PART	0.333	
CDKN2A	147	1_KEGG_CELL_CYCLE	0.816	0_HALLMARK_E2F_TARGETS	0.660	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.605	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.599	2_CELL_CYCLE_GO_0007049	0.599	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	0.571	2_REGULATION_OF_PHOSPHORYLATION	0.551	0_HALLMARK_G2M_CHECKPOINT	0.537	1_KEGG_P53_SIGNALING_PATHWAY	0.517	1_KEGG_ECM_RECEPTOR_INTERACTION	0.490	1_KEGG_FOCAL_ADHESION	0.483	2_GABA_RECEPTOR_ACTIVITY	0.422	2_CELL_CYCLE_PHASE	0.388	2_CELL_CYCLE_PROCESS	0.374	2_REGULATION_OF_CELL_CYCLE	0.374	1_KEGG_PATHWAYS_IN_CANCER	0.333	1_KEGG_MELANOMA	0.320	2_INTERPHASE	0.320	2_MITOTIC_CELL_CYCLE	0.320	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.320	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	0.320	2_EXTRACELLULAR_MATRIX_PART	0.299	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	0.299	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.286	2_EXTRACELLULAR_MATRIX	0.279	
CDKN2B	125	1_KEGG_CELL_CYCLE	0.856	0_HALLMARK_E2F_TARGETS	0.696	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.648	2_CELL_CYCLE_GO_0007049	0.648	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.616	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	0.608	2_REGULATION_OF_PHOSPHORYLATION	0.592	0_HALLMARK_G2M_CHECKPOINT	0.576	1_KEGG_P53_SIGNALING_PATHWAY	0.552	1_KEGG_ECM_RECEPTOR_INTERACTION	0.504	1_KEGG_FOCAL_ADHESION	0.488	2_CELL_CYCLE_PHASE	0.448	2_GABA_RECEPTOR_ACTIVITY	0.432	2_CELL_CYCLE_PROCESS	0.424	2_REGULATION_OF_CELL_CYCLE	0.408	2_INTERPHASE	0.368	2_MITOTIC_CELL_CYCLE	0.360	1_KEGG_PATHWAYS_IN_CANCER	0.344	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	0.344	2_EXTRACELLULAR_MATRIX_PART	0.328	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.320	2_EXTRACELLULAR_MATRIX	0.312	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.304	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	0.304	1_KEGG_MELANOMA	0.296	
CEBPB	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
CELSR1	5	2_MICROVILLUS	0.200	2_PHOTORECEPTOR_CELL_MAINTENANCE	0.200	
CELSR2	1	
CELSR3	4	
CEP135	8	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	2_CHROMOSOME	0.500	2_CELL_CYCLE_GO_0007049	0.500	0_HALLMARK_MYC_TARGETS_V1	0.375	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.375	1_KEGG_DNA_REPLICATION	0.375	1_KEGG_FOCAL_ADHESION	0.375	1_KEGG_ECM_RECEPTOR_INTERACTION	0.375	1_KEGG_PATHWAYS_IN_CANCER	0.375	2_NON_MEMBRANE_BOUND_ORGANELLE	0.375	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.375	2_CHROMOSOMAL_PART	0.375	2_CELL_CYCLE_PROCESS	0.375	2_MITOTIC_CELL_CYCLE	0.375	2_REGULATION_OF_PHOSPHORYLATION	0.375	2_CELL_CYCLE_PHASE	0.375	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.375	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.375	2_REGULATION_OF_CELL_CYCLE	0.375	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	0.375	0_HALLMARK_UV_RESPONSE_DN	0.250	0_HALLMARK_ANGIOGENESIS	0.250	
CEP250	3	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_CELL_CYCLE	0.667	2_CELL_CYCLE_GO_0007049	0.667	0_HALLMARK_MITOTIC_SPINDLE	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_ECM_RECEPTOR_INTERACTION	0.333	1_KEGG_MELANOMA	0.333	2_ORGANELLE_PART	0.333	2_MICROTUBULE_CYTOSKELETON	0.333	2_NON_MEMBRANE_BOUND_ORGANELLE	0.333	2_CYTOSKELETAL_PART	0.333	2_NUCLEUS	0.333	2_SPINDLE	0.333	2_CYTOSKELETON	0.333	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.333	2_INTRACELLULAR_ORGANELLE_PART	0.333	2_CHROMOSOMAL_PART	0.333	2_CHROMOSOME	0.333	2_M_PHASE	0.333	2_MICROTUBULE_CYTOSKELETON_ORGANIZATION_AND_BIOGENESIS	0.333	
CEP63	3	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	2_EXTRACELLULAR_MATRIX_PART	0.667	2_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_COLLAGEN	0.667	2_CHROMOSOME	0.667	2_DNA_METABOLIC_PROCESS	0.667	2_CELL_CYCLE_GO_0007049	0.667	2_REGULATION_OF_CELL_CYCLE	0.667	0_HALLMARK_APOPTOSIS	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	0_HALLMARK_KRAS_SIGNALING_UP	0.333	1_KEGG_MISMATCH_REPAIR	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	1_KEGG_ALLOGRAFT_REJECTION	0.333	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.333	
CEP70	2	
CHEK1	4	0_HALLMARK_E2F_TARGETS	0.750	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.750	2_EXTRACELLULAR_MATRIX_PART	0.750	2_EXTRACELLULAR_MATRIX	0.750	2_COLLAGEN	0.750	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.750	2_CELL_CYCLE_GO_0007049	0.750	2_REGULATION_OF_CELL_CYCLE	0.750	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	2_REGULATION_OF_KINASE_ACTIVITY	0.500	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	0.500	2_REGULATION_OF_TRANSFERASE_ACTIVITY	0.500	2_CELL_CYCLE_PROCESS	0.500	2_CELL_CYCLE_PHASE	0.500	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	0_HALLMARK_APOPTOSIS	0.250	
CHEK2	4	1_KEGG_CELL_CYCLE	1.000	0_HALLMARK_E2F_TARGETS	0.750	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.750	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.750	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.750	1_KEGG_LEISHMANIA_INFECTION	0.750	1_KEGG_ASTHMA	0.750	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.750	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.750	1_KEGG_ALLOGRAFT_REJECTION	0.750	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.750	1_KEGG_VIRAL_MYOCARDITIS	0.750	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	0_HALLMARK_G2M_CHECKPOINT	0.250	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.250	0_HALLMARK_UV_RESPONSE_DN	0.250	0_HALLMARK_ALLOGRAFT_REJECTION	0.250	1_KEGG_DNA_REPLICATION	0.250	1_KEGG_GLIOMA	0.250	
CHL1	5	0_HALLMARK_E2F_TARGETS	0.400	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.400	1_KEGG_CELL_CYCLE	0.400	1_KEGG_P53_SIGNALING_PATHWAY	0.400	1_KEGG_ECM_RECEPTOR_INTERACTION	0.400	1_KEGG_PATHWAYS_IN_CANCER	0.400	1_KEGG_GLIOMA	0.400	2_GABA_RECEPTOR_ACTIVITY	0.400	0_HALLMARK_G2M_CHECKPOINT	0.200	0_HALLMARK_P53_PATHWAY	0.200	1_KEGG_DNA_REPLICATION	0.200	1_KEGG_FOCAL_ADHESION	0.200	1_KEGG_LONG_TERM_POTENTIATION	0.200	1_KEGG_COLORECTAL_CANCER	0.200	1_KEGG_ENDOMETRIAL_CANCER	0.200	1_KEGG_PROSTATE_CANCER	0.200	1_KEGG_MELANOMA	0.200	1_KEGG_BLADDER_CANCER	0.200	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	0.200	1_KEGG_SMALL_CELL_LUNG_CANCER	0.200	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	0.200	2_ORGANELLE_PART	0.200	2_AXON	0.200	2_INTERMEDIATE_FILAMENT_CYTOSKELETON	0.200	2_NON_MEMBRANE_BOUND_ORGANELLE	0.200	
CHP2	2	0_HALLMARK_HYPOXIA	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_MELANOMA	0.500	2_EXTRACELLULAR_REGION_PART	0.500	2_CELL_DEVELOPMENT	0.500	2_CELL_CELL_SIGNALING	0.500	2_SYNAPTIC_TRANSMISSION	0.500	2_CELL_PROLIFERATION_GO_0008283	0.500	2_KINASE_REGULATOR_ACTIVITY	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	
CIITA	1	
CLSPN	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_MELANOMA	1.000	1_KEGG_BLADDER_CANCER	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
CNKSR2	2	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_ASTHMA	0.500	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.500	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.500	1_KEGG_VIRAL_MYOCARDITIS	0.500	2_CELL_CELL_SIGNALING	0.500	2_SYNAPTIC_TRANSMISSION	0.500	2_TRANSMISSION_OF_NERVE_IMPULSE	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	
CNOT2	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.750	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.750	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.750	1_KEGG_LEISHMANIA_INFECTION	0.750	1_KEGG_BLADDER_CANCER	0.750	1_KEGG_ASTHMA	0.750	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.750	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.750	1_KEGG_ALLOGRAFT_REJECTION	0.750	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.750	1_KEGG_VIRAL_MYOCARDITIS	0.750	2_CELL_CELL_SIGNALING	0.750	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_MELANOMA	0.500	2_SYNAPTIC_TRANSMISSION	0.500	2_TRANSMISSION_OF_NERVE_IMPULSE	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.250	0_HALLMARK_HYPOXIA	0.250	
CNTN1	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_ALLOGRAFT_REJECTION	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.500	1_KEGG_MISMATCH_REPAIR	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	0.500	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_ASTHMA	0.500	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.500	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.500	1_KEGG_VIRAL_MYOCARDITIS	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	
CNTN2	6	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	0_HALLMARK_ANGIOGENESIS	0.833	1_KEGG_CELL_CYCLE	0.833	2_REGULATION_OF_PHOSPHORYLATION	0.833	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	2_COLLAGEN	0.667	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.667	2_CELL_CYCLE_GO_0007049	0.667	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_APOPTOSIS	0.333	0_HALLMARK_KRAS_SIGNALING_UP	0.333	1_KEGG_PATHWAYS_IN_CANCER	0.333	1_KEGG_SMALL_CELL_LUNG_CANCER	0.333	1_KEGG_ASTHMA	0.333	2_EXTRACELLULAR_REGION	0.333	2_NON_MEMBRANE_BOUND_ORGANELLE	0.333	
CNTNAP1	2	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_ASTHMA	0.500	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.500	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.500	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.500	1_KEGG_VIRAL_MYOCARDITIS	0.500	2_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON	0.500	
COL11A2	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_CYCLE	0.750	1_KEGG_FOCAL_ADHESION	0.750	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	1_KEGG_ASTHMA	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.250	0_HALLMARK_ANGIOGENESIS	0.250	0_HALLMARK_COAGULATION	0.250	0_HALLMARK_KRAS_SIGNALING_UP	0.250	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.250	1_KEGG_MISMATCH_REPAIR	0.250	1_KEGG_LEISHMANIA_INFECTION	0.250	1_KEGG_PATHWAYS_IN_CANCER	0.250	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.250	2_EXTRACELLULAR_MATRIX_PART	0.250	2_AXON	0.250	2_CYTOSKELETON	0.250	
COL14A1	5	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_COLLAGEN	1.000	0_HALLMARK_ANGIOGENESIS	0.800	2_EXTRACELLULAR_MATRIX_PART	0.800	0_HALLMARK_G2M_CHECKPOINT	0.600	0_HALLMARK_E2F_TARGETS	0.600	0_HALLMARK_UV_RESPONSE_DN	0.600	1_KEGG_CELL_CYCLE	0.600	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.600	2_EXTRACELLULAR_MATRIX	0.600	2_GABA_RECEPTOR_ACTIVITY	0.600	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.400	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.400	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.400	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.400	1_KEGG_MELANOMA	0.400	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.400	1_KEGG_ALLOGRAFT_REJECTION	0.400	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.400	2_EXTRACELLULAR_REGION	0.400	2_EXTRACELLULAR_REGION_PART	0.400	2_CELL_CYCLE_PROCESS	0.400	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.400	
COL1A1	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_G2M_CHECKPOINT	0.750	0_HALLMARK_E2F_TARGETS	0.750	0_HALLMARK_UV_RESPONSE_DN	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_P53_SIGNALING_PATHWAY	0.750	1_KEGG_MELANOMA	0.750	2_COLLAGEN	0.750	2_REGULATION_OF_PHOSPHORYLATION	0.750	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_EXTRACELLULAR_MATRIX	0.500	0_HALLMARK_APOPTOSIS	0.250	0_HALLMARK_APICAL_JUNCTION	0.250	0_HALLMARK_COAGULATION	0.250	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.250	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.250	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.250	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	0.250	1_KEGG_GLIOMA	0.250	
COL1A2	14	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.857	1_KEGG_CELL_CYCLE	0.786	1_KEGG_ECM_RECEPTOR_INTERACTION	0.786	0_HALLMARK_E2F_TARGETS	0.714	1_KEGG_FOCAL_ADHESION	0.714	0_HALLMARK_G2M_CHECKPOINT	0.643	2_EXTRACELLULAR_MATRIX_PART	0.571	2_COLLAGEN	0.571	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_MELANOMA	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_CELL_CYCLE_GO_0007049	0.500	0_HALLMARK_UV_RESPONSE_DN	0.429	1_KEGG_DNA_REPLICATION	0.429	1_KEGG_PATHWAYS_IN_CANCER	0.429	1_KEGG_P53_SIGNALING_PATHWAY	0.357	1_KEGG_SMALL_CELL_LUNG_CANCER	0.357	2_EXTRACELLULAR_REGION_PART	0.357	2_CELL_PROLIFERATION_GO_0008283	0.357	2_GABA_RECEPTOR_ACTIVITY	0.357	2_REGULATION_OF_PHOSPHORYLATION	0.286	2_CELL_CELL_SIGNALING	0.286	0_HALLMARK_HYPOXIA	0.214	0_HALLMARK_APOPTOSIS	0.214	
COL2A1	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	0_HALLMARK_ANGIOGENESIS	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.667	2_EXTRACELLULAR_MATRIX_PART	0.667	2_EXTRACELLULAR_REGION	0.667	2_EXTRACELLULAR_REGION_PART	0.667	2_EXTRACELLULAR_MATRIX	0.667	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.333	0_HALLMARK_HYPOXIA	0.333	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	0.333	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_APOPTOSIS	0.333	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.333	0_HALLMARK_APICAL_JUNCTION	0.333	0_HALLMARK_COMPLEMENT	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	0_HALLMARK_INFLAMMATORY_RESPONSE	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	0_HALLMARK_COAGULATION	0.333	0_HALLMARK_ALLOGRAFT_REJECTION	0.333	0_HALLMARK_KRAS_SIGNALING_UP	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_CELL_CYCLE	0.333	
COL4A1	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_UV_RESPONSE_DN	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_MELANOMA	0.667	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.667	2_EXTRACELLULAR_MATRIX_PART	0.667	2_EXTRACELLULAR_MATRIX	0.667	2_COLLAGEN	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_APICAL_JUNCTION	0.333	0_HALLMARK_ANGIOGENESIS	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	1_KEGG_BLADDER_CANCER	0.333	2_EXTRACELLULAR_REGION_PART	0.333	2_REGULATION_OF_PHOSPHORYLATION	0.333	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.333	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	0.333	2_ENZYME_INHIBITOR_ACTIVITY	0.333	
COL4A3	1	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1.000	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_LEISHMANIA_INFECTION	1.000	1_KEGG_MELANOMA	1.000	1_KEGG_BLADDER_CANCER	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	1.000	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	1.000	1_KEGG_VIRAL_MYOCARDITIS	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
COL4A5	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_COLLAGEN	0.500	2_CELL_CYCLE_GO_0007049	0.500	0_HALLMARK_APOPTOSIS	0.250	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.250	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.250	0_HALLMARK_ALLOGRAFT_REJECTION	0.250	1_KEGG_DNA_REPLICATION	0.250	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.250	1_KEGG_MISMATCH_REPAIR	0.250	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.250	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.250	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	0.250	
COL5A2	2	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_COLLAGEN	0.500	2_REGULATION_OF_PHOSPHORYLATION	0.500	2_CELL_CELL_SIGNALING	0.500	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.500	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.500	2_SYNAPTIC_TRANSMISSION	0.500	2_CELL_CYCLE_GO_0007049	0.500	2_TRANSMISSION_OF_NERVE_IMPULSE	0.500	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	
COL6A1	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_COLLAGEN	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_BLADDER_CANCER	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	2_EXTRACELLULAR_REGION	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_NUCLEUS	0.500	2_EXTRACELLULAR_REGION_PART	0.500	2_REPLICATION_FORK	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	
COL6A2	9	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.889	1_KEGG_FOCAL_ADHESION	0.889	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_G2M_CHECKPOINT	0.556	0_HALLMARK_E2F_TARGETS	0.556	1_KEGG_CELL_CYCLE	0.556	1_KEGG_MELANOMA	0.556	1_KEGG_P53_SIGNALING_PATHWAY	0.444	2_EXTRACELLULAR_MATRIX_PART	0.444	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.333	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	1_KEGG_LEISHMANIA_INFECTION	0.333	1_KEGG_ASTHMA	0.333	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.333	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.333	1_KEGG_ALLOGRAFT_REJECTION	0.333	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.333	1_KEGG_VIRAL_MYOCARDITIS	0.333	2_COLLAGEN	0.333	2_CELL_CELL_SIGNALING	0.333	0_HALLMARK_COMPLEMENT	0.222	
COL6A3	11	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.909	1_KEGG_ECM_RECEPTOR_INTERACTION	0.909	2_GABA_RECEPTOR_ACTIVITY	0.818	1_KEGG_FOCAL_ADHESION	0.727	2_COLLAGEN	0.727	0_HALLMARK_E2F_TARGETS	0.545	1_KEGG_CELL_CYCLE	0.545	2_EXTRACELLULAR_MATRIX_PART	0.545	2_CELL_CELL_SIGNALING	0.545	0_HALLMARK_G2M_CHECKPOINT	0.455	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.455	2_EXTRACELLULAR_MATRIX	0.455	0_HALLMARK_UV_RESPONSE_DN	0.364	0_HALLMARK_ANGIOGENESIS	0.364	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.364	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.364	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.364	1_KEGG_MELANOMA	0.364	1_KEGG_ASTHMA	0.364	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.364	1_KEGG_ALLOGRAFT_REJECTION	0.364	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.364	1_KEGG_P53_SIGNALING_PATHWAY	0.273	1_KEGG_SMALL_CELL_LUNG_CANCER	0.273	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.273	
CREBBP	5	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.800	1_KEGG_CELL_CYCLE	0.600	2_REGULATION_OF_PHOSPHORYLATION	0.600	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.600	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	0.600	0_HALLMARK_G2M_CHECKPOINT	0.400	0_HALLMARK_E2F_TARGETS	0.400	0_HALLMARK_ANGIOGENESIS	0.400	1_KEGG_P53_SIGNALING_PATHWAY	0.400	1_KEGG_FOCAL_ADHESION	0.400	1_KEGG_ECM_RECEPTOR_INTERACTION	0.400	1_KEGG_PATHWAYS_IN_CANCER	0.400	2_EXTRACELLULAR_MATRIX_PART	0.400	2_CELL_CELL_SIGNALING	0.400	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.400	2_CELL_CYCLE_GO_0007049	0.400	2_REGULATION_OF_CELL_CYCLE	0.400	2_GABA_RECEPTOR_ACTIVITY	0.400	0_HALLMARK_APOPTOSIS	0.200	0_HALLMARK_UV_RESPONSE_DN	0.200	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.200	1_KEGG_ENDOMETRIAL_CANCER	0.200	1_KEGG_GLIOMA	0.200	1_KEGG_THYROID_CANCER	0.200	1_KEGG_MELANOMA	0.200	
CRKL	2	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_MELANOMA	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_ALLOGRAFT_REJECTION	0.500	1_KEGG_OOCYTE_MEIOSIS	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	1_KEGG_GLIOMA	0.500	1_KEGG_PROSTATE_CANCER	0.500	1_KEGG_BLADDER_CANCER	0.500	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	1_KEGG_ASTHMA	0.500	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.500	
CSNK1G1	1	
CSNK2B	3	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_MYC_TARGETS_V1	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	2_INTERPHASE	0.667	2_CELL_CYCLE_PROCESS	0.667	2_MITOTIC_CELL_CYCLE	0.667	2_CELL_CYCLE_PHASE	0.667	2_CELL_CYCLE_GO_0007049	0.667	2_REGULATION_OF_CELL_CYCLE	0.667	0_HALLMARK_APOPTOSIS	0.333	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	0_HALLMARK_KRAS_SIGNALING_UP	0.333	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_ECM_RECEPTOR_INTERACTION	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	1_KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	0.333	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	1_KEGG_ALLOGRAFT_REJECTION	0.333	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.333	2_EXTRACELLULAR_MATRIX_PART	0.333	2_NUCLEAR_CHROMOSOME	0.333	
CTBP1	1	
CTDSP2	6	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.833	1_KEGG_ECM_RECEPTOR_INTERACTION	0.833	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_BLADDER_CANCER	0.667	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_DNA_REPLICATION	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_EXTRACELLULAR_MATRIX	0.500	0_HALLMARK_UV_RESPONSE_DN	0.333	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.333	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.333	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	1_KEGG_LEISHMANIA_INFECTION	0.333	1_KEGG_PATHWAYS_IN_CANCER	0.333	1_KEGG_MELANOMA	0.333	1_KEGG_SMALL_CELL_LUNG_CANCER	0.333	1_KEGG_ASTHMA	0.333	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.333	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.333	1_KEGG_ALLOGRAFT_REJECTION	0.333	
CTNNA2	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_ANGIOGENESIS	0.333	1_KEGG_CELL_CYCLE	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.333	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	1_KEGG_PATHWAYS_IN_CANCER	0.333	1_KEGG_ASTHMA	0.333	1_KEGG_ALLOGRAFT_REJECTION	0.333	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.333	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.333	2_EXTRACELLULAR_MATRIX_PART	0.333	2_EXTRACELLULAR_REGION	0.333	2_EXTRACELLULAR_REGION_PART	0.333	2_EXTRACELLULAR_MATRIX	0.333	2_COLLAGEN	0.333	2_CELL_CELL_SIGNALING	0.333	
CTNNB1	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_MELANOMA	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_COLLAGEN	0.500	2_REGULATION_OF_PHOSPHORYLATION	0.500	2_CELL_CELL_SIGNALING	0.500	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.500	2_SYNAPTIC_TRANSMISSION	0.500	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.500	2_TRANSMISSION_OF_NERVE_IMPULSE	0.500	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	0.500	2_ENZYME_INHIBITOR_ACTIVITY	0.500	
CUBN	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_COAGULATION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_HYPOXIA	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_AXON	0.500	2_EXTRACELLULAR_REGION	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_CYTOSKELETON	0.500	2_EXTRACELLULAR_REGION_PART	0.500	2_CELL_PROJECTION	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_COLLAGEN	0.500	
CUGBP2	1	
DACH1	1	
DBF4	3	1_KEGG_CELL_CYCLE	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_MELANOMA	0.667	1_KEGG_SMALL_CELL_LUNG_CANCER	0.667	2_CELL_PROLIFERATION_GO_0008283	0.667	2_CELL_CYCLE_GO_0007049	0.667	0_HALLMARK_APOPTOSIS	0.333	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.333	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.333	0_HALLMARK_COMPLEMENT	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	0_HALLMARK_ANGIOGENESIS	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.333	1_KEGG_MISMATCH_REPAIR	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.333	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.333	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	
DBNL	4	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	2_MICROTUBULE_CYTOSKELETON	0.500	2_CELL_CYCLE_GO_0007049	0.500	2_REGULATION_OF_CELL_CYCLE	0.500	0_HALLMARK_APOPTOSIS	0.250	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.250	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.250	0_HALLMARK_MYC_TARGETS_V1	0.250	1_KEGG_DNA_REPLICATION	0.250	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.250	1_KEGG_MISMATCH_REPAIR	0.250	1_KEGG_FOCAL_ADHESION	0.250	1_KEGG_ECM_RECEPTOR_INTERACTION	0.250	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.250	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.250	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.250	1_KEGG_PATHWAYS_IN_CANCER	0.250	1_KEGG_MELANOMA	0.250	1_KEGG_SMALL_CELL_LUNG_CANCER	0.250	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.250	1_KEGG_ALLOGRAFT_REJECTION	0.250	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.250	
DCHS1	2	
DCHS2	5	
DCTN2	20	0_HALLMARK_E2F_TARGETS	0.650	1_KEGG_CELL_CYCLE	0.650	0_HALLMARK_G2M_CHECKPOINT	0.600	2_NON_MEMBRANE_BOUND_ORGANELLE	0.600	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.600	2_CELL_CYCLE_GO_0007049	0.600	1_KEGG_P53_SIGNALING_PATHWAY	0.550	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	2_REGULATION_OF_CELL_CYCLE	0.500	2_MICROTUBULE_CYTOSKELETON	0.450	2_CHROMOSOME	0.450	2_CHROMOSOMAL_PART	0.400	2_CELL_CYCLE_PHASE	0.400	2_CELL_PROLIFERATION_GO_0008283	0.400	1_KEGG_FOCAL_ADHESION	0.350	1_KEGG_ECM_RECEPTOR_INTERACTION	0.350	1_KEGG_BLADDER_CANCER	0.350	1_KEGG_ASTHMA	0.350	2_CELL_CYCLE_PROCESS	0.350	2_MITOTIC_CELL_CYCLE	0.350	0_HALLMARK_UV_RESPONSE_DN	0.300	1_KEGG_DNA_REPLICATION	0.300	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.300	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.300	1_KEGG_LEISHMANIA_INFECTION	0.300	
DDB1	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	2_NUCLEAR_REPLICATION_FORK	1.000	2_NUCLEAR_CHROMOSOME	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_REPLICATION_FORK	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_CHROMOSOMAL_PART	1.000	2_CHROMOSOME	1.000	2_NUCLEAR_CHROMOSOME_PART	1.000	2_DNA_METABOLIC_PROCESS	1.000	2_DNA_REPLICATION	1.000	2_CELL_CYCLE_GO_0007049	1.000	
DDIT3	6	1_KEGG_P53_SIGNALING_PATHWAY	0.667	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_BLADDER_CANCER	0.500	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.333	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.333	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	1_KEGG_LEISHMANIA_INFECTION	0.333	1_KEGG_PATHWAYS_IN_CANCER	0.333	1_KEGG_GLIOMA	0.333	1_KEGG_MELANOMA	0.333	1_KEGG_SMALL_CELL_LUNG_CANCER	0.333	1_KEGG_ASTHMA	0.333	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.333	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.333	1_KEGG_ALLOGRAFT_REJECTION	0.333	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.333	1_KEGG_VIRAL_MYOCARDITIS	0.333	2_CHROMOSOME	0.333	
DFFB	3	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_MELANOMA	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.667	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.667	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.667	1_KEGG_SMALL_CELL_LUNG_CANCER	0.667	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.667	1_KEGG_ALLOGRAFT_REJECTION	0.667	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.667	1_KEGG_VIRAL_MYOCARDITIS	0.667	2_MICROTUBULE_CYTOSKELETON	0.667	2_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_CHROMOSOMAL_PART	0.667	2_CHROMOSOME	0.667	2_INTERPHASE	0.667	2_CELL_CYCLE_PROCESS	0.667	
DLG1	1	2_PHOSPHOTRANSFERASE_ACTIVITY_PHOSPHATE_GROUP_AS_ACCEPTOR	1.000	2_NUCLEOTIDE_KINASE_ACTIVITY	1.000	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_KINASE_ACTIVITY	1.000	
DLG4	2	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_KRAS_SIGNALING_UP	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	1_KEGG_BLADDER_CANCER	0.500	1_KEGG_ASTHMA	0.500	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.500	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.500	1_KEGG_VIRAL_MYOCARDITIS	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	
DMD	9	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	0.889	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.778	2_EXTRACELLULAR_MATRIX_PART	0.778	2_EXTRACELLULAR_MATRIX	0.778	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_CELL_CYCLE	0.667	0_HALLMARK_ANGIOGENESIS	0.556	1_KEGG_P53_SIGNALING_PATHWAY	0.444	2_EXTRACELLULAR_REGION	0.444	2_EXTRACELLULAR_REGION_PART	0.444	2_COLLAGEN	0.444	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.333	0_HALLMARK_COMPLEMENT	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	0_HALLMARK_ALLOGRAFT_REJECTION	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.333	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.333	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	1_KEGG_LEISHMANIA_INFECTION	0.333	1_KEGG_ASTHMA	0.333	1_KEGG_ALLOGRAFT_REJECTION	0.333	
DNAH9	9	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.556	2_EXTRACELLULAR_MATRIX_PART	0.556	2_EXTRACELLULAR_MATRIX	0.556	2_COLLAGEN	0.556	0_HALLMARK_E2F_TARGETS	0.444	1_KEGG_CELL_CYCLE	0.444	1_KEGG_PATHWAYS_IN_CANCER	0.444	1_KEGG_MELANOMA	0.444	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_ANGIOGENESIS	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	2_NON_MEMBRANE_BOUND_ORGANELLE	0.333	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.333	1_KEGG_DNA_REPLICATION	0.222	1_KEGG_PANCREATIC_CANCER	0.222	1_KEGG_ENDOMETRIAL_CANCER	0.222	1_KEGG_GLIOMA	0.222	1_KEGG_PROSTATE_CANCER	0.222	1_KEGG_BLADDER_CANCER	0.222	1_KEGG_SMALL_CELL_LUNG_CANCER	0.222	2_EXTRACELLULAR_REGION_PART	0.222	2_CELL_CELL_SIGNALING	0.222	
DNMBP	6	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	0.833	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_ASTHMA	0.500	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.500	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	0_HALLMARK_ANGIOGENESIS	0.333	0_HALLMARK_COAGULATION	0.333	0_HALLMARK_ALLOGRAFT_REJECTION	0.333	0_HALLMARK_KRAS_SIGNALING_UP	0.333	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	0.333	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.333	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	1_KEGG_PATHWAYS_IN_CANCER	0.333	1_KEGG_GLIOMA	0.333	1_KEGG_BLADDER_CANCER	0.333	1_KEGG_SMALL_CELL_LUNG_CANCER	0.333	
DNMT1	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	1.000	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_ASTHMA	0.500	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.500	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.500	1_KEGG_VIRAL_MYOCARDITIS	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_REGULATION_OF_PHOSPHORYLATION	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	
DOCK1	1	2_PHAGOCYTOSIS	1.000	
DOCK2	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	0_HALLMARK_UV_RESPONSE_DN	0.750	0_HALLMARK_ANGIOGENESIS	0.750	1_KEGG_FOCAL_ADHESION	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	1_KEGG_MELANOMA	0.750	2_EXTRACELLULAR_MATRIX_PART	0.750	2_COLLAGEN	0.750	2_ENZYME_REGULATOR_ACTIVITY	0.750	1_KEGG_CELL_CYCLE	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_ASTHMA	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_CELL_CELL_SIGNALING	0.500	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.500	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.250	0_HALLMARK_COAGULATION	0.250	0_HALLMARK_KRAS_SIGNALING_UP	0.250	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	0.250	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.250	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.250	1_KEGG_LEISHMANIA_INFECTION	0.250	
DRD5	9	2_GABA_RECEPTOR_ACTIVITY	0.889	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	0_HALLMARK_G2M_CHECKPOINT	0.556	0_HALLMARK_E2F_TARGETS	0.556	1_KEGG_CELL_CYCLE	0.556	1_KEGG_FOCAL_ADHESION	0.444	2_CELL_CELL_SIGNALING	0.444	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.444	2_CELL_CYCLE_GO_0007049	0.444	0_HALLMARK_UV_RESPONSE_DN	0.333	0_HALLMARK_ANGIOGENESIS	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	2_EXTRACELLULAR_MATRIX_PART	0.333	2_COLLAGEN	0.333	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.333	2_SYNAPTIC_TRANSMISSION	0.333	2_TRANSMISSION_OF_NERVE_IMPULSE	0.333	2_REGULATION_OF_CELL_CYCLE	0.333	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	0.222	1_KEGG_PATHWAYS_IN_CANCER	0.222	1_KEGG_MELANOMA	0.222	1_KEGG_SMALL_CELL_LUNG_CANCER	0.222	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.222	2_EXTRACELLULAR_MATRIX	0.222	
DSP	4	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_CELL_CYCLE_GO_0007049	1.000	1_KEGG_DNA_REPLICATION	0.750	1_KEGG_P53_SIGNALING_PATHWAY	0.750	2_CYTOSKELETON	0.750	2_DNA_REPLICATION	0.750	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	1_KEGG_ASTHMA	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_CHROMOSOME	0.500	2_DNA_METABOLIC_PROCESS	0.500	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.500	2_REGULATION_OF_CELL_CYCLE	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.250	0_HALLMARK_APICAL_JUNCTION	0.250	
DYRK1B	1	
E2F4	1	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	1.000	0_HALLMARK_HYPOXIA	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	1.000	0_HALLMARK_COMPLEMENT	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_INFLAMMATORY_RESPONSE	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ANGIOGENESIS	1.000	0_HALLMARK_COAGULATION	1.000	0_HALLMARK_ALLOGRAFT_REJECTION	1.000	0_HALLMARK_KRAS_SIGNALING_UP	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	1.000	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1.000	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_LEISHMANIA_INFECTION	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	1.000	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	1.000	
EEF1A1	3	
EGF	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_MELANOMA	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.333	0_HALLMARK_COMPLEMENT	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	0_HALLMARK_COAGULATION	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	0.333	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.333	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	1_KEGG_LEISHMANIA_INFECTION	0.333	1_KEGG_ENDOMETRIAL_CANCER	0.333	1_KEGG_GLIOMA	0.333	1_KEGG_BLADDER_CANCER	0.333	1_KEGG_SMALL_CELL_LUNG_CANCER	0.333	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	0.333	
EGFR	129	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.822	1_KEGG_ECM_RECEPTOR_INTERACTION	0.721	1_KEGG_FOCAL_ADHESION	0.713	2_GABA_RECEPTOR_ACTIVITY	0.620	1_KEGG_CELL_CYCLE	0.566	0_HALLMARK_E2F_TARGETS	0.504	2_CELL_CELL_SIGNALING	0.450	1_KEGG_MELANOMA	0.442	0_HALLMARK_G2M_CHECKPOINT	0.411	0_HALLMARK_ANGIOGENESIS	0.380	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.372	2_EXTRACELLULAR_MATRIX	0.364	1_KEGG_P53_SIGNALING_PATHWAY	0.357	2_EXTRACELLULAR_MATRIX_PART	0.357	2_COLLAGEN	0.349	2_CELL_CYCLE_GO_0007049	0.333	2_SYNAPTIC_TRANSMISSION	0.295	0_HALLMARK_UV_RESPONSE_DN	0.279	1_KEGG_PATHWAYS_IN_CANCER	0.271	2_REGULATION_OF_PHOSPHORYLATION	0.256	2_TRANSMISSION_OF_NERVE_IMPULSE	0.256	1_KEGG_ASTHMA	0.240	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.225	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.225	1_KEGG_ALLOGRAFT_REJECTION	0.225	
EGR1	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_MELANOMA	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.667	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_BLADDER_CANCER	0.667	0_HALLMARK_HYPOXIA	0.333	0_HALLMARK_APOPTOSIS	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.333	1_KEGG_PANCREATIC_CANCER	0.333	1_KEGG_SMALL_CELL_LUNG_CANCER	0.333	2_EXTRACELLULAR_REGION	0.333	2_NON_MEMBRANE_BOUND_ORGANELLE	0.333	
EIF4A1	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	1.000	1_KEGG_PANCREATIC_CANCER	1.000	1_KEGG_GLIOMA	1.000	1_KEGG_MELANOMA	1.000	1_KEGG_BLADDER_CANCER	1.000	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	1.000	2_AXON	1.000	2_NEURON_PROJECTION	1.000	2_CELL_CELL_SIGNALING	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
ELAVL1	1	
ELAVL2	29	2_MRNA_BINDING	1.000	
EP300	3	2_GABA_RECEPTOR_ACTIVITY	1.000	1_KEGG_CELL_CYCLE	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	2_CELL_CELL_SIGNALING	0.667	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_APOPTOSIS	0.333	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.333	0_HALLMARK_COMPLEMENT	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	0_HALLMARK_COAGULATION	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	0.333	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.333	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.333	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	1_KEGG_LEISHMANIA_INFECTION	0.333	1_KEGG_COLORECTAL_CANCER	0.333	1_KEGG_ENDOMETRIAL_CANCER	0.333	1_KEGG_GLIOMA	0.333	1_KEGG_PROSTATE_CANCER	0.333	1_KEGG_MELANOMA	0.333	
EPC1	6	0_HALLMARK_G2M_CHECKPOINT	0.833	0_HALLMARK_E2F_TARGETS	0.833	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.833	1_KEGG_CELL_CYCLE	0.833	1_KEGG_P53_SIGNALING_PATHWAY	0.833	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_BLADDER_CANCER	0.667	2_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_CHROMOSOMAL_PART	0.667	2_CHROMOSOME	0.667	2_CELL_CYCLE_GO_0007049	0.667	1_KEGG_GLIOMA	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	2_MICROTUBULE_CYTOSKELETON	0.500	2_SPINDLE	0.500	2_M_PHASE	0.500	2_CELL_CYCLE_PROCESS	0.500	2_MITOTIC_CELL_CYCLE	0.500	2_CELL_CYCLE_PHASE	0.500	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.500	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.500	
EPHA1	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.500	1_KEGG_MISMATCH_REPAIR	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_AXON_GUIDANCE	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.500	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.500	1_KEGG_VIRAL_MYOCARDITIS	0.500	2_ORGANELLE_PART	0.500	2_MICROTUBULE_CYTOSKELETON	0.500	
EPS8	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_LEISHMANIA_INFECTION	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_REGION_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_COLLAGEN	1.000	
ERBB2	7	0_HALLMARK_UV_RESPONSE_DN	0.857	1_KEGG_FOCAL_ADHESION	0.857	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.714	1_KEGG_ECM_RECEPTOR_INTERACTION	0.714	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.714	2_EXTRACELLULAR_MATRIX	0.714	2_EXTRACELLULAR_MATRIX_PART	0.571	2_COLLAGEN	0.571	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.571	0_HALLMARK_ANGIOGENESIS	0.429	2_EXTRACELLULAR_REGION	0.429	2_EXTRACELLULAR_REGION_PART	0.429	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	0.429	2_GABA_RECEPTOR_ACTIVITY	0.429	1_KEGG_CELL_CYCLE	0.286	2_SYSTEM_DEVELOPMENT	0.286	2_ORGAN_DEVELOPMENT	0.286	2_TRANSMISSION_OF_NERVE_IMPULSE	0.286	0_HALLMARK_HYPOXIA	0.143	0_HALLMARK_G2M_CHECKPOINT	0.143	0_HALLMARK_APOPTOSIS	0.143	0_HALLMARK_COMPLEMENT	0.143	0_HALLMARK_E2F_TARGETS	0.143	0_HALLMARK_MYC_TARGETS_V1	0.143	0_HALLMARK_P53_PATHWAY	0.143	
ERBB4	1	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1.000	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_LEISHMANIA_INFECTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	1.000	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	1.000	1_KEGG_VIRAL_MYOCARDITIS	1.000	2_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON	1.000	
ERCC6L	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_EXTRACELLULAR_REGION_PART	0.500	2_REPLICATION_FORK	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_CHROMOSOMAL_PART	0.500	2_COLLAGEN	0.500	2_CHROMOSOME	0.500	2_REGULATION_OF_PHOSPHORYLATION	0.500	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.500	2_DNA_REPLICATION	0.500	2_CELL_CYCLE_GO_0007049	0.500	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	0.500	
ERG	4	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	1_KEGG_DNA_REPLICATION	0.750	2_NON_MEMBRANE_BOUND_ORGANELLE	0.750	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.750	2_DNA_METABOLIC_PROCESS	0.750	2_REGULATION_OF_PHOSPHORYLATION	0.750	2_CELL_CYCLE_GO_0007049	0.750	2_GABA_RECEPTOR_ACTIVITY	0.750	0_HALLMARK_MYC_TARGETS_V1	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_ASTHMA	0.500	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.500	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.500	1_KEGG_VIRAL_MYOCARDITIS	0.500	2_NUCLEUS	0.500	2_CELL_CYCLE_PROCESS	0.500	
ESR1	1	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	1.000	0_HALLMARK_HYPOXIA	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	1.000	0_HALLMARK_COMPLEMENT	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_INFLAMMATORY_RESPONSE	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ANGIOGENESIS	1.000	0_HALLMARK_COAGULATION	1.000	0_HALLMARK_ALLOGRAFT_REJECTION	1.000	0_HALLMARK_KRAS_SIGNALING_UP	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	1.000	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1.000	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_LEISHMANIA_INFECTION	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	1.000	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	1.000	
ETS2	1	0_HALLMARK_MITOTIC_SPINDLE	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_NUCLEUS	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_CHROMOSOMAL_PART	1.000	2_CHROMOSOME	1.000	2_DNA_METABOLIC_PROCESS	1.000	2_M_PHASE	1.000	2_INTERPHASE	1.000	2_CELL_CYCLE_PROCESS	1.000	2_MITOTIC_CELL_CYCLE	1.000	2_REGULATION_OF_PHOSPHORYLATION	1.000	2_CELL_CYCLE_PHASE	1.000	2_CELL_CYCLE_CHECKPOINT_GO_0000075	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	1.000	2_DNA_REPLICATION	1.000	2_CELL_PROLIFERATION_GO_0008283	1.000	
EZH2	4	0_HALLMARK_G2M_CHECKPOINT	0.750	0_HALLMARK_E2F_TARGETS	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_FOCAL_ADHESION	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	1_KEGG_PATHWAYS_IN_CANCER	0.750	1_KEGG_MELANOMA	0.750	2_CELL_CYCLE_GO_0007049	0.750	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_COLLAGEN	0.500	2_CHROMOSOME	0.500	2_DNA_METABOLIC_PROCESS	0.500	2_INTERPHASE	0.500	2_CELL_CYCLE_PROCESS	0.500	2_CELL_CYCLE_PHASE	0.500	2_DNA_REPLICATION	0.500	2_CELL_PROLIFERATION_GO_0008283	0.500	
EZR	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_EXTRACELLULAR_MATRIX	0.500	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.250	0_HALLMARK_G2M_CHECKPOINT	0.250	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.250	0_HALLMARK_COMPLEMENT	0.250	0_HALLMARK_MYC_TARGETS_V1	0.250	0_HALLMARK_COAGULATION	0.250	0_HALLMARK_ALLOGRAFT_REJECTION	0.250	1_KEGG_DNA_REPLICATION	0.250	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.250	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	0.250	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.250	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.250	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.250	
F10	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_REGION	1.000	2_EXTRACELLULAR_REGION_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_COLLAGEN	1.000	2_HEMOSTASIS	1.000	2_REGULATION_OF_BODY_FLUID_LEVELS	1.000	2_BLOOD_COAGULATION	1.000	2_WOUND_HEALING	1.000	2_COAGULATION	1.000	2_ORGAN_DEVELOPMENT	1.000	
F2	2	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	1.000	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	1.000	1_KEGG_VIRAL_MYOCARDITIS	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_COMPLEMENT	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	0_HALLMARK_COAGULATION	0.500	0_HALLMARK_ALLOGRAFT_REJECTION	0.500	0_HALLMARK_KRAS_SIGNALING_UP	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	
F8	5	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.600	1_KEGG_ECM_RECEPTOR_INTERACTION	0.600	2_CELL_CELL_SIGNALING	0.400	2_GABA_RECEPTOR_ACTIVITY	0.400	0_HALLMARK_COMPLEMENT	0.200	0_HALLMARK_E2F_TARGETS	0.200	0_HALLMARK_P53_PATHWAY	0.200	0_HALLMARK_UV_RESPONSE_DN	0.200	0_HALLMARK_COAGULATION	0.200	1_KEGG_DNA_REPLICATION	0.200	1_KEGG_CELL_CYCLE	0.200	1_KEGG_P53_SIGNALING_PATHWAY	0.200	1_KEGG_FOCAL_ADHESION	0.200	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	0.200	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.200	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.200	1_KEGG_LONG_TERM_POTENTIATION	0.200	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.200	1_KEGG_PATHWAYS_IN_CANCER	0.200	1_KEGG_GLIOMA	0.200	1_KEGG_ASTHMA	0.200	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.200	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.200	1_KEGG_ALLOGRAFT_REJECTION	0.200	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.200	
F9	3	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_APICAL_JUNCTION	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	0_HALLMARK_ANGIOGENESIS	0.333	0_HALLMARK_COAGULATION	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_CELL_CYCLE	0.333	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_ECM_RECEPTOR_INTERACTION	0.333	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.333	2_EXTRACELLULAR_MATRIX_PART	0.333	2_EXTRACELLULAR_REGION	0.333	2_NON_MEMBRANE_BOUND_ORGANELLE	0.333	2_CYTOSKELETON	0.333	2_EXTRACELLULAR_REGION_PART	0.333	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.333	2_EXTRACELLULAR_MATRIX	0.333	2_DNA_METABOLIC_PROCESS	0.333	2_HEMOSTASIS	0.333	2_REGULATION_OF_BODY_FLUID_LEVELS	0.333	2_BLOOD_COAGULATION	0.333	2_DNA_REPLICATION	0.333	2_WOUND_HEALING	0.333	
FAS	6	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_G2M_CHECKPOINT	0.833	0_HALLMARK_E2F_TARGETS	0.833	1_KEGG_CELL_CYCLE	0.833	1_KEGG_P53_SIGNALING_PATHWAY	0.833	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_BLADDER_CANCER	0.667	2_CELL_CYCLE_GO_0007049	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_UV_RESPONSE_DN	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_COLLAGEN	0.500	0_HALLMARK_HYPOXIA	0.333	0_HALLMARK_MITOTIC_SPINDLE	0.333	0_HALLMARK_ANGIOGENESIS	0.333	0_HALLMARK_COAGULATION	0.333	1_KEGG_GLIOMA	0.333	1_KEGG_SMALL_CELL_LUNG_CANCER	0.333	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.333	2_MICROTUBULE_CYTOSKELETON	0.333	2_CYTOSKELETAL_PART	0.333	
FAT2	9	
FBLN1	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_GLIOMA	0.667	1_KEGG_PROSTATE_CANCER	0.667	1_KEGG_MELANOMA	0.667	1_KEGG_BLADDER_CANCER	0.667	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	0.667	1_KEGG_SMALL_CELL_LUNG_CANCER	0.667	2_INTERPHASE	0.667	2_CELL_CYCLE_PROCESS	0.667	2_MITOTIC_CELL_CYCLE	0.667	2_CELL_CYCLE_PHASE	0.667	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.667	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.667	2_CELL_CYCLE_GO_0007049	0.667	2_REGULATION_OF_CELL_CYCLE	0.667	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	0.667	1_KEGG_OOCYTE_MEIOSIS	0.333	1_KEGG_COLORECTAL_CANCER	0.333	
FBLN2	6	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_CYCLE	0.833	1_KEGG_P53_SIGNALING_PATHWAY	0.833	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.833	2_EXTRACELLULAR_MATRIX	0.833	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.833	2_CELL_CYCLE_GO_0007049	0.833	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	0.833	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_ANGIOGENESIS	0.667	2_EXTRACELLULAR_MATRIX_PART	0.667	2_COLLAGEN	0.667	0_HALLMARK_UV_RESPONSE_DN	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	2_REGULATION_OF_PHOSPHORYLATION	0.500	2_CELL_CYCLE_PHASE	0.500	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.500	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.500	2_REGULATION_OF_CELL_CYCLE	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	
FBN2	6	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.833	1_KEGG_FOCAL_ADHESION	0.833	0_HALLMARK_ANGIOGENESIS	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.667	2_EXTRACELLULAR_MATRIX_PART	0.667	2_EXTRACELLULAR_MATRIX	0.667	2_COLLAGEN	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.500	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	1_KEGG_MELANOMA	0.333	1_KEGG_ASTHMA	0.333	2_EXTRACELLULAR_REGION	0.333	2_EXTRACELLULAR_REGION_PART	0.333	2_CELL_CELL_SIGNALING	0.333	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	0.333	2_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT	0.333	0_HALLMARK_KRAS_SIGNALING_UP	0.167	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.167	
FCER1A	1	0_HALLMARK_HYPOXIA	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_MELANOMA	1.000	2_EXTRACELLULAR_REGION_PART	1.000	2_CELL_DEVELOPMENT	1.000	2_CELL_CELL_SIGNALING	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_CELL_PROLIFERATION_GO_0008283	1.000	2_KINASE_REGULATOR_ACTIVITY	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
FGF13	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_COLLAGEN	1.000	2_REGULATION_OF_PHOSPHORYLATION	1.000	2_CELL_CYCLE_PHASE	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	1.000	
FGF18	2	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_COMPLEMENT	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_INFLAMMATORY_RESPONSE	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	0_HALLMARK_COAGULATION	0.500	0_HALLMARK_ALLOGRAFT_REJECTION	0.500	0_HALLMARK_KRAS_SIGNALING_UP	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	1_KEGG_ASTHMA	0.500	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.500	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.500	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	
FGFR1	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_G2M_CHECKPOINT	0.750	0_HALLMARK_E2F_TARGETS	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_P53_SIGNALING_PATHWAY	0.750	1_KEGG_FOCAL_ADHESION	0.750	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_BLADDER_CANCER	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_INTERPHASE	0.500	2_MITOTIC_CELL_CYCLE	0.500	2_REGULATION_OF_PHOSPHORYLATION	0.500	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.500	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.500	2_CELL_CYCLE_GO_0007049	0.500	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	0.500	2_REGULATION_OF_CELL_CYCLE	0.500	
FGFR2	9	0_HALLMARK_E2F_TARGETS	0.778	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.778	1_KEGG_CELL_CYCLE	0.778	0_HALLMARK_G2M_CHECKPOINT	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.556	1_KEGG_MELANOMA	0.556	2_NON_MEMBRANE_BOUND_ORGANELLE	0.556	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.556	2_CELL_CYCLE_GO_0007049	0.556	2_GABA_RECEPTOR_ACTIVITY	0.556	1_KEGG_BLADDER_CANCER	0.444	2_MICROTUBULE_CYTOSKELETON	0.444	2_CHROMOSOMAL_PART	0.444	2_CHROMOSOME	0.444	2_M_PHASE	0.444	2_CELL_CYCLE_PROCESS	0.444	2_MITOTIC_CELL_CYCLE	0.444	2_CELL_CYCLE_PHASE	0.444	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.444	2_CELL_PROLIFERATION_GO_0008283	0.444	2_MITOSIS	0.444	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	0.444	
FGFR3	5	0_HALLMARK_E2F_TARGETS	0.600	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.600	0_HALLMARK_UV_RESPONSE_DN	0.600	1_KEGG_CELL_CYCLE	0.600	1_KEGG_FOCAL_ADHESION	0.600	1_KEGG_ECM_RECEPTOR_INTERACTION	0.600	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.600	1_KEGG_PATHWAYS_IN_CANCER	0.600	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.600	2_EXTRACELLULAR_MATRIX_PART	0.600	2_EXTRACELLULAR_REGION_PART	0.600	2_EXTRACELLULAR_MATRIX	0.600	0_HALLMARK_G2M_CHECKPOINT	0.400	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.400	0_HALLMARK_ANGIOGENESIS	0.400	1_KEGG_P53_SIGNALING_PATHWAY	0.400	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.400	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.400	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.400	1_KEGG_LEISHMANIA_INFECTION	0.400	1_KEGG_MELANOMA	0.400	1_KEGG_ASTHMA	0.400	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.400	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.400	1_KEGG_ALLOGRAFT_REJECTION	0.400	
FGFR4	4	0_HALLMARK_G2M_CHECKPOINT	0.750	0_HALLMARK_E2F_TARGETS	0.750	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_P53_SIGNALING_PATHWAY	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	2_CELL_CYCLE_PROCESS	0.750	2_MITOTIC_CELL_CYCLE	0.750	2_CELL_CYCLE_PHASE	0.750	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.750	2_CELL_CYCLE_GO_0007049	0.750	2_REGULATION_OF_CELL_CYCLE	0.750	2_GABA_RECEPTOR_ACTIVITY	0.750	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_ENDOMETRIAL_CANCER	0.500	1_KEGG_GLIOMA	0.500	1_KEGG_BLADDER_CANCER	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	0.500	
FLI1	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_ENDOMETRIAL_CANCER	0.667	1_KEGG_GLIOMA	0.667	1_KEGG_BLADDER_CANCER	0.667	1_KEGG_SMALL_CELL_LUNG_CANCER	0.667	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	0.667	2_DNA_METABOLIC_PROCESS	0.667	2_INTERPHASE	0.667	2_CELL_CYCLE_PROCESS	0.667	2_MITOTIC_CELL_CYCLE	0.667	2_CELL_CYCLE_PHASE	0.667	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.667	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.667	2_CELL_CYCLE_GO_0007049	0.667	2_REGULATION_OF_CELL_CYCLE	0.667	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_APOPTOSIS	0.333	
FLNA	6	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.833	1_KEGG_FOCAL_ADHESION	0.833	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	2_EXTRACELLULAR_MATRIX_PART	0.667	2_COLLAGEN	0.667	0_HALLMARK_UV_RESPONSE_DN	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_CELL_CYCLE	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	2_EXTRACELLULAR_REGION	0.333	2_NON_MEMBRANE_BOUND_ORGANELLE	0.333	2_EXTRACELLULAR_REGION_PART	0.333	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.333	2_CHROMOSOME	0.333	2_DNA_METABOLIC_PROCESS	0.333	2_INTERPHASE	0.333	2_CELL_CYCLE_PROCESS	0.333	2_MITOTIC_CELL_CYCLE	0.333	2_CELL_CYCLE_PHASE	0.333	
FLNB	2	1_KEGG_FOCAL_ADHESION	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_ASTHMA	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.500	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_EXTRACELLULAR_REGION	0.500	2_EXTRACELLULAR_REGION_PART	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_COLLAGEN	0.500	2_CELL_CELL_SIGNALING	0.500	
FLNC	8	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.875	1_KEGG_FOCAL_ADHESION	0.875	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_MELANOMA	0.500	2_CELL_CYCLE_GO_0007049	0.500	0_HALLMARK_ANGIOGENESIS	0.375	1_KEGG_P53_SIGNALING_PATHWAY	0.375	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.375	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.375	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.375	1_KEGG_ALLOGRAFT_REJECTION	0.375	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.375	1_KEGG_VIRAL_MYOCARDITIS	0.375	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.375	2_EXTRACELLULAR_MATRIX_PART	0.375	2_EXTRACELLULAR_MATRIX	0.375	2_COLLAGEN	0.375	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.375	2_CELL_PROLIFERATION_GO_0008283	0.375	2_REGULATION_OF_CELL_CYCLE	0.375	2_GABA_RECEPTOR_ACTIVITY	0.375	
FLT1	6	0_HALLMARK_G2M_CHECKPOINT	0.833	0_HALLMARK_E2F_TARGETS	0.833	1_KEGG_CELL_CYCLE	0.833	2_CELL_CYCLE_GO_0007049	0.833	2_GABA_RECEPTOR_ACTIVITY	0.833	1_KEGG_P53_SIGNALING_PATHWAY	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_GLIOMA	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.500	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_ECM_RECEPTOR_INTERACTION	0.333	1_KEGG_PANCREATIC_CANCER	0.333	2_MICROTUBULE_CYTOSKELETON	0.333	2_CYTOSKELETON	0.333	2_INTERPHASE	0.333	2_CELL_CYCLE_PROCESS	0.333	2_MITOTIC_CELL_CYCLE	0.333	2_REGULATION_OF_PHOSPHORYLATION	0.333	2_CELL_CYCLE_PHASE	0.333	2_CELL_CELL_SIGNALING	0.333	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.333	2_SYNAPTIC_TRANSMISSION	0.333	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	0.333	
FN1	6	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_G2M_CHECKPOINT	0.833	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.833	1_KEGG_ECM_RECEPTOR_INTERACTION	0.833	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_MELANOMA	0.667	2_CELL_CYCLE_GO_0007049	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_BLADDER_CANCER	0.500	2_REGULATION_OF_PHOSPHORYLATION	0.500	2_REGULATION_OF_CELL_CYCLE	0.500	0_HALLMARK_UV_RESPONSE_DN	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.333	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	1_KEGG_GLIOMA	0.333	1_KEGG_ASTHMA	0.333	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.333	1_KEGG_ALLOGRAFT_REJECTION	0.333	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.333	1_KEGG_VIRAL_MYOCARDITIS	0.333	2_NON_MEMBRANE_BOUND_ORGANELLE	0.333	
FOS	1	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	1.000	0_HALLMARK_COMPLEMENT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_INFLAMMATORY_RESPONSE	1.000	0_HALLMARK_ANGIOGENESIS	1.000	0_HALLMARK_ALLOGRAFT_REJECTION	1.000	0_HALLMARK_KRAS_SIGNALING_UP	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1.000	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_LEISHMANIA_INFECTION	1.000	1_KEGG_BLADDER_CANCER	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	1.000	1_KEGG_VIRAL_MYOCARDITIS	1.000	
FOXG1	1	0_HALLMARK_HYPOXIA	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_MELANOMA	1.000	2_EXTRACELLULAR_REGION_PART	1.000	2_CELL_DEVELOPMENT	1.000	2_CELL_CELL_SIGNALING	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_CELL_PROLIFERATION_GO_0008283	1.000	2_KINASE_REGULATOR_ACTIVITY	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
FOXO3	1	2_REGULATION_OF_CELL_DIFFERENTIATION	1.000	
FRS2	8	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.625	1_KEGG_ECM_RECEPTOR_INTERACTION	0.625	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_BLADDER_CANCER	0.500	2_CELL_CELL_SIGNALING	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	0_HALLMARK_G2M_CHECKPOINT	0.375	0_HALLMARK_E2F_TARGETS	0.375	1_KEGG_DNA_REPLICATION	0.375	1_KEGG_CELL_CYCLE	0.375	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.375	1_KEGG_LEISHMANIA_INFECTION	0.375	1_KEGG_ASTHMA	0.375	1_KEGG_ALLOGRAFT_REJECTION	0.375	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.375	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.375	2_EXTRACELLULAR_MATRIX_PART	0.375	2_EXTRACELLULAR_REGION_PART	0.375	2_EXTRACELLULAR_MATRIX	0.375	2_SYNAPTIC_TRANSMISSION	0.375	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.375	2_TRANSMISSION_OF_NERVE_IMPULSE	0.375	0_HALLMARK_UV_RESPONSE_DN	0.250	0_HALLMARK_ANGIOGENESIS	0.250	
FRYL	1	1_KEGG_ONE_CARBON_POOL_BY_FOLATE	1.000	
FZD10	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_WNT_SIGNALING_PATHWAY	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	
FZD4	1	
GABBR2	1	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	1.000	2_PLASMA_MEMBRANE	1.000	2_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
GABRA1	5	0_HALLMARK_E2F_TARGETS	0.600	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.600	1_KEGG_CELL_CYCLE	0.600	1_KEGG_P53_SIGNALING_PATHWAY	0.600	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.600	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.600	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.600	1_KEGG_ASTHMA	0.600	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.600	1_KEGG_ALLOGRAFT_REJECTION	0.600	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.600	1_KEGG_VIRAL_MYOCARDITIS	0.600	2_GABA_RECEPTOR_ACTIVITY	0.600	0_HALLMARK_G2M_CHECKPOINT	0.400	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.400	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.400	0_HALLMARK_ALLOGRAFT_REJECTION	0.400	1_KEGG_ECM_RECEPTOR_INTERACTION	0.400	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.400	1_KEGG_LEISHMANIA_INFECTION	0.400	2_SYNAPTIC_TRANSMISSION	0.400	2_CELL_CYCLE_GO_0007049	0.400	0_HALLMARK_APOPTOSIS	0.200	0_HALLMARK_UV_RESPONSE_DN	0.200	0_HALLMARK_ANGIOGENESIS	0.200	
GABRA5	3	2_GABA_RECEPTOR_ACTIVITY	1.000	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	0_HALLMARK_ANGIOGENESIS	0.333	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_ECM_RECEPTOR_INTERACTION	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.333	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	1_KEGG_LEISHMANIA_INFECTION	0.333	1_KEGG_ASTHMA	0.333	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.333	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.333	1_KEGG_ALLOGRAFT_REJECTION	0.333	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.333	1_KEGG_VIRAL_MYOCARDITIS	0.333	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.333	2_INTRINSIC_TO_PLASMA_MEMBRANE	0.333	2_EXTRACELLULAR_MATRIX_PART	0.333	2_EXTRACELLULAR_REGION	0.333	2_INTRINSIC_TO_MEMBRANE	0.333	2_MEMBRANE_PART	0.333	2_MEMBRANE	0.333	2_EXTRACELLULAR_REGION_PART	0.333	
GABRA6	8	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.625	1_KEGG_CELL_CYCLE	0.625	2_GABA_RECEPTOR_ACTIVITY	0.625	0_HALLMARK_G2M_CHECKPOINT	0.375	0_HALLMARK_E2F_TARGETS	0.375	1_KEGG_FOCAL_ADHESION	0.375	1_KEGG_ECM_RECEPTOR_INTERACTION	0.375	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.375	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.375	1_KEGG_LEISHMANIA_INFECTION	0.375	1_KEGG_MELANOMA	0.375	1_KEGG_ASTHMA	0.375	1_KEGG_ALLOGRAFT_REJECTION	0.375	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.375	2_CELL_CELL_SIGNALING	0.375	2_CELL_CYCLE_GO_0007049	0.375	0_HALLMARK_APOPTOSIS	0.250	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.250	0_HALLMARK_UV_RESPONSE_DN	0.250	0_HALLMARK_ANGIOGENESIS	0.250	1_KEGG_P53_SIGNALING_PATHWAY	0.250	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.250	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.250	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.250	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.250	
GABRB2	5	2_CELL_CELL_SIGNALING	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.600	2_SYNAPTIC_TRANSMISSION	0.600	2_TRANSMISSION_OF_NERVE_IMPULSE	0.600	0_HALLMARK_COMPLEMENT	0.400	0_HALLMARK_ALLOGRAFT_REJECTION	0.400	0_HALLMARK_KRAS_SIGNALING_UP	0.400	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.400	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	0.400	1_KEGG_LEISHMANIA_INFECTION	0.400	1_KEGG_ASTHMA	0.400	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.400	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.400	2_NEUROLOGICAL_SYSTEM_PROCESS	0.400	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.400	2_RECEPTOR_ACTIVITY	0.400	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.200	0_HALLMARK_G2M_CHECKPOINT	0.200	0_HALLMARK_APOPTOSIS	0.200	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.200	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.200	0_HALLMARK_E2F_TARGETS	0.200	0_HALLMARK_INFLAMMATORY_RESPONSE	0.200	0_HALLMARK_ANGIOGENESIS	0.200	
GABRB3	7	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.571	1_KEGG_ECM_RECEPTOR_INTERACTION	0.571	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.429	0_HALLMARK_UV_RESPONSE_DN	0.429	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	0.429	1_KEGG_FOCAL_ADHESION	0.429	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.429	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.429	1_KEGG_ASTHMA	0.429	1_KEGG_ALLOGRAFT_REJECTION	0.429	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.429	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.429	2_EXTRACELLULAR_MATRIX_PART	0.429	2_EXTRACELLULAR_MATRIX	0.429	2_CELL_CELL_SIGNALING	0.429	2_RECEPTOR_ACTIVITY	0.429	0_HALLMARK_G2M_CHECKPOINT	0.286	0_HALLMARK_APOPTOSIS	0.286	0_HALLMARK_COMPLEMENT	0.286	0_HALLMARK_E2F_TARGETS	0.286	0_HALLMARK_ANGIOGENESIS	0.286	0_HALLMARK_ALLOGRAFT_REJECTION	0.286	0_HALLMARK_KRAS_SIGNALING_UP	0.286	1_KEGG_CELL_CYCLE	0.286	
GABRG2	3	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	0_HALLMARK_COAGULATION	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	2_EXTRACELLULAR_REGION	0.667	2_EXTRACELLULAR_REGION_PART	0.667	0_HALLMARK_HYPOXIA	0.333	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.333	0_HALLMARK_COMPLEMENT	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	0_HALLMARK_ANGIOGENESIS	0.333	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	0.333	1_KEGG_CELL_CYCLE	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	0.333	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.333	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	1_KEGG_LEISHMANIA_INFECTION	0.333	1_KEGG_MELANOMA	0.333	1_KEGG_ASTHMA	0.333	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.333	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.333	
GABRQ	1	2_CELL_CELL_SIGNALING	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	
GLI1	13	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.692	0_HALLMARK_E2F_TARGETS	0.538	1_KEGG_CELL_CYCLE	0.538	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.538	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.538	1_KEGG_LEISHMANIA_INFECTION	0.538	1_KEGG_ASTHMA	0.538	1_KEGG_ALLOGRAFT_REJECTION	0.538	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.538	0_HALLMARK_APOPTOSIS	0.462	1_KEGG_P53_SIGNALING_PATHWAY	0.462	1_KEGG_FOCAL_ADHESION	0.462	1_KEGG_ECM_RECEPTOR_INTERACTION	0.462	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.462	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.462	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.462	1_KEGG_VIRAL_MYOCARDITIS	0.462	2_NON_MEMBRANE_BOUND_ORGANELLE	0.462	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.462	2_GABA_RECEPTOR_ACTIVITY	0.462	0_HALLMARK_G2M_CHECKPOINT	0.385	0_HALLMARK_UV_RESPONSE_DN	0.385	1_KEGG_BLADDER_CANCER	0.385	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.385	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.385	
GLI2	1	
GLI3	6	0_HALLMARK_E2F_TARGETS	0.833	1_KEGG_CELL_CYCLE	0.833	2_GABA_RECEPTOR_ACTIVITY	0.833	0_HALLMARK_G2M_CHECKPOINT	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	2_CELL_CYCLE_GO_0007049	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_MELANOMA	0.500	2_MICROTUBULE_CYTOSKELETON	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_CELL_CELL_SIGNALING	0.500	2_SYNAPTIC_TRANSMISSION	0.500	2_DNA_REPLICATION	0.500	2_TRANSMISSION_OF_NERVE_IMPULSE	0.500	2_REGULATION_OF_CELL_CYCLE	0.500	0_HALLMARK_MYC_TARGETS_V1	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	2_ORGANELLE_PART	0.333	2_AXON	0.333	2_NUCLEUS	0.333	
GNA15	1	2_G_PROTEIN_SIGNALING_COUPLED_TO_IP3_SECOND_MESSENGERPHOSPHOLIPASE_C_ACTIVATING	1.000	2_PHOSPHOLIPASE_C_ACTIVATION	1.000	2_POSITIVE_REGULATION_OF_HYDROLASE_ACTIVITY	1.000	2_PHOSPHOINOSITIDE_MEDIATED_SIGNALING	1.000	
GNAO1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_GLIOMA	1.000	1_KEGG_BLADDER_CANCER	1.000	2_DNA_METABOLIC_PROCESS	1.000	2_CELL_CYCLE_PROCESS	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_DNA_REPLICATION	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
GNAT3	8	1_KEGG_ECM_RECEPTOR_INTERACTION	0.375	0_HALLMARK_G2M_CHECKPOINT	0.250	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.250	0_HALLMARK_E2F_TARGETS	0.250	1_KEGG_DNA_REPLICATION	0.250	1_KEGG_CELL_CYCLE	0.250	1_KEGG_FOCAL_ADHESION	0.250	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.250	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.250	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.250	1_KEGG_MELANOMA	0.250	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.250	1_KEGG_ALLOGRAFT_REJECTION	0.250	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.250	1_KEGG_VIRAL_MYOCARDITIS	0.250	2_CELL_CYCLE_PROCESS	0.250	2_CELL_CELL_SIGNALING	0.250	2_SYNAPTIC_TRANSMISSION	0.250	2_NEUROLOGICAL_SYSTEM_PROCESS	0.250	2_CELL_CYCLE_GO_0007049	0.250	2_TRANSMISSION_OF_NERVE_IMPULSE	0.250	2_SYSTEM_PROCESS	0.250	2_GABA_RECEPTOR_ACTIVITY	0.250	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.125	0_HALLMARK_COMPLEMENT	0.125	
GNG12	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_COAGULATION	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_AXON	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_CYTOSKELETON	1.000	2_CELL_PROJECTION	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
GRASP	1	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	1.000	2_INTRINSIC_TO_PLASMA_MEMBRANE	1.000	2_INTRINSIC_TO_MEMBRANE	1.000	2_INTEGRAL_TO_MEMBRANE	1.000	2_INTEGRAL_TO_PLASMA_MEMBRANE	1.000	2_PLASMA_MEMBRANE_PART	1.000	2_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY	1.000	2_METABOTROPIC_GLUTAMATEGABA_B_LIKE_RECEPTOR_ACTIVITY	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	2_RECEPTOR_ACTIVITY	1.000	
GRB10	7	0_HALLMARK_G2M_CHECKPOINT	0.714	0_HALLMARK_E2F_TARGETS	0.714	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.714	1_KEGG_CELL_CYCLE	0.714	1_KEGG_FOCAL_ADHESION	0.571	1_KEGG_ECM_RECEPTOR_INTERACTION	0.571	1_KEGG_MELANOMA	0.571	2_CELL_CYCLE_GO_0007049	0.571	0_HALLMARK_ANGIOGENESIS	0.429	1_KEGG_DNA_REPLICATION	0.429	1_KEGG_P53_SIGNALING_PATHWAY	0.429	1_KEGG_PATHWAYS_IN_CANCER	0.429	2_EXTRACELLULAR_REGION	0.429	2_NON_MEMBRANE_BOUND_ORGANELLE	0.429	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.429	2_REGULATION_OF_CELL_CYCLE	0.429	2_GABA_RECEPTOR_ACTIVITY	0.429	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.286	0_HALLMARK_MYC_TARGETS_V1	0.286	0_HALLMARK_UV_RESPONSE_DN	0.286	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.286	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.286	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.286	1_KEGG_SMALL_CELL_LUNG_CANCER	0.286	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.286	
GRB2	1	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_CELL_CELL_SIGNALING	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
GRID2	1	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	1.000	2_CELL_CELL_SIGNALING	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_NEUROLOGICAL_SYSTEM_PROCESS	1.000	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	2_SYSTEM_PROCESS	1.000	2_GLUTAMATE_RECEPTOR_ACTIVITY	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
GRIN2A	8	2_CELL_CELL_SIGNALING	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	2_SYNAPTIC_TRANSMISSION	0.375	2_TRANSMISSION_OF_NERVE_IMPULSE	0.375	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.250	1_KEGG_FOCAL_ADHESION	0.250	1_KEGG_ECM_RECEPTOR_INTERACTION	0.250	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.250	1_KEGG_PATHWAYS_IN_CANCER	0.250	2_AXON	0.250	2_NEURON_PROJECTION	0.250	2_GLUTAMATE_RECEPTOR_ACTIVITY	0.250	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.125	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	0.125	0_HALLMARK_G2M_CHECKPOINT	0.125	0_HALLMARK_APOPTOSIS	0.125	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.125	0_HALLMARK_E2F_TARGETS	0.125	0_HALLMARK_INFLAMMATORY_RESPONSE	0.125	0_HALLMARK_UV_RESPONSE_DN	0.125	0_HALLMARK_ALLOGRAFT_REJECTION	0.125	0_HALLMARK_KRAS_SIGNALING_UP	0.125	1_KEGG_CALCIUM_SIGNALING_PATHWAY	0.125	1_KEGG_CELL_CYCLE	0.125	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.125	
GRIN2C	2	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	0.500	2_CELL_CELL_SIGNALING	0.500	2_SYNAPTIC_TRANSMISSION	0.500	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.500	2_TRANSMISSION_OF_NERVE_IMPULSE	0.500	2_GLUTAMATE_RECEPTOR_ACTIVITY	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	2_IONOTROPIC_GLUTAMATE_RECEPTOR_ACTIVITY	0.500	
GRK5	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_PANCREATIC_CANCER	0.500	1_KEGG_ENDOMETRIAL_CANCER	0.500	1_KEGG_GLIOMA	0.500	1_KEGG_PROSTATE_CANCER	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_BLADDER_CANCER	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_COLLAGEN	0.500	2_CELL_CYCLE_GO_0007049	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	
HCLS1	3	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.667	2_EXTRACELLULAR_MATRIX	0.667	2_CELL_CELL_SIGNALING	0.667	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_UV_RESPONSE_DN	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	1_KEGG_PATHWAYS_IN_CANCER	0.333	1_KEGG_SMALL_CELL_LUNG_CANCER	0.333	1_KEGG_ASTHMA	0.333	2_EXTRACELLULAR_MATRIX_PART	0.333	2_EXTRACELLULAR_REGION_PART	0.333	2_COLLAGEN	0.333	2_SYNAPTIC_TRANSMISSION	0.333	2_REGULATION_OF_TRANSPORT	0.333	2_TRANSMISSION_OF_NERVE_IMPULSE	0.333	
HDAC2	4	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	2_CELL_CYCLE_GO_0007049	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	1_KEGG_P53_SIGNALING_PATHWAY	0.750	1_KEGG_MELANOMA	0.750	2_NON_MEMBRANE_BOUND_ORGANELLE	0.750	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.750	2_CHROMOSOMAL_PART	0.750	2_CHROMOSOME	0.750	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.750	2_REGULATION_OF_CELL_CYCLE	0.750	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_BLADDER_CANCER	0.500	1_KEGG_ASTHMA	0.500	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.500	
HGF	6	1_KEGG_FOCAL_ADHESION	0.667	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_MELANOMA	0.500	2_CELL_CELL_SIGNALING	0.500	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	1_KEGG_SMALL_CELL_LUNG_CANCER	0.333	2_SYNAPTIC_TRANSMISSION	0.333	2_NEUROLOGICAL_SYSTEM_PROCESS	0.333	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.333	2_CELL_PROLIFERATION_GO_0008283	0.333	2_CELL_CYCLE_GO_0007049	0.333	2_TRANSMISSION_OF_NERVE_IMPULSE	0.333	2_SYSTEM_PROCESS	0.333	2_GABA_RECEPTOR_ACTIVITY	0.333	0_HALLMARK_APOPTOSIS	0.167	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.167	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.167	0_HALLMARK_COMPLEMENT	0.167	0_HALLMARK_MYC_TARGETS_V1	0.167	0_HALLMARK_UV_RESPONSE_DN	0.167	0_HALLMARK_ANGIOGENESIS	0.167	
HLA-A	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_MYC_TARGETS_V1	0.667	0_HALLMARK_KRAS_SIGNALING_UP	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.667	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.667	1_KEGG_ALLOGRAFT_REJECTION	0.667	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.667	2_EXTRACELLULAR_MATRIX_PART	0.667	2_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_COLLAGEN	0.667	2_CHROMOSOME	0.667	2_MITOTIC_CELL_CYCLE	0.667	2_CELL_CYCLE_PHASE	0.667	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.667	2_CELL_CYCLE_GO_0007049	0.667	0_HALLMARK_APOPTOSIS	0.333	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.333	
HLA-DOA	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1.000	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_LEISHMANIA_INFECTION	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	1.000	1_KEGG_VIRAL_MYOCARDITIS	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	
HLA-DQB1	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_MELANOMA	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_INTERPHASE	1.000	2_REGULATION_OF_PHOSPHORYLATION	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	1.000	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	
HLA-DRA	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	1.000	0_HALLMARK_COMPLEMENT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_COAGULATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	1.000	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_LEISHMANIA_INFECTION	1.000	1_KEGG_MELANOMA	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	1.000	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	1.000	1_KEGG_VIRAL_MYOCARDITIS	1.000	2_EXTRACELLULAR_REGION	1.000	2_EXTRACELLULAR_REGION_PART	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
HLA-DRB1	62	1_KEGG_ASTHMA	0.694	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.661	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.661	1_KEGG_ALLOGRAFT_REJECTION	0.661	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.661	1_KEGG_VIRAL_MYOCARDITIS	0.661	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.645	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.613	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.613	1_KEGG_LEISHMANIA_INFECTION	0.613	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.581	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.581	1_KEGG_ECM_RECEPTOR_INTERACTION	0.532	1_KEGG_FOCAL_ADHESION	0.484	1_KEGG_CELL_CYCLE	0.452	2_GABA_RECEPTOR_ACTIVITY	0.419	0_HALLMARK_E2F_TARGETS	0.403	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.371	0_HALLMARK_ANGIOGENESIS	0.355	1_KEGG_P53_SIGNALING_PATHWAY	0.339	2_EXTRACELLULAR_MATRIX_PART	0.323	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.306	0_HALLMARK_G2M_CHECKPOINT	0.290	0_HALLMARK_UV_RESPONSE_DN	0.290	2_EXTRACELLULAR_MATRIX	0.290	
HLF	1	
HMHA1	2	0_HALLMARK_ALLOGRAFT_REJECTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1.000	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_LEISHMANIA_INFECTION	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	1.000	1_KEGG_VIRAL_MYOCARDITIS	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.500	1_KEGG_MISMATCH_REPAIR	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.500	
HNRNPA2B1	3	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	2_MICROTUBULE_CYTOSKELETON	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_REGULATION_OF_CELL_CYCLE	1.000	0_HALLMARK_MYC_TARGETS_V1	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.667	2_ORGANELLE_PART	0.667	2_AXON	0.667	2_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_NUCLEUS	0.667	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_INTRACELLULAR_ORGANELLE_PART	0.667	2_CHROMOSOMAL_PART	0.667	2_NEURON_PROJECTION	0.667	2_CHROMOSOME	0.667	2_CELL_CYCLE_PROCESS	0.667	2_DNA_REPLICATION	0.667	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_APOPTOSIS	0.333	0_HALLMARK_ESTROGEN_RESPONSE_LATE	0.333	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.333	
HNRNPH3	1	2_RNA_PROCESSING	1.000	
HOXA2	1	
HOXA9	3	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.667	2_MICROTUBULE_CYTOSKELETON	0.667	2_CELL_CELL_SIGNALING	0.667	2_SYNAPTIC_TRANSMISSION	0.667	2_CELL_CYCLE_GO_0007049	0.667	2_TRANSMISSION_OF_NERVE_IMPULSE	0.667	2_REGULATION_OF_CELL_CYCLE	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_APOPTOSIS	0.333	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.333	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.333	1_KEGG_MISMATCH_REPAIR	0.333	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.333	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.333	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	1_KEGG_PATHWAYS_IN_CANCER	0.333	
HSPA8	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	2_COLLAGEN	0.500	2_REGULATION_OF_PHOSPHORYLATION	0.500	2_CELL_CELL_SIGNALING	0.500	2_SYNAPTIC_TRANSMISSION	0.500	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.500	2_TRANSMISSION_OF_NERVE_IMPULSE	0.500	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	
IFI16	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	
IFNG	11	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.818	0_HALLMARK_E2F_TARGETS	0.727	1_KEGG_CELL_CYCLE	0.727	0_HALLMARK_G2M_CHECKPOINT	0.636	1_KEGG_FOCAL_ADHESION	0.636	1_KEGG_ECM_RECEPTOR_INTERACTION	0.636	1_KEGG_BLADDER_CANCER	0.636	1_KEGG_P53_SIGNALING_PATHWAY	0.545	2_CELL_CYCLE_GO_0007049	0.545	2_GABA_RECEPTOR_ACTIVITY	0.545	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.455	1_KEGG_LEISHMANIA_INFECTION	0.455	1_KEGG_MELANOMA	0.455	1_KEGG_ASTHMA	0.455	1_KEGG_ALLOGRAFT_REJECTION	0.455	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.455	2_EXTRACELLULAR_MATRIX_PART	0.455	2_NON_MEMBRANE_BOUND_ORGANELLE	0.455	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.455	0_HALLMARK_UV_RESPONSE_DN	0.364	0_HALLMARK_ANGIOGENESIS	0.364	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.364	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.364	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.364	1_KEGG_VIRAL_MYOCARDITIS	0.364	
IFNGR1	1	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_ALLOGRAFT_REJECTION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1.000	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	1.000	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_LEISHMANIA_INFECTION	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	1.000	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	1.000	1_KEGG_VIRAL_MYOCARDITIS	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_RECEPTOR_ACTIVITY	1.000	2_TRANSMEMBRANE_RECEPTOR_ACTIVITY	1.000	2_HEMATOPOIETIN_INTERFERON_CLASSD200_DOMAIN_CYTOKINE_RECEPTOR_ACTIVITY	1.000	2_INTERLEUKIN_RECEPTOR_ACTIVITY	1.000	
IGF1R	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_MELANOMA	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX	1.000	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.500	0_HALLMARK_HYPOXIA	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_COMPLEMENT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	0_HALLMARK_COAGULATION	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	0.500	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_AXON	0.500	2_EXTRACELLULAR_REGION	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	
IGF2R	2	0_HALLMARK_COMPLEMENT	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_ANGIOGENESIS	1.000	0_HALLMARK_COAGULATION	1.000	0_HALLMARK_ALLOGRAFT_REJECTION	1.000	0_HALLMARK_KRAS_SIGNALING_UP	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	1.000	1_KEGG_LEISHMANIA_INFECTION	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	1.000	2_EXTRACELLULAR_REGION	1.000	2_EXTRACELLULAR_REGION_PART	1.000	2_CELL_CELL_SIGNALING	1.000	2_RESPONSE_TO_EXTERNAL_STIMULUS	1.000	2_RESPONSE_TO_WOUNDING	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.500	0_HALLMARK_HYPOXIA	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_INFLAMMATORY_RESPONSE	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	
IGFBP3	6	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_CELL_CYCLE	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	2_NON_MEMBRANE_BOUND_ORGANELLE	0.333	2_NUCLEUS	0.333	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.333	2_CELL_CELL_SIGNALING	0.333	2_SYNAPTIC_TRANSMISSION	0.333	2_CELL_CYCLE_GO_0007049	0.333	2_TRANSMISSION_OF_NERVE_IMPULSE	0.333	2_REGULATION_OF_CELL_CYCLE	0.333	0_HALLMARK_ESTROGEN_RESPONSE_LATE	0.167	1_KEGG_DNA_REPLICATION	0.167	1_KEGG_FOCAL_ADHESION	0.167	1_KEGG_ECM_RECEPTOR_INTERACTION	0.167	2_ORGANELLE_PART	0.167	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.167	2_AXON	0.167	2_INTERMEDIATE_FILAMENT_CYTOSKELETON	0.167	2_MICROTUBULE_CYTOSKELETON	0.167	2_CYTOSKELETAL_PART	0.167	
IGFBP7	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	1_KEGG_FOCAL_ADHESION	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_EXTRACELLULAR_REGION_PART	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_COLLAGEN	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	0_HALLMARK_MITOTIC_SPINDLE	0.250	0_HALLMARK_G2M_CHECKPOINT	0.250	0_HALLMARK_E2F_TARGETS	0.250	1_KEGG_CELL_CYCLE	0.250	1_KEGG_OOCYTE_MEIOSIS	0.250	1_KEGG_P53_SIGNALING_PATHWAY	0.250	1_KEGG_ENDOCYTOSIS	0.250	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.250	1_KEGG_GLIOMA	0.250	1_KEGG_MELANOMA	0.250	1_KEGG_BLADDER_CANCER	0.250	1_KEGG_SMALL_CELL_LUNG_CANCER	0.250	2_ORGANELLE_PART	0.250	
IKBKE	1	
IKZF1	10	0_HALLMARK_G2M_CHECKPOINT	0.800	0_HALLMARK_E2F_TARGETS	0.800	1_KEGG_CELL_CYCLE	0.800	2_CELL_CYCLE_GO_0007049	0.800	2_REGULATION_OF_CELL_CYCLE	0.600	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	1_KEGG_DNA_REPLICATION	0.400	1_KEGG_FOCAL_ADHESION	0.400	1_KEGG_ECM_RECEPTOR_INTERACTION	0.400	2_NON_MEMBRANE_BOUND_ORGANELLE	0.400	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.400	0_HALLMARK_MYC_TARGETS_V1	0.300	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.300	1_KEGG_PATHWAYS_IN_CANCER	0.300	1_KEGG_MELANOMA	0.300	1_KEGG_BLADDER_CANCER	0.300	1_KEGG_SMALL_CELL_LUNG_CANCER	0.300	2_MICROTUBULE_CYTOSKELETON	0.300	2_NUCLEUS	0.300	2_CHROMOSOMAL_PART	0.300	2_CHROMOSOME	0.300	2_CELL_CYCLE_PROCESS	0.300	2_DNA_REPLICATION	0.300	
IKZF3	2	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.500	0_HALLMARK_HYPOXIA	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_COMPLEMENT	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_INFLAMMATORY_RESPONSE	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	0_HALLMARK_COAGULATION	0.500	0_HALLMARK_ALLOGRAFT_REJECTION	0.500	0_HALLMARK_KRAS_SIGNALING_UP	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	1_KEGG_ASTHMA	0.500	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.500	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.500	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.500	
IL12B	1	
IL12RB2	3	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	2_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.667	0_HALLMARK_MITOTIC_SPINDLE	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	0_HALLMARK_ANGIOGENESIS	0.333	0_HALLMARK_COAGULATION	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	1_KEGG_MELANOMA	0.333	1_KEGG_SMALL_CELL_LUNG_CANCER	0.333	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.333	2_EXTRACELLULAR_MATRIX_PART	0.333	2_AXON	0.333	2_CYTOSKELETON	0.333	2_CELL_PROJECTION	0.333	2_REPLICATION_FORK	0.333	2_EXTRACELLULAR_MATRIX	0.333	2_COLLAGEN	0.333	2_CHROMOSOME	0.333	
IL32	1	
IL7	1	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	1.000	0_HALLMARK_HYPOXIA	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_EXTRACELLULAR_REGION	1.000	2_COLLAGEN	1.000	2_RESPONSE_TO_EXTERNAL_STIMULUS	1.000	2_RESPONSE_TO_WOUNDING	1.000	
ING3	3	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_DNA_REPLICATION	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_REGULATION_OF_CELL_CYCLE	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_MELANOMA	0.667	2_ORGANELLE_PART	0.667	2_AXON	0.667	2_MICROTUBULE_CYTOSKELETON	0.667	2_CYTOSKELETAL_PART	0.667	2_NUCLEUS	0.667	2_REPLICATION_FORK	0.667	2_INTRACELLULAR_ORGANELLE_PART	0.667	2_NEURON_PROJECTION	0.667	2_DNA_METABOLIC_PROCESS	0.667	2_CELL_CYCLE_PROCESS	0.667	2_MITOTIC_CELL_CYCLE	0.667	2_CELL_CYCLE_PHASE	0.667	
INSR	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_REGION	1.000	2_BASEMENT_MEMBRANE	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_CYTOSKELETAL_PART	1.000	2_CYTOSKELETON	1.000	2_EXTRACELLULAR_REGION_PART	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_COLLAGEN	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_REGULATION_OF_CELL_CYCLE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	2_STRUCTURAL_MOLECULE_ACTIVITY	1.000	2_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT	1.000	
ITGA1	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.500	1_KEGG_MISMATCH_REPAIR	0.500	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_ASTHMA	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_REPLICATION_FORK	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_CHROMOSOMAL_PART	0.500	2_CHROMOSOME	0.500	2_DNA_METABOLIC_PROCESS	0.500	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.500	2_DNA_REPLICATION	0.500	2_CELL_CYCLE_GO_0007049	0.500	2_REGULATION_OF_CELL_CYCLE	0.500	
ITGA10	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	0_HALLMARK_ANGIOGENESIS	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.667	2_EXTRACELLULAR_REGION_PART	0.667	2_EXTRACELLULAR_MATRIX	0.667	2_COLLAGEN	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	0.333	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_INFLAMMATORY_RESPONSE	0.333	0_HALLMARK_ALLOGRAFT_REJECTION	0.333	0_HALLMARK_KRAS_SIGNALING_UP	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_CELL_CYCLE	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.333	1_KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	0.333	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.333	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	1_KEGG_LEISHMANIA_INFECTION	0.333	
ITGA4	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_COLLAGEN	1.000	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.667	0_HALLMARK_COMPLEMENT	0.667	0_HALLMARK_UV_RESPONSE_DN	0.667	0_HALLMARK_ANGIOGENESIS	0.667	0_HALLMARK_COAGULATION	0.667	0_HALLMARK_KRAS_SIGNALING_UP	0.667	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.667	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	0.667	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.667	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.667	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.667	1_KEGG_LEISHMANIA_INFECTION	0.667	1_KEGG_ASTHMA	0.667	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.667	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.667	1_KEGG_ALLOGRAFT_REJECTION	0.667	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.667	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.667	2_EXTRACELLULAR_MATRIX	0.667	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.333	
ITGA7	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.500	0_HALLMARK_HYPOXIA	0.500	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_MYOGENESIS	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_COMPLEMENT	0.500	0_HALLMARK_INFLAMMATORY_RESPONSE	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	0_HALLMARK_COAGULATION	0.500	0_HALLMARK_ALLOGRAFT_REJECTION	0.500	0_HALLMARK_KRAS_SIGNALING_UP	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	
ITGA8	5	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_G2M_CHECKPOINT	0.600	0_HALLMARK_E2F_TARGETS	0.600	0_HALLMARK_ANGIOGENESIS	0.600	1_KEGG_CELL_CYCLE	0.600	1_KEGG_P53_SIGNALING_PATHWAY	0.600	1_KEGG_PATHWAYS_IN_CANCER	0.600	1_KEGG_BLADDER_CANCER	0.600	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.600	2_EXTRACELLULAR_MATRIX_PART	0.600	2_MICROTUBULE_CYTOSKELETON	0.600	2_NON_MEMBRANE_BOUND_ORGANELLE	0.600	2_SPINDLE	0.600	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.600	2_EXTRACELLULAR_MATRIX	0.600	2_CHROMOSOMAL_PART	0.600	2_CHROMOSOME	0.600	2_M_PHASE	0.600	2_CELL_CYCLE_PROCESS	0.600	2_MITOTIC_CELL_CYCLE	0.600	2_CELL_CYCLE_PHASE	0.600	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.600	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.600	
ITGAM	5	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	0_HALLMARK_G2M_CHECKPOINT	0.800	0_HALLMARK_E2F_TARGETS	0.800	1_KEGG_CELL_CYCLE	0.800	1_KEGG_ECM_RECEPTOR_INTERACTION	0.800	2_COLLAGEN	0.800	2_GABA_RECEPTOR_ACTIVITY	0.800	0_HALLMARK_UV_RESPONSE_DN	0.600	1_KEGG_P53_SIGNALING_PATHWAY	0.600	1_KEGG_BLADDER_CANCER	0.600	1_KEGG_SMALL_CELL_LUNG_CANCER	0.600	2_EXTRACELLULAR_MATRIX_PART	0.600	2_CELL_CYCLE_GO_0007049	0.600	0_HALLMARK_ANGIOGENESIS	0.400	1_KEGG_DNA_REPLICATION	0.400	1_KEGG_PATHWAYS_IN_CANCER	0.400	1_KEGG_GLIOMA	0.400	1_KEGG_MELANOMA	0.400	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.400	2_EXTRACELLULAR_MATRIX	0.400	2_CELL_CYCLE_PHASE	0.400	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.400	2_REGULATION_OF_CELL_CYCLE	0.400	0_HALLMARK_APOPTOSIS	0.200	
ITGAX	5	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.800	1_KEGG_FOCAL_ADHESION	0.800	1_KEGG_ECM_RECEPTOR_INTERACTION	0.800	1_KEGG_PATHWAYS_IN_CANCER	0.600	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.600	2_GABA_RECEPTOR_ACTIVITY	0.600	0_HALLMARK_G2M_CHECKPOINT	0.400	0_HALLMARK_E2F_TARGETS	0.400	0_HALLMARK_UV_RESPONSE_DN	0.400	1_KEGG_CELL_CYCLE	0.400	1_KEGG_P53_SIGNALING_PATHWAY	0.400	1_KEGG_SMALL_CELL_LUNG_CANCER	0.400	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.400	2_EXTRACELLULAR_MATRIX_PART	0.400	2_EXTRACELLULAR_REGION_PART	0.400	2_EXTRACELLULAR_MATRIX	0.400	2_COLLAGEN	0.400	2_CELL_CELL_SIGNALING	0.400	2_SYNAPTIC_TRANSMISSION	0.400	0_HALLMARK_ANGIOGENESIS	0.200	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.200	1_KEGG_BLADDER_CANCER	0.200	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	0.200	2_EXTRACELLULAR_REGION	0.200	2_SYSTEM_DEVELOPMENT	0.200	
ITGB1	6	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_BLADDER_CANCER	0.667	2_EXTRACELLULAR_MATRIX_PART	0.667	2_CELL_CYCLE_GO_0007049	0.667	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_GLIOMA	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_MICROTUBULE_CYTOSKELETON	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_SPINDLE	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_CHROMOSOMAL_PART	0.500	2_CHROMOSOME	0.500	2_M_PHASE	0.500	2_CELL_CYCLE_PROCESS	0.500	
ITGB2	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_FOCAL_ADHESION	0.667	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	0_HALLMARK_ANGIOGENESIS	0.333	1_KEGG_CELL_CYCLE	0.333	1_KEGG_ECM_RECEPTOR_INTERACTION	0.333	1_KEGG_PATHWAYS_IN_CANCER	0.333	1_KEGG_MELANOMA	0.333	2_COLLAGEN	0.333	2_REGULATION_OF_PHOSPHORYLATION	0.333	2_CELL_CELL_SIGNALING	0.333	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.333	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.333	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	0.333	
ITGB3	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	0_HALLMARK_E2F_TARGETS	0.750	0_HALLMARK_UV_RESPONSE_DN	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_P53_SIGNALING_PATHWAY	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	1_KEGG_MELANOMA	0.750	2_NON_MEMBRANE_BOUND_ORGANELLE	0.750	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.750	2_GABA_RECEPTOR_ACTIVITY	0.750	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_BLADDER_CANCER	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_CYTOSKELETAL_PART	0.500	2_CYTOSKELETON	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_COLLAGEN	0.500	2_REGULATION_OF_PHOSPHORYLATION	0.500	2_DNA_REPLICATION	0.500	2_CELL_CYCLE_GO_0007049	0.500	0_HALLMARK_HYPOXIA	0.250	
ITGB4	4	2_GABA_RECEPTOR_ACTIVITY	1.000	1_KEGG_FOCAL_ADHESION	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	2_CELL_CELL_SIGNALING	0.750	2_SYNAPTIC_TRANSMISSION	0.750	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.750	2_TRANSMISSION_OF_NERVE_IMPULSE	0.750	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.250	0_HALLMARK_COMPLEMENT	0.250	0_HALLMARK_E2F_TARGETS	0.250	0_HALLMARK_P53_PATHWAY	0.250	0_HALLMARK_UV_RESPONSE_DN	0.250	0_HALLMARK_ANGIOGENESIS	0.250	0_HALLMARK_ALLOGRAFT_REJECTION	0.250	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	0.250	1_KEGG_CELL_CYCLE	0.250	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.250	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.250	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.250	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.250	1_KEGG_LEISHMANIA_INFECTION	0.250	1_KEGG_GLIOMA	0.250	1_KEGG_MELANOMA	0.250	1_KEGG_ASTHMA	0.250	
ITGB7	3	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.667	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.667	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.667	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.667	1_KEGG_LEISHMANIA_INFECTION	0.667	1_KEGG_ASTHMA	0.667	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.667	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.667	1_KEGG_ALLOGRAFT_REJECTION	0.667	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.667	1_KEGG_VIRAL_MYOCARDITIS	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_APOPTOSIS	0.333	0_HALLMARK_ALLOGRAFT_REJECTION	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	1_KEGG_PATHWAYS_IN_CANCER	0.333	1_KEGG_MELANOMA	0.333	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.333	
ITGB8	5	0_HALLMARK_G2M_CHECKPOINT	0.800	0_HALLMARK_E2F_TARGETS	0.800	1_KEGG_CELL_CYCLE	0.800	1_KEGG_FOCAL_ADHESION	0.800	1_KEGG_ECM_RECEPTOR_INTERACTION	0.800	2_CELL_CYCLE_GO_0007049	0.800	0_HALLMARK_MYC_TARGETS_V1	0.600	1_KEGG_DNA_REPLICATION	0.600	1_KEGG_P53_SIGNALING_PATHWAY	0.600	2_NUCLEUS	0.600	2_CHROMOSOME	0.600	2_DNA_METABOLIC_PROCESS	0.600	2_CELL_CYCLE_PROCESS	0.600	2_DNA_REPLICATION	0.600	2_REGULATION_OF_CELL_CYCLE	0.600	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.400	0_HALLMARK_UV_RESPONSE_DN	0.400	1_KEGG_PATHWAYS_IN_CANCER	0.400	1_KEGG_SMALL_CELL_LUNG_CANCER	0.400	2_ORGANELLE_PART	0.400	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.400	2_EXTRACELLULAR_MATRIX_PART	0.400	2_MICROTUBULE_CYTOSKELETON	0.400	2_NON_MEMBRANE_BOUND_ORGANELLE	0.400	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.400	
ITPR1	4	2_CELL_CELL_SIGNALING	0.500	2_SYNAPTIC_TRANSMISSION	0.500	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.500	2_TRANSMISSION_OF_NERVE_IMPULSE	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	2_RECEPTOR_ACTIVITY	0.500	1_KEGG_CALCIUM_SIGNALING_PATHWAY	0.250	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	0.250	1_KEGG_OOCYTE_MEIOSIS	0.250	2_NEUROLOGICAL_SYSTEM_PROCESS	0.250	2_SYSTEM_PROCESS	0.250	2_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	0.250	2_SUBSTRATE_SPECIFIC_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	0.250	2_SUBSTRATE_SPECIFIC_TRANSPORTER_ACTIVITY	0.250	2_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	0.250	2_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	0.250	2_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	0.250	
ITSN1	3	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_CELL_CYCLE_PROCESS	1.000	2_CELL_CYCLE_PHASE	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_REGULATION_OF_CELL_CYCLE	1.000	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.667	0_HALLMARK_MYC_TARGETS_V1	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	0_HALLMARK_UV_RESPONSE_DN	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.667	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.667	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_SMALL_CELL_LUNG_CANCER	0.667	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.667	1_KEGG_ALLOGRAFT_REJECTION	0.667	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.667	
JAK1	2	2_CELL_CELL_SIGNALING	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	0.500	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.500	1_KEGG_LONG_TERM_POTENTIATION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	1_KEGG_GLIOMA	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_BLADDER_CANCER	0.500	1_KEGG_ASTHMA	0.500	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.500	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.500	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.500	1_KEGG_VIRAL_MYOCARDITIS	0.500	
KALRN	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_COLORECTAL_CANCER	0.500	1_KEGG_ENDOMETRIAL_CANCER	0.500	1_KEGG_GLIOMA	0.500	1_KEGG_PROSTATE_CANCER	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_BLADDER_CANCER	0.500	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	0.500	2_COLLAGEN	0.500	2_DNA_METABOLIC_PROCESS	0.500	2_INTERPHASE	0.500	2_CELL_CYCLE_PROCESS	0.500	2_MITOTIC_CELL_CYCLE	0.500	2_CELL_CYCLE_PHASE	0.500	
KCNA4	2	
KCNB1	2	
KCNB2	4	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.250	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.250	0_HALLMARK_ANGIOGENESIS	0.250	1_KEGG_CELL_CYCLE	0.250	1_KEGG_P53_SIGNALING_PATHWAY	0.250	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.250	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.250	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.250	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.250	1_KEGG_LEISHMANIA_INFECTION	0.250	1_KEGG_MELANOMA	0.250	1_KEGG_BLADDER_CANCER	0.250	1_KEGG_ASTHMA	0.250	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.250	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.250	1_KEGG_ALLOGRAFT_REJECTION	0.250	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.250	1_KEGG_VIRAL_MYOCARDITIS	0.250	2_GABA_RECEPTOR_ACTIVITY	0.250	
KCNG1	3	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_CELL_CYCLE	0.333	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_ECM_RECEPTOR_INTERACTION	0.333	1_KEGG_PATHWAYS_IN_CANCER	0.333	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.333	2_EXTRACELLULAR_MATRIX_PART	0.333	2_EXTRACELLULAR_MATRIX	0.333	2_COLLAGEN	0.333	2_REGULATION_OF_PHOSPHORYLATION	0.333	2_CELL_CYCLE_PHASE	0.333	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.333	2_SYNAPTIC_TRANSMISSION	0.333	2_CELL_CYCLE_GO_0007049	0.333	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	0.333	
KCNH1	2	
KCNJ4	1	
KCNS3	2	2_AUXILIARY_TRANSPORT_PROTEIN_ACTIVITY	0.500	2_POTASSIUM_CHANNEL_REGULATOR_ACTIVITY	0.500	2_CHANNEL_REGULATOR_ACTIVITY	0.500	
KCNV1	2	
KCNV2	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_BLADDER_CANCER	0.500	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_REPLICATION_FORK	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_COLLAGEN	0.500	2_DNA_METABOLIC_PROCESS	0.500	2_CELL_CELL_SIGNALING	0.500	2_SYNAPTIC_TRANSMISSION	0.500	2_DNA_REPLICATION	0.500	2_CELL_CYCLE_GO_0007049	0.500	2_TRANSMISSION_OF_NERVE_IMPULSE	0.500	
KDR	18	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.778	1_KEGG_FOCAL_ADHESION	0.778	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	0_HALLMARK_UV_RESPONSE_DN	0.611	1_KEGG_CELL_CYCLE	0.556	1_KEGG_PATHWAYS_IN_CANCER	0.556	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	2_COLLAGEN	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	0_HALLMARK_ANGIOGENESIS	0.444	1_KEGG_P53_SIGNALING_PATHWAY	0.444	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.444	1_KEGG_MELANOMA	0.389	2_EXTRACELLULAR_MATRIX_PART	0.389	2_CELL_CYCLE_GO_0007049	0.389	1_KEGG_DNA_REPLICATION	0.333	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.333	2_EXTRACELLULAR_MATRIX	0.333	1_KEGG_BLADDER_CANCER	0.278	1_KEGG_SMALL_CELL_LUNG_CANCER	0.278	2_NON_MEMBRANE_BOUND_ORGANELLE	0.278	2_EXTRACELLULAR_REGION_PART	0.278	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.278	2_CHROMOSOME	0.278	
KIF15	1	
KIF5A	12	2_MICROTUBULE_CYTOSKELETON	0.583	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_CELL_CYCLE	0.500	0_HALLMARK_G2M_CHECKPOINT	0.417	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.417	1_KEGG_P53_SIGNALING_PATHWAY	0.417	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.417	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.417	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.417	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.417	1_KEGG_LEISHMANIA_INFECTION	0.417	1_KEGG_ASTHMA	0.417	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.417	1_KEGG_ALLOGRAFT_REJECTION	0.417	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.417	1_KEGG_VIRAL_MYOCARDITIS	0.417	2_MICROTUBULE_ASSOCIATED_COMPLEX	0.417	2_NON_MEMBRANE_BOUND_ORGANELLE	0.417	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.417	2_CELL_CYCLE_GO_0007049	0.417	0_HALLMARK_APOPTOSIS	0.333	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.333	2_KINESIN_COMPLEX	0.333	2_CYTOSKELETAL_PART	0.333	2_CYTOSKELETON	0.333	
KIFC3	1	
KIR3DL2	2	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	1.000	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	1.000	1_KEGG_VIRAL_MYOCARDITIS	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_COMPLEMENT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	0_HALLMARK_COAGULATION	0.500	0_HALLMARK_ALLOGRAFT_REJECTION	0.500	0_HALLMARK_KRAS_SIGNALING_UP	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	
KIT	24	1_KEGG_FOCAL_ADHESION	0.708	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.625	1_KEGG_CELL_CYCLE	0.583	0_HALLMARK_G2M_CHECKPOINT	0.542	0_HALLMARK_E2F_TARGETS	0.542	0_HALLMARK_UV_RESPONSE_DN	0.542	1_KEGG_P53_SIGNALING_PATHWAY	0.542	1_KEGG_MELANOMA	0.542	2_CELL_CYCLE_GO_0007049	0.458	2_GABA_RECEPTOR_ACTIVITY	0.458	2_EXTRACELLULAR_MATRIX_PART	0.417	2_NON_MEMBRANE_BOUND_ORGANELLE	0.417	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.417	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.375	2_EXTRACELLULAR_MATRIX	0.375	2_COLLAGEN	0.375	2_CHROMOSOME	0.375	1_KEGG_GLIOMA	0.333	1_KEGG_BLADDER_CANCER	0.333	1_KEGG_SMALL_CELL_LUNG_CANCER	0.333	2_CELL_CYCLE_PHASE	0.333	0_HALLMARK_ANGIOGENESIS	0.292	1_KEGG_DNA_REPLICATION	0.292	
KLC2	1	2_MICROTUBULE_ASSOCIATED_COMPLEX	1.000	2_MICROTUBULE_CYTOSKELETON	1.000	2_KINESIN_COMPLEX	1.000	
KLHL9	34	0_HALLMARK_E2F_TARGETS	0.441	1_KEGG_CELL_CYCLE	0.441	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.412	0_HALLMARK_G2M_CHECKPOINT	0.382	1_KEGG_P53_SIGNALING_PATHWAY	0.382	1_KEGG_ECM_RECEPTOR_INTERACTION	0.353	1_KEGG_FOCAL_ADHESION	0.324	2_REGULATION_OF_PHOSPHORYLATION	0.294	2_COLLAGEN	0.265	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.265	2_CELL_CYCLE_GO_0007049	0.265	2_GABA_RECEPTOR_ACTIVITY	0.265	2_EXTRACELLULAR_MATRIX_PART	0.235	0_HALLMARK_UV_RESPONSE_DN	0.206	1_KEGG_DNA_REPLICATION	0.206	1_KEGG_PATHWAYS_IN_CANCER	0.206	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.206	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.206	0_HALLMARK_ANGIOGENESIS	0.176	1_KEGG_SMALL_CELL_LUNG_CANCER	0.176	2_EXTRACELLULAR_MATRIX	0.176	2_CELL_CYCLE_PROCESS	0.176	2_CELL_CYCLE_PHASE	0.176	2_REGULATION_OF_CELL_CYCLE	0.176	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	0.176	
LAMA1	6	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_UV_RESPONSE_DN	0.667	0_HALLMARK_ANGIOGENESIS	0.667	1_KEGG_CELL_CYCLE	0.667	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.667	2_EXTRACELLULAR_MATRIX	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	0_HALLMARK_HYPOXIA	0.333	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_COMPLEMENT	0.333	0_HALLMARK_COAGULATION	0.333	1_KEGG_PATHWAYS_IN_CANCER	0.333	1_KEGG_MELANOMA	0.333	2_AXON	0.333	2_EXTRACELLULAR_REGION_PART	0.333	2_CELL_PROJECTION	0.333	2_COLLAGEN	0.333	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.167	0_HALLMARK_APOPTOSIS	0.167	
LAMA2	6	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.833	1_KEGG_ECM_RECEPTOR_INTERACTION	0.833	0_HALLMARK_UV_RESPONSE_DN	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.667	2_EXTRACELLULAR_MATRIX_PART	0.667	0_HALLMARK_COMPLEMENT	0.500	0_HALLMARK_COAGULATION	0.500	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_ASTHMA	0.500	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.500	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.500	1_KEGG_VIRAL_MYOCARDITIS	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_CELL_CELL_SIGNALING	0.500	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.333	0_HALLMARK_HYPOXIA	0.333	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.333	0_HALLMARK_ANGIOGENESIS	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.333	
LAMA3	4	0_HALLMARK_E2F_TARGETS	0.750	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_FOCAL_ADHESION	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	2_GABA_RECEPTOR_ACTIVITY	0.750	0_HALLMARK_G2M_CHECKPOINT	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_GLIOMA	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_BLADDER_CANCER	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	2_ORGANELLE_PART	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_INTRACELLULAR_ORGANELLE_PART	0.500	2_CHROMOSOMAL_PART	0.500	2_CHROMOSOME	0.500	2_CELL_CYCLE_PROCESS	0.500	2_MITOTIC_CELL_CYCLE	0.500	2_REGULATION_OF_PHOSPHORYLATION	0.500	2_CELL_CYCLE_PHASE	0.500	2_CELL_CELL_SIGNALING	0.500	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.500	
LAMA4	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_ANGIOGENESIS	0.500	0_HALLMARK_KRAS_SIGNALING_UP	0.500	1_KEGG_OOCYTE_MEIOSIS	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_GLIOMA	0.500	1_KEGG_PROSTATE_CANCER	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_BLADDER_CANCER	0.500	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	0.500	1_KEGG_ASTHMA	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_MICROTUBULE_CYTOSKELETON	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_SPINDLE	0.500	
LAMA5	5	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.800	1_KEGG_FOCAL_ADHESION	0.800	1_KEGG_ECM_RECEPTOR_INTERACTION	0.800	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.600	1_KEGG_ASTHMA	0.600	2_EXTRACELLULAR_MATRIX_PART	0.600	2_GABA_RECEPTOR_ACTIVITY	0.600	0_HALLMARK_COMPLEMENT	0.400	0_HALLMARK_UV_RESPONSE_DN	0.400	0_HALLMARK_ANGIOGENESIS	0.400	0_HALLMARK_KRAS_SIGNALING_UP	0.400	1_KEGG_P53_SIGNALING_PATHWAY	0.400	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.400	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.400	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.400	1_KEGG_LEISHMANIA_INFECTION	0.400	1_KEGG_SMALL_CELL_LUNG_CANCER	0.400	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.400	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.400	1_KEGG_ALLOGRAFT_REJECTION	0.400	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.400	1_KEGG_VIRAL_MYOCARDITIS	0.400	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.400	2_EXTRACELLULAR_MATRIX	0.400	2_COLLAGEN	0.400	
LAMB1	5	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.800	1_KEGG_PATHWAYS_IN_CANCER	0.800	1_KEGG_MELANOMA	0.800	0_HALLMARK_G2M_CHECKPOINT	0.600	0_HALLMARK_E2F_TARGETS	0.600	1_KEGG_CELL_CYCLE	0.600	1_KEGG_SMALL_CELL_LUNG_CANCER	0.600	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.600	2_EXTRACELLULAR_MATRIX	0.600	2_CELL_CYCLE_GO_0007049	0.600	2_EXTRACELLULAR_MATRIX_PART	0.400	2_DNA_METABOLIC_PROCESS	0.400	2_CELL_CYCLE_PROCESS	0.400	2_MITOTIC_CELL_CYCLE	0.400	2_CELL_CYCLE_PHASE	0.400	2_CELL_CELL_SIGNALING	0.400	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.400	2_CELL_PROLIFERATION_GO_0008283	0.400	2_GABA_RECEPTOR_ACTIVITY	0.400	0_HALLMARK_APOPTOSIS	0.200	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.200	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.200	0_HALLMARK_COMPLEMENT	0.200	
LAMB3	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_G2M_CHECKPOINT	0.750	0_HALLMARK_E2F_TARGETS	0.750	1_KEGG_CELL_CYCLE	0.750	2_CELL_CYCLE_GO_0007049	0.750	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_DNA_METABOLIC_PROCESS	0.500	2_CELL_CYCLE_PROCESS	0.500	2_REGULATION_OF_PHOSPHORYLATION	0.500	2_CELL_CELL_SIGNALING	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	0_HALLMARK_APOPTOSIS	0.250	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.250	0_HALLMARK_APICAL_JUNCTION	0.250	0_HALLMARK_COMPLEMENT	0.250	0_HALLMARK_UV_RESPONSE_DN	0.250	0_HALLMARK_COAGULATION	0.250	0_HALLMARK_ALLOGRAFT_REJECTION	0.250	
LAMB4	6	1_KEGG_CELL_CYCLE	0.833	1_KEGG_FOCAL_ADHESION	0.833	1_KEGG_ECM_RECEPTOR_INTERACTION	0.833	1_KEGG_PATHWAYS_IN_CANCER	0.833	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_COLLAGEN	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.333	2_CELL_CELL_SIGNALING	0.333	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.333	2_CELL_PROLIFERATION_GO_0008283	0.333	2_CELL_CYCLE_GO_0007049	0.333	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	0.333	2_GABA_RECEPTOR_ACTIVITY	0.333	
LAMC1	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_BLADDER_CANCER	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_REGULATION_OF_PHOSPHORYLATION	1.000	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.500	0_HALLMARK_MITOTIC_SPINDLE	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_COMPLEMENT	0.500	0_HALLMARK_INFLAMMATORY_RESPONSE	0.500	0_HALLMARK_ALLOGRAFT_REJECTION	0.500	0_HALLMARK_KRAS_SIGNALING_UP	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.500	
LAMC3	5	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_G2M_CHECKPOINT	0.800	0_HALLMARK_E2F_TARGETS	0.800	1_KEGG_CELL_CYCLE	0.800	1_KEGG_P53_SIGNALING_PATHWAY	0.800	1_KEGG_PATHWAYS_IN_CANCER	0.800	1_KEGG_SMALL_CELL_LUNG_CANCER	0.800	2_CELL_CYCLE_GO_0007049	0.800	1_KEGG_FOCAL_ADHESION	0.600	1_KEGG_MELANOMA	0.600	1_KEGG_BLADDER_CANCER	0.600	2_NON_MEMBRANE_BOUND_ORGANELLE	0.600	2_NUCLEUS	0.600	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.600	2_REGULATION_OF_PHOSPHORYLATION	0.600	2_REGULATION_OF_CELL_CYCLE	0.600	1_KEGG_PANCREATIC_CANCER	0.400	2_DNA_METABOLIC_PROCESS	0.400	2_CELL_CYCLE_PROCESS	0.400	2_CELL_CELL_SIGNALING	0.400	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.400	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.400	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	0.400	2_GABA_RECEPTOR_ACTIVITY	0.400	
LILRB3	3	1_KEGG_ASTHMA	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.667	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.667	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.667	1_KEGG_LEISHMANIA_INFECTION	0.667	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.667	1_KEGG_ALLOGRAFT_REJECTION	0.667	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.667	1_KEGG_VIRAL_MYOCARDITIS	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	0_HALLMARK_ANGIOGENESIS	0.333	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_ECM_RECEPTOR_INTERACTION	0.333	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.333	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.333	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.333	2_EXTRACELLULAR_MATRIX_PART	0.333	2_EXTRACELLULAR_REGION	0.333	2_EXTRACELLULAR_REGION_PART	0.333	2_EXTRACELLULAR_MATRIX	0.333	2_COLLAGEN	0.333	2_SYSTEM_DEVELOPMENT	0.333	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	0.333	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	0.333	
LRP1	11	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.909	0_HALLMARK_UV_RESPONSE_DN	0.727	1_KEGG_CELL_CYCLE	0.636	1_KEGG_ECM_RECEPTOR_INTERACTION	0.636	2_EXTRACELLULAR_MATRIX_PART	0.636	0_HALLMARK_E2F_TARGETS	0.545	1_KEGG_P53_SIGNALING_PATHWAY	0.545	1_KEGG_FOCAL_ADHESION	0.545	2_GABA_RECEPTOR_ACTIVITY	0.545	0_HALLMARK_G2M_CHECKPOINT	0.455	0_HALLMARK_ANGIOGENESIS	0.455	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.455	2_EXTRACELLULAR_MATRIX	0.455	2_COLLAGEN	0.455	2_CELL_CELL_SIGNALING	0.455	1_KEGG_BLADDER_CANCER	0.364	0_HALLMARK_APOPTOSIS	0.273	0_HALLMARK_COMPLEMENT	0.273	0_HALLMARK_COAGULATION	0.273	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.273	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.273	1_KEGG_LEISHMANIA_INFECTION	0.273	1_KEGG_PATHWAYS_IN_CANCER	0.273	1_KEGG_SMALL_CELL_LUNG_CANCER	0.273	1_KEGG_ASTHMA	0.273	
LRP2	8	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.875	1_KEGG_FOCAL_ADHESION	0.875	1_KEGG_ECM_RECEPTOR_INTERACTION	0.875	0_HALLMARK_G2M_CHECKPOINT	0.625	0_HALLMARK_E2F_TARGETS	0.625	0_HALLMARK_ANGIOGENESIS	0.625	1_KEGG_DNA_REPLICATION	0.625	1_KEGG_CELL_CYCLE	0.625	1_KEGG_P53_SIGNALING_PATHWAY	0.625	2_GABA_RECEPTOR_ACTIVITY	0.625	0_HALLMARK_UV_RESPONSE_DN	0.500	2_COLLAGEN	0.500	2_REGULATION_OF_PHOSPHORYLATION	0.500	0_HALLMARK_COAGULATION	0.375	0_HALLMARK_KRAS_SIGNALING_UP	0.375	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.375	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	0.375	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.375	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.375	1_KEGG_LEISHMANIA_INFECTION	0.375	1_KEGG_ASTHMA	0.375	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.375	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.375	1_KEGG_ALLOGRAFT_REJECTION	0.375	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.375	
LRP8	1	2_GLUTAMATE_RECEPTOR_ACTIVITY	1.000	2_IONOTROPIC_GLUTAMATE_RECEPTOR_ACTIVITY	1.000	
LRRC7	5	0_HALLMARK_G2M_CHECKPOINT	0.200	0_HALLMARK_E2F_TARGETS	0.200	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.200	0_HALLMARK_COAGULATION	0.200	1_KEGG_DNA_REPLICATION	0.200	1_KEGG_CELL_CYCLE	0.200	1_KEGG_P53_SIGNALING_PATHWAY	0.200	1_KEGG_FOCAL_ADHESION	0.200	1_KEGG_ECM_RECEPTOR_INTERACTION	0.200	1_KEGG_SMALL_CELL_LUNG_CANCER	0.200	2_AXON	0.200	2_NON_MEMBRANE_BOUND_ORGANELLE	0.200	2_CYTOSKELETON	0.200	2_CELL_PROJECTION	0.200	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.200	2_GABA_RECEPTOR_ACTIVITY	0.200	
LUM	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_REGION_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	0_HALLMARK_UV_RESPONSE_DN	0.667	0_HALLMARK_ANGIOGENESIS	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	2_EXTRACELLULAR_REGION	0.667	2_COLLAGEN	0.667	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_APOPTOSIS	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_CELL_CYCLE	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	1_KEGG_SMALL_CELL_LUNG_CANCER	0.333	2_CELL_CELL_SIGNALING	0.333	2_DNA_REPLICATION	0.333	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.333	2_CELL_CYCLE_GO_0007049	0.333	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	0.333	2_ENZYME_ACTIVATOR_ACTIVITY	0.333	
LYN	3	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_BLADDER_CANCER	1.000	2_REGULATION_OF_PHOSPHORYLATION	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_GLIOMA	0.667	1_KEGG_MELANOMA	0.667	2_CELL_CYCLE_GO_0007049	0.667	2_REGULATION_OF_CELL_PROLIFERATION	0.667	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.333	0_HALLMARK_APOPTOSIS	0.333	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.333	0_HALLMARK_COMPLEMENT	0.333	0_HALLMARK_INFLAMMATORY_RESPONSE	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	0_HALLMARK_ANGIOGENESIS	0.333	0_HALLMARK_ALLOGRAFT_REJECTION	0.333	0_HALLMARK_KRAS_SIGNALING_UP	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.333	
MACF1	3	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_CELL_CYCLE	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_ECM_RECEPTOR_INTERACTION	0.333	1_KEGG_PATHWAYS_IN_CANCER	0.333	1_KEGG_GLIOMA	0.333	1_KEGG_MELANOMA	0.333	2_CHROMOSOMAL_PART	0.333	2_COLLAGEN	0.333	2_CHROMOSOME	0.333	2_CELL_CELL_SIGNALING	0.333	2_SYNAPTIC_TRANSMISSION	0.333	2_DNA_REPLICATION	0.333	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.333	2_CELL_CYCLE_GO_0007049	0.333	2_REGULATION_OF_CELL_CYCLE	0.333	2_GABA_RECEPTOR_ACTIVITY	0.333	
MAG	1	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1.000	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_MELANOMA	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	1.000	2_CELL_CELL_SIGNALING	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
MAP2K3	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_GLIOMA	1.000	1_KEGG_BLADDER_CANCER	1.000	2_DNA_METABOLIC_PROCESS	1.000	2_CELL_CYCLE_PROCESS	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_DNA_REPLICATION	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
MAP3K4	3	1_KEGG_CELL_CYCLE	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	
MAP4K1	3	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	0_HALLMARK_ALLOGRAFT_REJECTION	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.667	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.667	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.667	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.667	1_KEGG_LEISHMANIA_INFECTION	0.667	1_KEGG_ASTHMA	0.667	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.667	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.667	1_KEGG_ALLOGRAFT_REJECTION	0.667	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.667	2_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_NUCLEUS	0.667	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_IMMUNE_SYSTEM_PROCESS	0.667	2_CELL_CYCLE_GO_0007049	0.667	2_REGULATION_OF_CELL_CYCLE	0.667	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.333	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.333	
MAPK1	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_GLIOMA	1.000	1_KEGG_MELANOMA	1.000	1_KEGG_BLADDER_CANCER	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_SMALL_CELL_LUNG_CANCER	0.667	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	0.667	2_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_CHROMOSOMAL_PART	0.667	2_CHROMOSOME	0.667	2_INTERPHASE	0.667	2_CELL_CYCLE_PROCESS	0.667	2_MITOTIC_CELL_CYCLE	0.667	2_CELL_CYCLE_PHASE	0.667	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.667	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.667	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.667	2_CELL_PROLIFERATION_GO_0008283	0.667	
MAPK8	6	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	0_HALLMARK_G2M_CHECKPOINT	0.833	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.833	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	2_MICROTUBULE_CYTOSKELETON	0.667	2_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_CELL_CYCLE_GO_0007049	0.667	1_KEGG_GLIOMA	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_BLADDER_CANCER	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	2_CHROMOSOME	0.500	2_M_PHASE	0.500	2_CELL_CYCLE_PROCESS	0.500	2_CELL_CYCLE_PHASE	0.500	2_REGULATION_OF_CELL_CYCLE	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	1_KEGG_OOCYTE_MEIOSIS	0.333	1_KEGG_PROSTATE_CANCER	0.333	2_EXTRACELLULAR_MATRIX_PART	0.333	
MAPKAPK3	1	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	1.000	2_AXON	1.000	2_MICROTUBULE_ASSOCIATED_COMPLEX	1.000	2_NEURON_PROJECTION	1.000	2_CELL_CELL_SIGNALING	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
MASTL	4	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_CHROMOSOMAL_PART	1.000	2_CHROMOSOME	1.000	2_CELL_CYCLE_GO_0007049	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	1_KEGG_P53_SIGNALING_PATHWAY	0.750	1_KEGG_FOCAL_ADHESION	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	1_KEGG_PATHWAYS_IN_CANCER	0.750	1_KEGG_BLADDER_CANCER	0.750	2_MICROTUBULE_CYTOSKELETON	0.750	2_SPINDLE	0.750	2_M_PHASE	0.750	2_CELL_CYCLE_PROCESS	0.750	2_MITOTIC_CELL_CYCLE	0.750	2_CELL_CYCLE_PHASE	0.750	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.750	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.750	2_CELL_PROLIFERATION_GO_0008283	0.750	2_MITOSIS	0.750	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	0.750	
MCM3	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	2_CELL_CYCLE_GO_0007049	1.000	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_BLADDER_CANCER	0.500	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_REPLICATION_FORK	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_CHROMOSOMAL_PART	0.500	2_CHROMOSOME	0.500	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.500	2_SYNAPTIC_TRANSMISSION	0.500	2_DNA_REPLICATION	0.500	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.500	2_REGULATION_OF_CELL_CYCLE	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	
MCM4	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_COLLAGEN	0.500	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	0.500	2_INTERPHASE	0.500	2_CELL_CYCLE_PROCESS	0.500	2_MITOTIC_CELL_CYCLE	0.500	2_REGULATION_OF_PHOSPHORYLATION	0.500	2_CELL_CYCLE_PHASE	0.500	2_CELL_CELL_SIGNALING	0.500	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.500	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.500	2_CELL_PROLIFERATION_GO_0008283	0.500	
MCM5	3	1_KEGG_CELL_CYCLE	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_MYC_TARGETS_V1	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	2_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_DNA_METABOLIC_PROCESS	0.667	2_INTERPHASE	0.667	2_CELL_CYCLE_PROCESS	0.667	2_CELL_CYCLE_PHASE	0.667	2_CELL_CYCLE_GO_0007049	0.667	2_REGULATION_OF_CELL_CYCLE	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_APOPTOSIS	0.333	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	0_HALLMARK_KRAS_SIGNALING_UP	0.333	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_ECM_RECEPTOR_INTERACTION	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	1_KEGG_PATHWAYS_IN_CANCER	0.333	1_KEGG_ALLOGRAFT_REJECTION	0.333	
MCM6	3	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	2_COLLAGEN	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_UV_RESPONSE_DN	0.333	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.333	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	1_KEGG_ALLOGRAFT_REJECTION	0.333	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.333	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.333	2_EXTRACELLULAR_MATRIX_PART	0.333	2_MICROTUBULE_ASSOCIATED_COMPLEX	0.333	2_MICROTUBULE_CYTOSKELETON	0.333	2_NON_MEMBRANE_BOUND_ORGANELLE	0.333	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.333	2_EXTRACELLULAR_MATRIX	0.333	2_CONDENSED_CHROMOSOME	0.333	2_CHROMOSOME	0.333	2_M_PHASE	0.333	2_CELL_CYCLE_PROCESS	0.333	
MCM7	3	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_MELANOMA	0.667	1_KEGG_SMALL_CELL_LUNG_CANCER	0.667	2_REPLICATION_FORK	0.667	2_CELL_PROLIFERATION_GO_0008283	0.667	2_CELL_CYCLE_GO_0007049	0.667	0_HALLMARK_APOPTOSIS	0.333	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.333	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.333	0_HALLMARK_COMPLEMENT	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	0_HALLMARK_ANGIOGENESIS	0.333	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.333	1_KEGG_MISMATCH_REPAIR	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.333	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.333	
MDM2	16	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.875	0_HALLMARK_E2F_TARGETS	0.813	1_KEGG_CELL_CYCLE	0.813	1_KEGG_ECM_RECEPTOR_INTERACTION	0.813	0_HALLMARK_G2M_CHECKPOINT	0.750	1_KEGG_FOCAL_ADHESION	0.750	1_KEGG_P53_SIGNALING_PATHWAY	0.688	1_KEGG_BLADDER_CANCER	0.688	2_CELL_CYCLE_GO_0007049	0.625	2_GABA_RECEPTOR_ACTIVITY	0.625	2_EXTRACELLULAR_MATRIX_PART	0.563	2_REGULATION_OF_CELL_CYCLE	0.563	1_KEGG_MELANOMA	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	0_HALLMARK_ANGIOGENESIS	0.438	1_KEGG_PATHWAYS_IN_CANCER	0.438	2_EXTRACELLULAR_MATRIX	0.438	2_COLLAGEN	0.438	0_HALLMARK_UV_RESPONSE_DN	0.375	1_KEGG_GLIOMA	0.375	2_SYNAPTIC_TRANSMISSION	0.375	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.375	1_KEGG_DNA_REPLICATION	0.313	
MDM4	5	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.800	2_CELL_CYCLE_GO_0007049	0.800	0_HALLMARK_APOPTOSIS	0.600	1_KEGG_DNA_REPLICATION	0.600	1_KEGG_FOCAL_ADHESION	0.600	1_KEGG_ECM_RECEPTOR_INTERACTION	0.600	1_KEGG_MELANOMA	0.600	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.600	2_EXTRACELLULAR_MATRIX	0.600	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.600	2_GABA_RECEPTOR_ACTIVITY	0.600	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.400	0_HALLMARK_MYC_TARGETS_V1	0.400	0_HALLMARK_UV_RESPONSE_DN	0.400	0_HALLMARK_ANGIOGENESIS	0.400	0_HALLMARK_ALLOGRAFT_REJECTION	0.400	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.400	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.400	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.400	
MED13	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.667	0_HALLMARK_HYPOXIA	0.667	1_KEGG_MELANOMA	0.667	2_EXTRACELLULAR_REGION	0.667	2_COLLAGEN	0.667	2_RESPONSE_TO_EXTERNAL_STIMULUS	0.667	2_RESPONSE_TO_WOUNDING	0.667	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.333	0_HALLMARK_COMPLEMENT	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	0_HALLMARK_COAGULATION	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_CELL_CYCLE	0.333	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	0.333	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.333	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.333	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	0.333	1_KEGG_LEISHMANIA_INFECTION	0.333	
MELK	2	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	2_AXON	0.500	2_MICROTUBULE_CYTOSKELETON	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_NEURON_PROJECTION	0.500	2_INTERPHASE	0.500	2_CELL_CYCLE_PROCESS	0.500	2_MITOTIC_CELL_CYCLE	0.500	2_REGULATION_OF_PHOSPHORYLATION	0.500	2_CELL_CYCLE_PHASE	0.500	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.500	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.500	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.500	2_CELL_CYCLE_ARREST_GO_0007050	0.500	2_CELL_CYCLE_GO_0007049	0.500	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	0.500	2_REGULATION_OF_CELL_CYCLE	0.500	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	0.500	2_REGULATION_OF_CELL_PROLIFERATION	0.500	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	0.500	2_KINASE_REGULATOR_ACTIVITY	0.500	
MET	10	1_KEGG_FOCAL_ADHESION	0.900	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.800	1_KEGG_ECM_RECEPTOR_INTERACTION	0.800	1_KEGG_MELANOMA	0.700	1_KEGG_PATHWAYS_IN_CANCER	0.600	2_GABA_RECEPTOR_ACTIVITY	0.600	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	2_CELL_CELL_SIGNALING	0.500	2_TRANSMISSION_OF_NERVE_IMPULSE	0.500	0_HALLMARK_G2M_CHECKPOINT	0.400	1_KEGG_SMALL_CELL_LUNG_CANCER	0.400	2_SYNAPTIC_TRANSMISSION	0.400	2_CELL_CYCLE_GO_0007049	0.400	0_HALLMARK_ANGIOGENESIS	0.300	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.300	2_EXTRACELLULAR_MATRIX_PART	0.300	2_EXTRACELLULAR_MATRIX	0.300	2_COLLAGEN	0.300	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.300	2_REGULATION_OF_CELL_CYCLE	0.300	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.200	0_HALLMARK_COMPLEMENT	0.200	
MLL	3	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	0_HALLMARK_UV_RESPONSE_DN	0.667	0_HALLMARK_ANGIOGENESIS	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.667	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.667	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.667	1_KEGG_LEISHMANIA_INFECTION	0.667	1_KEGG_ASTHMA	0.667	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.667	1_KEGG_ALLOGRAFT_REJECTION	0.667	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.667	1_KEGG_VIRAL_MYOCARDITIS	0.667	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.667	2_EXTRACELLULAR_MATRIX_PART	0.667	2_EXTRACELLULAR_REGION_PART	0.667	2_EXTRACELLULAR_MATRIX	0.667	2_COLLAGEN	0.667	2_CELL_CYCLE_GO_0007049	0.667	0_HALLMARK_MITOTIC_SPINDLE	0.333	
MLLT4	5	1_KEGG_CELL_CYCLE	0.800	0_HALLMARK_G2M_CHECKPOINT	0.600	0_HALLMARK_E2F_TARGETS	0.600	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.600	0_HALLMARK_UV_RESPONSE_DN	0.600	1_KEGG_P53_SIGNALING_PATHWAY	0.600	1_KEGG_FOCAL_ADHESION	0.600	1_KEGG_ECM_RECEPTOR_INTERACTION	0.600	2_EXTRACELLULAR_MATRIX_PART	0.600	0_HALLMARK_MYC_TARGETS_V1	0.400	0_HALLMARK_ANGIOGENESIS	0.400	1_KEGG_DNA_REPLICATION	0.400	1_KEGG_PATHWAYS_IN_CANCER	0.400	1_KEGG_MELANOMA	0.400	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.400	2_NON_MEMBRANE_BOUND_ORGANELLE	0.400	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.400	2_EXTRACELLULAR_MATRIX	0.400	2_COLLAGEN	0.400	2_CHROMOSOME	0.400	2_REGULATION_OF_PHOSPHORYLATION	0.400	2_CELL_CYCLE_PHASE	0.400	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.400	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.400	2_CELL_CYCLE_GO_0007049	0.400	
MMP7	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_REGION	1.000	2_EXTRACELLULAR_REGION_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.500	0_HALLMARK_HYPOXIA	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_COMPLEMENT	0.500	0_HALLMARK_INFLAMMATORY_RESPONSE	0.500	0_HALLMARK_COAGULATION	0.500	0_HALLMARK_ALLOGRAFT_REJECTION	0.500	0_HALLMARK_KRAS_SIGNALING_UP	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	
MNDA	1	
MORF4L1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	2_AXON	1.000	2_MICROTUBULE_CYTOSKELETON	1.000	2_NEURON_PROJECTION	1.000	2_REGULATION_OF_KINASE_ACTIVITY	1.000	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	1.000	2_REGULATION_OF_TRANSFERASE_ACTIVITY	1.000	2_CELL_CELL_SIGNALING	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_NEUROLOGICAL_SYSTEM_PROCESS	1.000	2_REGULATION_OF_CATALYTIC_ACTIVITY	1.000	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	2_REGULATION_OF_CELL_CYCLE	1.000	2_CENTRAL_NERVOUS_SYSTEM_DEVELOPMENT	1.000	2_ENZYME_REGULATOR_ACTIVITY	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
MRE11A	1	
MSH6	5	0_HALLMARK_E2F_TARGETS	0.800	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.800	1_KEGG_CELL_CYCLE	0.800	1_KEGG_P53_SIGNALING_PATHWAY	0.800	1_KEGG_FOCAL_ADHESION	0.800	1_KEGG_PATHWAYS_IN_CANCER	0.800	1_KEGG_MELANOMA	0.800	2_CELL_CYCLE_GO_0007049	0.800	2_GABA_RECEPTOR_ACTIVITY	0.800	0_HALLMARK_G2M_CHECKPOINT	0.600	1_KEGG_ECM_RECEPTOR_INTERACTION	0.600	1_KEGG_BLADDER_CANCER	0.600	2_NON_MEMBRANE_BOUND_ORGANELLE	0.600	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.600	2_DNA_REPLICATION	0.600	0_HALLMARK_UV_RESPONSE_DN	0.400	1_KEGG_GLIOMA	0.400	2_DNA_METABOLIC_PROCESS	0.400	2_INTERPHASE	0.400	2_CELL_CYCLE_PROCESS	0.400	2_REGULATION_OF_PHOSPHORYLATION	0.400	2_CELL_CYCLE_PHASE	0.400	2_CELL_CELL_SIGNALING	0.400	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.400	2_REGULATION_OF_CELL_CYCLE	0.400	
MVP	1	
MXD1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_INTERPHASE	1.000	2_CELL_CYCLE_PROCESS	1.000	2_REGULATION_OF_PHOSPHORYLATION	1.000	2_CELL_CYCLE_PHASE	1.000	2_CELL_CELL_SIGNALING	1.000	2_CELL_CYCLE_CHECKPOINT_GO_0000075	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_NEGATIVE_REGULATION_OF_CATALYTIC_ACTIVITY	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	2_REGULATION_OF_CELL_CYCLE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
MYBL1	1	
MYF5	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	1_KEGG_ASTHMA	0.500	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.500	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.500	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.500	1_KEGG_VIRAL_MYOCARDITIS	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_EXTRACELLULAR_REGION	0.500	2_EXTRACELLULAR_REGION_PART	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_COLLAGEN	0.500	2_NEGATIVE_REGULATION_OF_DNA_BINDING	0.500	2_NEGATIVE_REGULATION_OF_BINDING	0.500	2_NEGATIVE_REGULATION_OF_TRANSCRIPTION_FACTOR_ACTIVITY	0.500	2_RESPONSE_TO_WOUNDING	0.500	
MYOD1	1	
MYOG	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_BLADDER_CANCER	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_CYTOSKELETON	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_COLLAGEN	1.000	2_REGULATION_OF_PHOSPHORYLATION	1.000	2_CELL_CYCLE_CHECKPOINT_GO_0000075	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	1.000	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	1.000	2_CELL_PROLIFERATION_GO_0008283	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	1.000	
MYST4	4	0_HALLMARK_E2F_TARGETS	0.750	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_P53_SIGNALING_PATHWAY	0.750	1_KEGG_FOCAL_ADHESION	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	1_KEGG_MELANOMA	0.750	2_GABA_RECEPTOR_ACTIVITY	0.750	0_HALLMARK_G2M_CHECKPOINT	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_EXTRACELLULAR_MATRIX	0.500	0_HALLMARK_APOPTOSIS	0.250	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.250	0_HALLMARK_UV_RESPONSE_DN	0.250	0_HALLMARK_ANGIOGENESIS	0.250	0_HALLMARK_ALLOGRAFT_REJECTION	0.250	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.250	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.250	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.250	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.250	1_KEGG_LEISHMANIA_INFECTION	0.250	1_KEGG_COLORECTAL_CANCER	0.250	1_KEGG_ENDOMETRIAL_CANCER	0.250	
NAP1L1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_MELANOMA	1.000	1_KEGG_BLADDER_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_NUCLEUS	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_DNA_METABOLIC_PROCESS	1.000	2_CELL_CYCLE_PROCESS	1.000	2_REGULATION_OF_PHOSPHORYLATION	1.000	2_CELL_CELL_SIGNALING	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_REGULATION_OF_CELL_CYCLE	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	1.000	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	1.000	
NBN	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	1.000	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_LEISHMANIA_INFECTION	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	1.000	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	1.000	1_KEGG_VIRAL_MYOCARDITIS	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_AXON	1.000	2_EXTRACELLULAR_REGION	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_EXTRACELLULAR_REGION_PART	1.000	
NCAPG	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_OOCYTE_MEIOSIS	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_GLIOMA	0.500	1_KEGG_PROSTATE_CANCER	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_BLADDER_CANCER	0.500	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	2_MICROTUBULE_CYTOSKELETON	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_SPINDLE	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_CHROMOSOMAL_PART	0.500	2_CHROMOSOME	0.500	2_M_PHASE	0.500	2_INTERPHASE	0.500	2_CELL_CYCLE_PROCESS	0.500	2_MITOTIC_CELL_CYCLE	0.500	
NCAPH	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_MICROTUBULE_ASSOCIATED_COMPLEX	1.000	2_MICROTUBULE_CYTOSKELETON	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_CONDENSED_CHROMOSOME	1.000	2_COLLAGEN	1.000	2_CHROMOSOME	1.000	2_M_PHASE	1.000	2_CELL_CYCLE_PROCESS	1.000	2_CELL_CYCLE_PHASE	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_REGULATION_OF_CELL_CYCLE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
NCF1	6	1_KEGG_ECM_RECEPTOR_INTERACTION	0.833	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_FOCAL_ADHESION	0.667	2_CELL_CYCLE_GO_0007049	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_MELANOMA	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.333	0_HALLMARK_COMPLEMENT	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.333	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	1_KEGG_PATHWAYS_IN_CANCER	0.333	1_KEGG_SMALL_CELL_LUNG_CANCER	0.333	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.333	1_KEGG_ALLOGRAFT_REJECTION	0.333	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.333	1_KEGG_VIRAL_MYOCARDITIS	0.333	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.333	2_EXTRACELLULAR_MATRIX_PART	0.333	
NCL	1	
NDN	1	
NEFH	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	1.000	2_AXON	1.000	2_NEURON_PROJECTION	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
NEK2	2	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_CELL_CYCLE	0.500	2_MICROTUBULE_CYTOSKELETON	0.500	2_KINESIN_COMPLEX	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	0.500	2_INTERPHASE	0.500	2_CELL_CYCLE_PROCESS	0.500	2_MITOTIC_CELL_CYCLE	0.500	2_CELL_CYCLE_PHASE	0.500	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.500	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.500	2_CELL_PROLIFERATION_GO_0008283	0.500	2_CELL_CYCLE_GO_0007049	0.500	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	0.500	2_REGULATION_OF_CELL_CYCLE	0.500	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	0.500	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	0.500	2_PROTEIN_KINASE_INHIBITOR_ACTIVITY	0.500	2_KINASE_INHIBITOR_ACTIVITY	0.500	
NF1	18	2_GABA_RECEPTOR_ACTIVITY	0.722	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	2_EXTRACELLULAR_MATRIX_PART	0.556	2_COLLAGEN	0.556	0_HALLMARK_UV_RESPONSE_DN	0.500	1_KEGG_CELL_CYCLE	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX	0.500	0_HALLMARK_E2F_TARGETS	0.444	2_CELL_CELL_SIGNALING	0.444	2_TRANSMISSION_OF_NERVE_IMPULSE	0.444	1_KEGG_P53_SIGNALING_PATHWAY	0.389	0_HALLMARK_G2M_CHECKPOINT	0.333	2_AXON	0.333	2_CELL_CYCLE_GO_0007049	0.333	0_HALLMARK_ANGIOGENESIS	0.278	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.278	1_KEGG_ASTHMA	0.278	2_NEURON_PROJECTION	0.278	2_SYNAPTIC_TRANSMISSION	0.278	2_REGULATION_OF_CELL_CYCLE	0.278	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.222	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.222	
NFATC1	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_CELL_CELL_SIGNALING	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
NFKBIA	1	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_COLLAGEN	1.000	2_CELL_CELL_SIGNALING	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
NGF	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_GLIOMA	0.500	1_KEGG_BLADDER_CANCER	0.500	2_DNA_METABOLIC_PROCESS	0.500	2_CELL_CYCLE_PROCESS	0.500	2_SYNAPTIC_TRANSMISSION	0.500	2_DNA_REPLICATION	0.500	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.500	2_CELL_CYCLE_GO_0007049	0.500	2_TRANSMISSION_OF_NERVE_IMPULSE	0.500	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	
NID1	1	2_CELL_CELL_SIGNALING	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_NEUROLOGICAL_SYSTEM_PROCESS	1.000	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	2_SYSTEM_PROCESS	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	2_RECEPTOR_ACTIVITY	1.000	
NKX3-2	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	2_REGULATION_OF_PHOSPHORYLATION	1.000	2_CELL_CYCLE_CHECKPOINT_GO_0000075	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	1.000	
NLRP12	1	2_REGULATION_OF_SECRETION	1.000	2_REGULATION_OF_CYTOKINE_SECRETION	1.000	2_INTERLEUKIN_1_SECRETION	1.000	2_PROTEIN_SECRETION	1.000	2_REGULATION_OF_PROTEIN_SECRETION	1.000	2_CYTOKINE_SECRETION	1.000	
NOD1	4	1_KEGG_FOCAL_ADHESION	0.750	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.500	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.500	1_KEGG_VIRAL_MYOCARDITIS	0.500	2_CELL_CELL_SIGNALING	0.500	2_TRANSMISSION_OF_NERVE_IMPULSE	0.500	0_HALLMARK_G2M_CHECKPOINT	0.250	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.250	0_HALLMARK_COMPLEMENT	0.250	0_HALLMARK_MYC_TARGETS_V1	0.250	0_HALLMARK_UV_RESPONSE_DN	0.250	0_HALLMARK_ALLOGRAFT_REJECTION	0.250	0_HALLMARK_KRAS_SIGNALING_UP	0.250	1_KEGG_DNA_REPLICATION	0.250	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.250	
NOS1	6	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	2_CELL_CELL_SIGNALING	0.667	2_SYNAPTIC_TRANSMISSION	0.667	2_TRANSMISSION_OF_NERVE_IMPULSE	0.667	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.333	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.333	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	1_KEGG_LEISHMANIA_INFECTION	0.333	1_KEGG_BLADDER_CANCER	0.333	1_KEGG_ASTHMA	0.333	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.333	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.333	1_KEGG_ALLOGRAFT_REJECTION	0.333	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.333	1_KEGG_VIRAL_MYOCARDITIS	0.333	
NOS3	9	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	2_CELL_CYCLE_GO_0007049	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	0.889	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.778	1_KEGG_PATHWAYS_IN_CANCER	0.778	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_MELANOMA	0.667	2_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_CELL_CYCLE_PROCESS	0.667	2_CELL_CYCLE_PHASE	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	1_KEGG_SMALL_CELL_LUNG_CANCER	0.556	2_DNA_METABOLIC_PROCESS	0.556	2_INTERPHASE	0.556	2_DNA_REPLICATION	0.556	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	0.556	2_REGULATION_OF_CELL_CYCLE	0.556	1_KEGG_DNA_REPLICATION	0.444	1_KEGG_GLIOMA	0.444	1_KEGG_BLADDER_CANCER	0.444	2_CHROMOSOME	0.444	
NRXN1	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_CELL_CYCLE	0.667	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.667	2_EXTRACELLULAR_MATRIX	0.667	2_COLLAGEN	0.667	2_CELL_CELL_SIGNALING	0.667	2_SYNAPTIC_TRANSMISSION	0.667	2_TRANSMISSION_OF_NERVE_IMPULSE	0.667	0_HALLMARK_G2M_CHECKPOINT	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	0.333	1_KEGG_PANCREATIC_CANCER	0.333	1_KEGG_GLIOMA	0.333	1_KEGG_MELANOMA	0.333	1_KEGG_BLADDER_CANCER	0.333	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	0.333	2_EXTRACELLULAR_MATRIX_PART	0.333	2_AXON	0.333	2_MICROTUBULE_ASSOCIATED_COMPLEX	0.333	2_MICROTUBULE_CYTOSKELETON	0.333	2_NON_MEMBRANE_BOUND_ORGANELLE	0.333	
NTRK1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	2_REPLICATION_FORK	1.000	2_CHROMOSOME	1.000	2_DNA_METABOLIC_PROCESS	1.000	2_INTERPHASE	1.000	2_CELL_CYCLE_PROCESS	1.000	2_MITOTIC_CELL_CYCLE	1.000	2_REGULATION_OF_PHOSPHORYLATION	1.000	2_CELL_CYCLE_PHASE	1.000	2_CELL_CYCLE_CHECKPOINT_GO_0000075	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_DNA_REPLICATION	1.000	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	2_REGULATION_OF_CELL_CYCLE	1.000	2_REGULATION_OF_CELL_PROLIFERATION	1.000	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
NTRK3	1	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_APICAL_JUNCTION	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_ANGIOGENESIS	1.000	0_HALLMARK_COAGULATION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_MELANOMA	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_REGION	1.000	2_EXTRACELLULAR_REGION_PART	1.000	2_EXTRACELLULAR_SPACE	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_COLLAGEN	1.000	2_SYSTEM_DEVELOPMENT	1.000	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	1.000	2_PROTEOLYSIS	1.000	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	1.000	2_ANATOMICAL_STRUCTURE_DEVELOPMENT	1.000	2_ORGAN_DEVELOPMENT	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	2_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT	1.000	
NUMA1	3	1_KEGG_P53_SIGNALING_PATHWAY	1.000	2_CELL_CYCLE_PHASE	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	1.000	0_HALLMARK_MITOTIC_SPINDLE	0.667	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_SMALL_CELL_LUNG_CANCER	0.667	2_MICROTUBULE_CYTOSKELETON	0.667	2_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_SPINDLE	0.667	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_M_PHASE	0.667	2_CELL_CYCLE_PROCESS	0.667	2_MITOTIC_CELL_CYCLE	0.667	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.667	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.667	2_MITOSIS	0.667	2_REGULATION_OF_CELL_CYCLE	0.667	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	0.667	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	
NXF1	1	
P2RX2	1	2_LIGAND_GATED_CHANNEL_ACTIVITY	1.000	
PARP1	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_MELANOMA	1.000	1_KEGG_BLADDER_CANCER	1.000	2_CELL_PROLIFERATION_GO_0008283	1.000	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.500	0_HALLMARK_HYPOXIA	0.500	0_HALLMARK_DNA_REPAIR	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_PYRIMIDINE_METABOLISM	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.500	1_KEGG_MISMATCH_REPAIR	0.500	1_KEGG_PANCREATIC_CANCER	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	2_ORGANELLE_PART	0.500	
PCDH11X	6	
PCDH11Y	61	
PCDH15	9	2_MICROVILLUS	0.333	2_PHOTORECEPTOR_CELL_MAINTENANCE	0.333	
PCDH19	6	
PCDH24	1	
PCDH7	4	
PCDH9	5	2_MICROVILLUS	0.200	2_PHOTORECEPTOR_CELL_MAINTENANCE	0.200	
PCDHA8	4	
PCDHA9	8	
PCDHAC2	33	0_HALLMARK_G2M_CHECKPOINT	0.030	0_HALLMARK_E2F_TARGETS	0.030	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.030	1_KEGG_CELL_CYCLE	0.030	1_KEGG_P53_SIGNALING_PATHWAY	0.030	1_KEGG_FOCAL_ADHESION	0.030	1_KEGG_ECM_RECEPTOR_INTERACTION	0.030	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.030	1_KEGG_PATHWAYS_IN_CANCER	0.030	
PCDHB13	4	
PCDHB2	1	
PCDHB4	2	
PCDHB5	1	
PCDHB6	2	
PCDHB7	5	
PCDHGC5	35	2_MICROVILLUS	0.057	2_PHOTORECEPTOR_CELL_MAINTENANCE	0.057	
PCM1	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_REGULATION_OF_PHOSPHORYLATION	0.500	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.500	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.500	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.500	2_CELL_CYCLE_GO_0007049	0.500	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	0.500	2_REGULATION_OF_CELL_CYCLE	0.500	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	0.500	
PDGFD	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_EXTRACELLULAR_REGION	0.500	2_EXTRACELLULAR_REGION_PART	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_COLLAGEN	0.500	
PDGFRA	18	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.833	1_KEGG_FOCAL_ADHESION	0.833	1_KEGG_ECM_RECEPTOR_INTERACTION	0.722	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_MELANOMA	0.611	0_HALLMARK_G2M_CHECKPOINT	0.556	1_KEGG_PATHWAYS_IN_CANCER	0.556	1_KEGG_P53_SIGNALING_PATHWAY	0.500	2_CELL_CYCLE_GO_0007049	0.444	0_HALLMARK_ANGIOGENESIS	0.389	1_KEGG_GLIOMA	0.389	1_KEGG_BLADDER_CANCER	0.389	2_REGULATION_OF_PHOSPHORYLATION	0.389	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	0.389	2_GABA_RECEPTOR_ACTIVITY	0.389	1_KEGG_SMALL_CELL_LUNG_CANCER	0.333	2_NON_MEMBRANE_BOUND_ORGANELLE	0.333	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.333	2_COLLAGEN	0.333	2_CHROMOSOME	0.333	2_MITOTIC_CELL_CYCLE	0.333	2_CELL_PROLIFERATION_GO_0008283	0.333	2_REGULATION_OF_CELL_CYCLE	0.333	1_KEGG_DNA_REPLICATION	0.278	
PDGFRB	3	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_GLIOMA	1.000	1_KEGG_MELANOMA	1.000	1_KEGG_BLADDER_CANCER	1.000	2_CELL_CYCLE_GO_0007049	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	0.667	2_DNA_METABOLIC_PROCESS	0.667	2_INTERPHASE	0.667	2_CELL_CYCLE_PROCESS	0.667	2_MITOTIC_CELL_CYCLE	0.667	2_REGULATION_OF_PHOSPHORYLATION	0.667	2_CELL_CYCLE_PHASE	0.667	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.667	2_REGULATION_OF_CELL_CYCLE	0.667	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_UV_RESPONSE_DN	0.333	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	0.333	
PGR	5	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_G2M_CHECKPOINT	0.800	0_HALLMARK_E2F_TARGETS	0.800	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.800	1_KEGG_CELL_CYCLE	0.800	1_KEGG_PATHWAYS_IN_CANCER	0.800	2_NON_MEMBRANE_BOUND_ORGANELLE	0.800	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.800	2_DNA_REPLICATION	0.800	2_CELL_CYCLE_GO_0007049	0.800	1_KEGG_DNA_REPLICATION	0.600	1_KEGG_MELANOMA	0.600	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.600	2_EXTRACELLULAR_MATRIX_PART	0.600	2_EXTRACELLULAR_MATRIX	0.600	2_DNA_METABOLIC_PROCESS	0.600	2_GABA_RECEPTOR_ACTIVITY	0.600	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.400	0_HALLMARK_MYC_TARGETS_V1	0.400	0_HALLMARK_UV_RESPONSE_DN	0.400	0_HALLMARK_ANGIOGENESIS	0.400	1_KEGG_P53_SIGNALING_PATHWAY	0.400	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.400	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.400	
PIK3C2B	17	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.824	1_KEGG_ECM_RECEPTOR_INTERACTION	0.706	1_KEGG_FOCAL_ADHESION	0.647	0_HALLMARK_E2F_TARGETS	0.529	1_KEGG_CELL_CYCLE	0.529	0_HALLMARK_G2M_CHECKPOINT	0.471	0_HALLMARK_ANGIOGENESIS	0.471	1_KEGG_P53_SIGNALING_PATHWAY	0.471	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.471	2_EXTRACELLULAR_MATRIX	0.471	2_GABA_RECEPTOR_ACTIVITY	0.471	2_EXTRACELLULAR_MATRIX_PART	0.412	2_CELL_CYCLE_GO_0007049	0.412	1_KEGG_MELANOMA	0.353	2_EXTRACELLULAR_REGION	0.353	2_EXTRACELLULAR_REGION_PART	0.353	0_HALLMARK_APOPTOSIS	0.294	0_HALLMARK_UV_RESPONSE_DN	0.294	1_KEGG_DNA_REPLICATION	0.294	2_NON_MEMBRANE_BOUND_ORGANELLE	0.294	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.294	2_COLLAGEN	0.294	2_REGULATION_OF_PHOSPHORYLATION	0.294	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.235	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.235	
PIK3C2G	9	1_KEGG_CELL_CYCLE	0.778	2_GABA_RECEPTOR_ACTIVITY	0.778	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.556	1_KEGG_ECM_RECEPTOR_INTERACTION	0.556	2_CELL_CELL_SIGNALING	0.556	2_SYNAPTIC_TRANSMISSION	0.556	2_TRANSMISSION_OF_NERVE_IMPULSE	0.556	0_HALLMARK_G2M_CHECKPOINT	0.444	1_KEGG_P53_SIGNALING_PATHWAY	0.444	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.333	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	1_KEGG_MELANOMA	0.333	1_KEGG_ASTHMA	0.333	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.333	1_KEGG_ALLOGRAFT_REJECTION	0.333	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.333	1_KEGG_VIRAL_MYOCARDITIS	0.333	2_COLLAGEN	0.333	2_REGULATION_OF_PHOSPHORYLATION	0.333	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.333	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	0.333	0_HALLMARK_P53_PATHWAY	0.222	
PIK3CA	30	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.867	1_KEGG_FOCAL_ADHESION	0.700	2_GABA_RECEPTOR_ACTIVITY	0.700	1_KEGG_CELL_CYCLE	0.667	0_HALLMARK_E2F_TARGETS	0.600	1_KEGG_ECM_RECEPTOR_INTERACTION	0.600	0_HALLMARK_G2M_CHECKPOINT	0.500	2_EXTRACELLULAR_MATRIX_PART	0.433	0_HALLMARK_ANGIOGENESIS	0.400	1_KEGG_P53_SIGNALING_PATHWAY	0.400	0_HALLMARK_UV_RESPONSE_DN	0.367	1_KEGG_DNA_REPLICATION	0.367	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.367	2_CELL_CELL_SIGNALING	0.367	1_KEGG_SMALL_CELL_LUNG_CANCER	0.333	2_EXTRACELLULAR_MATRIX	0.333	2_CELL_CYCLE_GO_0007049	0.333	0_HALLMARK_COMPLEMENT	0.300	1_KEGG_ASTHMA	0.300	2_NON_MEMBRANE_BOUND_ORGANELLE	0.300	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.300	2_REGULATION_OF_PHOSPHORYLATION	0.300	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.300	1_KEGG_PATHWAYS_IN_CANCER	0.267	1_KEGG_MELANOMA	0.267	
PIK3CB	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	1.000	2_COLLAGEN	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_UV_RESPONSE_DN	0.667	0_HALLMARK_ANGIOGENESIS	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.667	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.667	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.667	1_KEGG_ASTHMA	0.667	1_KEGG_VIRAL_MYOCARDITIS	0.667	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.667	2_EXTRACELLULAR_MATRIX_PART	0.667	2_EXTRACELLULAR_MATRIX	0.667	2_REGULATION_OF_PHOSPHORYLATION	0.667	2_SYNAPTIC_TRANSMISSION	0.667	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.333	
PIK3CD	4	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_P53_SIGNALING_PATHWAY	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	1_KEGG_MELANOMA	0.750	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.750	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	0.750	0_HALLMARK_G2M_CHECKPOINT	0.500	1_KEGG_GLIOMA	0.500	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_CHROMOSOMAL_PART	0.500	2_CHROMOSOME	0.500	2_INTERPHASE	0.500	2_CELL_CYCLE_PROCESS	0.500	2_MITOTIC_CELL_CYCLE	0.500	2_CELL_CYCLE_PHASE	0.500	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.500	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.500	
PIK3CG	12	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.917	1_KEGG_FOCAL_ADHESION	0.833	0_HALLMARK_G2M_CHECKPOINT	0.750	0_HALLMARK_E2F_TARGETS	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	1_KEGG_SMALL_CELL_LUNG_CANCER	0.667	2_CELL_CYCLE_GO_0007049	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.583	1_KEGG_MELANOMA	0.583	0_HALLMARK_UV_RESPONSE_DN	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.417	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.333	0_HALLMARK_ANGIOGENESIS	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.333	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	1_KEGG_BLADDER_CANCER	0.333	1_KEGG_ASTHMA	0.333	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.333	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.333	1_KEGG_VIRAL_MYOCARDITIS	0.333	2_EXTRACELLULAR_MATRIX_PART	0.333	
PIK3R1	30	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.800	2_GABA_RECEPTOR_ACTIVITY	0.767	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_CELL_CYCLE	0.633	1_KEGG_ECM_RECEPTOR_INTERACTION	0.633	0_HALLMARK_E2F_TARGETS	0.567	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_UV_RESPONSE_DN	0.467	1_KEGG_P53_SIGNALING_PATHWAY	0.467	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.467	2_EXTRACELLULAR_MATRIX_PART	0.467	2_EXTRACELLULAR_MATRIX	0.467	1_KEGG_ASTHMA	0.400	2_COLLAGEN	0.400	1_KEGG_SMALL_CELL_LUNG_CANCER	0.367	1_KEGG_ALLOGRAFT_REJECTION	0.367	2_CELL_CYCLE_GO_0007049	0.367	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.333	2_CELL_CYCLE_PHASE	0.333	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.300	1_KEGG_VIRAL_MYOCARDITIS	0.300	0_HALLMARK_ANGIOGENESIS	0.267	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.267	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.267	
PIK3R5	1	
PIM1	2	0_HALLMARK_MITOTIC_SPINDLE	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	2_ORGANELLE_PART	0.500	2_MICROTUBULE_CYTOSKELETON	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_CYTOSKELETAL_PART	0.500	2_NUCLEUS	0.500	2_SPINDLE	0.500	2_CYTOSKELETON	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_INTRACELLULAR_ORGANELLE_PART	0.500	2_CHROMOSOMAL_PART	0.500	2_CHROMOSOME	0.500	2_M_PHASE	0.500	2_MICROTUBULE_CYTOSKELETON_ORGANIZATION_AND_BIOGENESIS	0.500	2_INTERPHASE	0.500	2_CELL_CYCLE_PROCESS	0.500	2_MITOTIC_CELL_CYCLE	0.500	2_CELL_CYCLE_PHASE	0.500	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.500	2_REGULATION_OF_CATALYTIC_ACTIVITY	0.500	
PIP5K1C	1	
PLAT	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
PLAU	7	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	0_HALLMARK_G2M_CHECKPOINT	0.857	1_KEGG_P53_SIGNALING_PATHWAY	0.857	1_KEGG_FOCAL_ADHESION	0.857	1_KEGG_ECM_RECEPTOR_INTERACTION	0.714	1_KEGG_PATHWAYS_IN_CANCER	0.714	2_NON_MEMBRANE_BOUND_ORGANELLE	0.714	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.714	2_CELL_CYCLE_GO_0007049	0.714	1_KEGG_MELANOMA	0.571	1_KEGG_BLADDER_CANCER	0.571	2_MICROTUBULE_CYTOSKELETON	0.571	2_CHROMOSOMAL_PART	0.571	2_CHROMOSOME	0.571	2_M_PHASE	0.571	2_CELL_CYCLE_PROCESS	0.571	2_MITOTIC_CELL_CYCLE	0.571	2_CELL_CYCLE_PHASE	0.571	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.571	2_CELL_PROLIFERATION_GO_0008283	0.571	2_MITOSIS	0.571	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	0.571	2_REGULATION_OF_CELL_CYCLE	0.571	
PLCB1	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_REGION_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_COLLAGEN	1.000	2_CELL_CELL_SIGNALING	1.000	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	1.000	2_REGULATION_OF_TRANSPORT	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
PLCG1	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	1_KEGG_ASTHMA	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.500	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_COLLAGEN	0.500	2_CELL_CELL_SIGNALING	0.500	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.250	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	0.250	0_HALLMARK_G2M_CHECKPOINT	0.250	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.250	0_HALLMARK_E2F_TARGETS	0.250	0_HALLMARK_MYC_TARGETS_V1	0.250	0_HALLMARK_INFLAMMATORY_RESPONSE	0.250	0_HALLMARK_UV_RESPONSE_DN	0.250	0_HALLMARK_ALLOGRAFT_REJECTION	0.250	
PLCG2	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_P53_PATHWAY	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	0_HALLMARK_ANGIOGENESIS	0.333	1_KEGG_CALCIUM_SIGNALING_PATHWAY	0.333	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	0.333	1_KEGG_CELL_CYCLE	0.333	1_KEGG_PATHWAYS_IN_CANCER	0.333	1_KEGG_GLIOMA	0.333	1_KEGG_MELANOMA	0.333	1_KEGG_SMALL_CELL_LUNG_CANCER	0.333	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.333	2_EXTRACELLULAR_MATRIX_PART	0.333	2_EXTRACELLULAR_REGION_PART	0.333	2_EXTRACELLULAR_MATRIX	0.333	2_COLLAGEN	0.333	2_REGULATION_OF_KINASE_ACTIVITY	0.333	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	0.333	2_REGULATION_OF_TRANSFERASE_ACTIVITY	0.333	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.333	
PLCZ1	1	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	1.000	
PLG	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	2_CELL_CELL_SIGNALING	1.000	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.667	2_SYNAPTIC_TRANSMISSION	0.667	2_TRANSMISSION_OF_NERVE_IMPULSE	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_COMPLEMENT	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	0_HALLMARK_COAGULATION	0.333	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	0.333	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.333	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	1_KEGG_MELANOMA	0.333	1_KEGG_ASTHMA	0.333	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.333	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.333	1_KEGG_ALLOGRAFT_REJECTION	0.333	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.333	1_KEGG_VIRAL_MYOCARDITIS	0.333	2_EXTRACELLULAR_MATRIX_PART	0.333	2_AXON	0.333	2_CYTOPLASMIC_PART	0.333	2_CYTOPLASM	0.333	
POLA1	1	1_KEGG_DNA_REPLICATION	1.000	2_REPLICATION_FORK	1.000	
POLR2A	2	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_P53_PATHWAY	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_LONG_TERM_POTENTIATION	0.500	1_KEGG_GLIOMA	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_BLADDER_CANCER	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	2_ORGANELLE_PART	0.500	2_AXON	0.500	2_INTERMEDIATE_FILAMENT_CYTOSKELETON	0.500	2_CYTOSKELETAL_PART	0.500	2_NUCLEUS	0.500	2_CYTOSKELETON	0.500	2_INTERMEDIATE_FILAMENT	0.500	2_INTRACELLULAR_ORGANELLE_PART	0.500	
POU2F1	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_APICAL_JUNCTION	0.500	0_HALLMARK_ANGIOGENESIS	0.500	0_HALLMARK_COAGULATION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_MELANOMA	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_AXON	0.500	2_EXTRACELLULAR_REGION	0.500	2_EXTRACELLULAR_REGION_PART	0.500	2_EXTRACELLULAR_SPACE	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_COLLAGEN	0.500	2_NEURON_PROJECTION	0.500	2_SYSTEM_DEVELOPMENT	0.500	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	0.500	2_PROTEOLYSIS	0.500	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.500	
PPARA	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_MELANOMA	0.667	1_KEGG_BLADDER_CANCER	0.667	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_ANGIOGENESIS	0.333	1_KEGG_OOCYTE_MEIOSIS	0.333	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_ECM_RECEPTOR_INTERACTION	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.333	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.333	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	1_KEGG_LEISHMANIA_INFECTION	0.333	1_KEGG_PATHWAYS_IN_CANCER	0.333	1_KEGG_GLIOMA	0.333	1_KEGG_PROSTATE_CANCER	0.333	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	0.333	1_KEGG_SMALL_CELL_LUNG_CANCER	0.333	1_KEGG_ASTHMA	0.333	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.333	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.333	
PPARG	1	
PPIA	6	0_HALLMARK_E2F_TARGETS	0.833	1_KEGG_CELL_CYCLE	0.833	0_HALLMARK_G2M_CHECKPOINT	0.667	2_CELL_CYCLE_GO_0007049	0.667	2_REGULATION_OF_CELL_CYCLE	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_MYC_TARGETS_V1	0.500	2_MICROTUBULE_CYTOSKELETON	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_NUCLEUS	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_CELL_CELL_SIGNALING	0.500	2_SYNAPTIC_TRANSMISSION	0.500	2_TRANSMISSION_OF_NERVE_IMPULSE	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_ECM_RECEPTOR_INTERACTION	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	2_ORGANELLE_PART	0.333	2_AXON	0.333	2_INTRACELLULAR_ORGANELLE_PART	0.333	2_CHROMOSOMAL_PART	0.333	2_NEURON_PROJECTION	0.333	
PPP1CC	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_OOCYTE_MEIOSIS	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_GLIOMA	1.000	1_KEGG_BLADDER_CANCER	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTERPHASE	1.000	2_MITOTIC_CELL_CYCLE	1.000	2_CELL_CYCLE_PHASE	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	1.000	2_REGULATION_OF_CELL_CYCLE	1.000	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
PPP1R1A	1	
PPP2R1B	1	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	1.000	0_HALLMARK_HYPOXIA	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	1.000	0_HALLMARK_COMPLEMENT	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_INFLAMMATORY_RESPONSE	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ANGIOGENESIS	1.000	0_HALLMARK_COAGULATION	1.000	0_HALLMARK_ALLOGRAFT_REJECTION	1.000	0_HALLMARK_KRAS_SIGNALING_UP	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	1.000	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1.000	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_LEISHMANIA_INFECTION	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	1.000	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	1.000	
PPP2R5D	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_CHROMOSOMAL_PART	1.000	2_CHROMOSOME	1.000	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	1.000	2_CELL_CYCLE_GO_0007049	1.000	
PPP3CB	6	0_HALLMARK_G2M_CHECKPOINT	0.167	0_HALLMARK_E2F_TARGETS	0.167	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.167	1_KEGG_CELL_CYCLE	0.167	2_AXON	0.167	2_MICROTUBULE_CYTOSKELETON	0.167	2_NON_MEMBRANE_BOUND_ORGANELLE	0.167	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.167	2_NEURON_PROJECTION	0.167	
PPP3CC	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_REGULATION_OF_PHOSPHORYLATION	1.000	2_CELL_CYCLE_CHECKPOINT_GO_0000075	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	1.000	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_POSITIVE_REGULATION_OF_CELLULAR_PROCESS	1.000	2_REGULATION_OF_CELL_CYCLE	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	1.000	
PRKACG	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_MICROTUBULE_ASSOCIATED_COMPLEX	1.000	2_MICROTUBULE_CYTOSKELETON	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_CONDENSED_CHROMOSOME	1.000	2_COLLAGEN	1.000	2_CHROMOSOME	1.000	2_M_PHASE	1.000	2_CELL_CYCLE_PROCESS	1.000	2_CELL_CYCLE_PHASE	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_REGULATION_OF_CELL_CYCLE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
PRKCA	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_REGULATION_OF_PHOSPHORYLATION	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	0.500	1_KEGG_GLIOMA	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_BLADDER_CANCER	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_CYTOSKELETON	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_COLLAGEN	0.500	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.500	2_DNA_REPLICATION	0.500	2_CELL_CYCLE_GO_0007049	0.500	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	0.500	
PRKCB	3	1_KEGG_CELL_CYCLE	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_DNA_REPLICATION	0.667	2_REGULATION_OF_PHOSPHORYLATION	0.667	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.667	0_HALLMARK_MITOTIC_SPINDLE	0.333	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.333	0_HALLMARK_COMPLEMENT	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_ECM_RECEPTOR_INTERACTION	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.333	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.333	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	1_KEGG_LEISHMANIA_INFECTION	0.333	1_KEGG_PATHWAYS_IN_CANCER	0.333	1_KEGG_ASTHMA	0.333	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.333	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.333	1_KEGG_ALLOGRAFT_REJECTION	0.333	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.333	1_KEGG_VIRAL_MYOCARDITIS	0.333	
PRKCD	3	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	2_CELL_CYCLE_CHECKPOINT_GO_0000075	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_REGULATION_OF_CELL_CYCLE	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_BLADDER_CANCER	0.667	1_KEGG_SMALL_CELL_LUNG_CANCER	0.667	2_REGULATION_OF_KINASE_ACTIVITY	0.667	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	0.667	2_REGULATION_OF_TRANSFERASE_ACTIVITY	0.667	2_CELL_CYCLE_PROCESS	0.667	2_CELL_CYCLE_PHASE	0.667	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.667	0_HALLMARK_DNA_REPAIR	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.333	1_KEGG_MISMATCH_REPAIR	0.333	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_ECM_RECEPTOR_INTERACTION	0.333	1_KEGG_PANCREATIC_CANCER	0.333	
PRKCG	2	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	0.500	1_KEGG_OOCYTE_MEIOSIS	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	2_CELL_CELL_SIGNALING	0.500	2_SYNAPTIC_TRANSMISSION	0.500	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.500	2_TRANSMISSION_OF_NERVE_IMPULSE	0.500	2_RECEPTOR_ACTIVITY	0.500	
PRKCQ	5	0_HALLMARK_G2M_CHECKPOINT	0.800	0_HALLMARK_E2F_TARGETS	0.800	1_KEGG_CELL_CYCLE	0.800	2_NON_MEMBRANE_BOUND_ORGANELLE	0.800	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.800	2_CHROMOSOMAL_PART	0.800	2_CHROMOSOME	0.800	2_CELL_CYCLE_GO_0007049	0.800	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.600	1_KEGG_P53_SIGNALING_PATHWAY	0.600	1_KEGG_FOCAL_ADHESION	0.600	1_KEGG_ECM_RECEPTOR_INTERACTION	0.600	1_KEGG_PATHWAYS_IN_CANCER	0.600	1_KEGG_BLADDER_CANCER	0.600	2_MICROTUBULE_CYTOSKELETON	0.600	2_SPINDLE	0.600	2_M_PHASE	0.600	2_CELL_CYCLE_PROCESS	0.600	2_MITOTIC_CELL_CYCLE	0.600	2_CELL_CYCLE_PHASE	0.600	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.600	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.600	2_CELL_PROLIFERATION_GO_0008283	0.600	2_MITOSIS	0.600	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	0.600	
PRKDC	7	0_HALLMARK_E2F_TARGETS	0.571	0_HALLMARK_G2M_CHECKPOINT	0.429	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.429	1_KEGG_CELL_CYCLE	0.429	1_KEGG_P53_SIGNALING_PATHWAY	0.429	1_KEGG_FOCAL_ADHESION	0.286	2_DNA_METABOLIC_PROCESS	0.286	2_MITOTIC_CELL_CYCLE	0.286	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.286	2_CELL_CYCLE_GO_0007049	0.286	2_REGULATION_OF_CELL_CYCLE	0.286	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	0.286	2_GABA_RECEPTOR_ACTIVITY	0.286	0_HALLMARK_COMPLEMENT	0.143	0_HALLMARK_MYC_TARGETS_V1	0.143	0_HALLMARK_P53_PATHWAY	0.143	0_HALLMARK_ANGIOGENESIS	0.143	0_HALLMARK_COAGULATION	0.143	0_HALLMARK_ALLOGRAFT_REJECTION	0.143	0_HALLMARK_KRAS_SIGNALING_UP	0.143	1_KEGG_DNA_REPLICATION	0.143	1_KEGG_ECM_RECEPTOR_INTERACTION	0.143	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.143	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	0.143	1_KEGG_LEISHMANIA_INFECTION	0.143	
PRKX	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_REPLICATION_FORK	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_CHROMOSOMAL_PART	1.000	2_CHROMOSOME	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.500	0_HALLMARK_COMPLEMENT	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	1_KEGG_MISMATCH_REPAIR	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_AXON	0.500	2_MICROTUBULE_CYTOSKELETON	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_COLLAGEN	0.500	2_NEURON_PROJECTION	0.500	
PRKY	53	2_GABA_RECEPTOR_ACTIVITY	0.453	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.396	1_KEGG_CELL_CYCLE	0.377	0_HALLMARK_E2F_TARGETS	0.321	1_KEGG_ECM_RECEPTOR_INTERACTION	0.302	0_HALLMARK_G2M_CHECKPOINT	0.245	1_KEGG_P53_SIGNALING_PATHWAY	0.245	2_COLLAGEN	0.245	2_SYNAPTIC_TRANSMISSION	0.245	0_HALLMARK_UV_RESPONSE_DN	0.226	2_CELL_CELL_SIGNALING	0.226	1_KEGG_FOCAL_ADHESION	0.208	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.189	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.189	2_EXTRACELLULAR_MATRIX_PART	0.189	2_EXTRACELLULAR_MATRIX	0.189	2_TRANSMISSION_OF_NERVE_IMPULSE	0.189	1_KEGG_ASTHMA	0.170	2_CELL_CYCLE_GO_0007049	0.170	0_HALLMARK_ANGIOGENESIS	0.151	2_REGULATION_OF_CELL_CYCLE	0.151	1_KEGG_DNA_REPLICATION	0.132	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.132	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.132	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.132	
PSIP1	3	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	2_CELL_CYCLE_PROCESS	0.667	2_MITOTIC_CELL_CYCLE	0.667	2_CELL_CYCLE_PHASE	0.667	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.667	2_CELL_CYCLE_GO_0007049	0.667	2_REGULATION_OF_CELL_CYCLE	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.333	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.333	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.333	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	1_KEGG_LEISHMANIA_INFECTION	0.333	1_KEGG_GLIOMA	0.333	1_KEGG_ASTHMA	0.333	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.333	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.333	1_KEGG_ALLOGRAFT_REJECTION	0.333	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.333	
PSMA2	5	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	0_HALLMARK_G2M_CHECKPOINT	0.800	2_CELL_CYCLE_GO_0007049	0.800	2_REGULATION_OF_CELL_CYCLE	0.800	0_HALLMARK_MYC_TARGETS_V1	0.600	2_MICROTUBULE_CYTOSKELETON	0.600	2_NON_MEMBRANE_BOUND_ORGANELLE	0.600	2_NUCLEUS	0.600	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.600	2_GABA_RECEPTOR_ACTIVITY	0.600	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.400	1_KEGG_DNA_REPLICATION	0.400	1_KEGG_P53_SIGNALING_PATHWAY	0.400	1_KEGG_FOCAL_ADHESION	0.400	1_KEGG_ECM_RECEPTOR_INTERACTION	0.400	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.400	2_ORGANELLE_PART	0.400	2_AXON	0.400	2_INTRACELLULAR_ORGANELLE_PART	0.400	2_CHROMOSOMAL_PART	0.400	2_NEURON_PROJECTION	0.400	2_CHROMOSOME	0.400	2_CELL_CYCLE_PROCESS	0.400	2_CELL_CELL_SIGNALING	0.400	
PSMA5	1	1_KEGG_PROTEASOME	1.000	
PSMB8	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_CELL_PROLIFERATION_GO_0008283	1.000	2_CELL_CYCLE_GO_0007049	1.000	0_HALLMARK_MITOTIC_SPINDLE	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_BLADDER_CANCER	0.500	1_KEGG_ASTHMA	0.500	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.500	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.500	
PSMC2	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_MELANOMA	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_CELL_PROLIFERATION_GO_0008283	1.000	2_CELL_CYCLE_GO_0007049	1.000	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_COMPLEMENT	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.500	1_KEGG_MISMATCH_REPAIR	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	
PSMD13	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.667	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.667	2_EXTRACELLULAR_MATRIX_PART	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.333	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	0_HALLMARK_ANGIOGENESIS	0.333	0_HALLMARK_ALLOGRAFT_REJECTION	0.333	1_KEGG_CELL_CYCLE	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.333	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.333	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	1_KEGG_LEISHMANIA_INFECTION	0.333	1_KEGG_SMALL_CELL_LUNG_CANCER	0.333	1_KEGG_ASTHMA	0.333	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.333	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.333	1_KEGG_ALLOGRAFT_REJECTION	0.333	
PSMD4	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_ESTROGEN_RESPONSE_LATE	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	2_ORGANELLE_PART	1.000	2_AXON	1.000	2_INTERMEDIATE_FILAMENT_CYTOSKELETON	1.000	2_CORNIFIED_ENVELOPE	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_CYTOSKELETAL_PART	1.000	2_CYTOSKELETON	1.000	2_INTERMEDIATE_FILAMENT	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_ORGANELLE_PART	1.000	2_CHROMOSOME	1.000	2_DNA_METABOLIC_PROCESS	1.000	2_TISSUE_DEVELOPMENT	1.000	2_EPIDERMIS_DEVELOPMENT	1.000	2_DNA_REPLICATION	1.000	2_DNA_DAMAGE_RESPONSESIGNAL_TRANSDUCTION	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_REGULATION_OF_CELL_CYCLE	1.000	
PTBP1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_MICROTUBULE_ASSOCIATED_COMPLEX	1.000	2_MICROTUBULE_CYTOSKELETON	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_CONDENSED_CHROMOSOME	1.000	2_COLLAGEN	1.000	2_CHROMOSOME	1.000	2_M_PHASE	1.000	2_CELL_CYCLE_PROCESS	1.000	2_CELL_CYCLE_PHASE	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_REGULATION_OF_CELL_CYCLE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
PTEN	95	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.695	1_KEGG_FOCAL_ADHESION	0.663	1_KEGG_ECM_RECEPTOR_INTERACTION	0.621	1_KEGG_CELL_CYCLE	0.558	0_HALLMARK_E2F_TARGETS	0.516	1_KEGG_P53_SIGNALING_PATHWAY	0.516	0_HALLMARK_UV_RESPONSE_DN	0.495	2_GABA_RECEPTOR_ACTIVITY	0.495	0_HALLMARK_G2M_CHECKPOINT	0.442	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.400	2_EXTRACELLULAR_MATRIX	0.400	2_COLLAGEN	0.400	2_EXTRACELLULAR_MATRIX_PART	0.389	0_HALLMARK_ANGIOGENESIS	0.379	1_KEGG_MELANOMA	0.368	2_CELL_CYCLE_GO_0007049	0.358	2_CELL_CELL_SIGNALING	0.284	2_REGULATION_OF_CELL_CYCLE	0.284	1_KEGG_DNA_REPLICATION	0.253	2_NON_MEMBRANE_BOUND_ORGANELLE	0.253	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.253	2_SYNAPTIC_TRANSMISSION	0.253	1_KEGG_PATHWAYS_IN_CANCER	0.232	2_TRANSMISSION_OF_NERVE_IMPULSE	0.232	1_KEGG_SMALL_CELL_LUNG_CANCER	0.221	
PTK2B	2	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_MELANOMA	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_COLLAGEN	0.500	2_REGULATION_OF_PHOSPHORYLATION	0.500	2_CELL_CELL_SIGNALING	0.500	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.500	2_SYNAPTIC_TRANSMISSION	0.500	2_NEUROLOGICAL_SYSTEM_PROCESS	0.500	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.500	2_CELL_PROLIFERATION_GO_0008283	0.500	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	0.500	2_TRANSMISSION_OF_NERVE_IMPULSE	0.500	2_SYSTEM_PROCESS	0.500	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	0.500	2_REGULATION_OF_CELL_PROLIFERATION	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	
PTPN11	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	2_GABA_RECEPTOR_ACTIVITY	0.750	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_FOCAL_ADHESION	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_COLLAGEN	0.500	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.500	2_RECEPTOR_ACTIVITY	0.500	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	0.250	0_HALLMARK_G2M_CHECKPOINT	0.250	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.250	0_HALLMARK_E2F_TARGETS	0.250	0_HALLMARK_INFLAMMATORY_RESPONSE	0.250	0_HALLMARK_UV_RESPONSE_DN	0.250	0_HALLMARK_ALLOGRAFT_REJECTION	0.250	0_HALLMARK_KRAS_SIGNALING_UP	0.250	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	0.250	1_KEGG_CELL_CYCLE	0.250	1_KEGG_OOCYTE_MEIOSIS	0.250	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.250	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.250	1_KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	0.250	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.250	
PTPN6	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	2_CELL_CELL_SIGNALING	0.667	2_SYNAPTIC_TRANSMISSION	0.667	2_TRANSMISSION_OF_NERVE_IMPULSE	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_APOPTOSIS	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	0_HALLMARK_ANGIOGENESIS	0.333	1_KEGG_CELL_CYCLE	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_ECM_RECEPTOR_INTERACTION	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.333	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.333	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	1_KEGG_LEISHMANIA_INFECTION	0.333	1_KEGG_PATHWAYS_IN_CANCER	0.333	1_KEGG_BLADDER_CANCER	0.333	1_KEGG_ASTHMA	0.333	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.333	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.333	1_KEGG_ALLOGRAFT_REJECTION	0.333	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.333	
PTPRB	7	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	0.857	2_EXTRACELLULAR_MATRIX_PART	0.857	0_HALLMARK_UV_RESPONSE_DN	0.714	1_KEGG_FOCAL_ADHESION	0.714	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.714	2_EXTRACELLULAR_MATRIX	0.714	2_COLLAGEN	0.714	0_HALLMARK_E2F_TARGETS	0.571	1_KEGG_CELL_CYCLE	0.571	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.571	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.571	1_KEGG_LEISHMANIA_INFECTION	0.571	1_KEGG_BLADDER_CANCER	0.571	1_KEGG_ASTHMA	0.571	1_KEGG_ALLOGRAFT_REJECTION	0.571	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.571	2_EXTRACELLULAR_REGION_PART	0.571	0_HALLMARK_G2M_CHECKPOINT	0.429	0_HALLMARK_ANGIOGENESIS	0.429	1_KEGG_P53_SIGNALING_PATHWAY	0.429	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.429	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.429	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.429	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.429	
PTPRC	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_COLLAGEN	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_COMPLEMENT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_KRAS_SIGNALING_UP	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.500	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.500	
PTPRM	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_GLIOMA	1.000	1_KEGG_MELANOMA	1.000	2_COLLAGEN	1.000	2_CELL_CELL_SIGNALING	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
PXN	2	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_BLADDER_CANCER	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APOPTOSIS	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_ASTHMA	0.500	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.500	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.500	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.500	1_KEGG_VIRAL_MYOCARDITIS	0.500	2_CELL_CELL_SIGNALING	0.500	2_SYNAPTIC_TRANSMISSION	0.500	2_TRANSMISSION_OF_NERVE_IMPULSE	0.500	
RAB3GAP2	4	2_CELL_CELL_SIGNALING	1.000	2_SYNAPTIC_TRANSMISSION	0.750	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.750	2_TRANSMISSION_OF_NERVE_IMPULSE	0.750	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.250	0_HALLMARK_ANGIOGENESIS	0.250	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.250	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.250	1_KEGG_MELANOMA	0.250	1_KEGG_ASTHMA	0.250	1_KEGG_ALLOGRAFT_REJECTION	0.250	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.250	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.250	2_EXTRACELLULAR_MATRIX_PART	0.250	2_EXTRACELLULAR_REGION	0.250	2_EXTRACELLULAR_REGION_PART	0.250	2_EXTRACELLULAR_MATRIX	0.250	2_COLLAGEN	0.250	2_TRANSPORT	0.250	2_RECEPTOR_BINDING	0.250	2_GROWTH_FACTOR_ACTIVITY	0.250	
RABIF	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_COLLAGEN	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_BLADDER_CANCER	0.500	2_EXTRACELLULAR_REGION	0.500	2_BASEMENT_MEMBRANE	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_CYTOSKELETON	0.500	2_EXTRACELLULAR_REGION_PART	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_REGULATION_OF_PHOSPHORYLATION	0.500	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.500	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.500	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.500	
RAC1	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	2_ORGANELLE_PART	1.000	2_MICROTUBULE_CYTOSKELETON	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_NUCLEUS	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_ORGANELLE_PART	1.000	2_CHROMOSOMAL_PART	1.000	2_CHROMOSOME	1.000	2_CELL_CYCLE_PROCESS	1.000	2_DNA_REPLICATION	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_REGULATION_OF_CELL_CYCLE	1.000	0_HALLMARK_ESTROGEN_RESPONSE_LATE	0.500	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.500	1_KEGG_MISMATCH_REPAIR	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	
RAD21	1	0_HALLMARK_G2M_CHECKPOINT	1.000	
RAD50	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_MICROTUBULE_ASSOCIATED_COMPLEX	0.500	2_MICROTUBULE_CYTOSKELETON	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_CONDENSED_CHROMOSOME	0.500	2_COLLAGEN	0.500	2_CHROMOSOME	0.500	2_M_PHASE	0.500	2_CELL_CYCLE_PROCESS	0.500	2_CELL_CYCLE_PHASE	0.500	2_CELL_CYCLE_GO_0007049	0.500	2_REGULATION_OF_CELL_CYCLE	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	
RAF1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_PANCREATIC_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_GLIOMA	1.000	1_KEGG_MELANOMA	1.000	1_KEGG_BLADDER_CANCER	1.000	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	1.000	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	1.000	2_MICROTUBULE_CYTOSKELETON	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_CELL_CYCLE_PROCESS	1.000	2_MITOTIC_CELL_CYCLE	1.000	2_CELL_CYCLE_PHASE	1.000	2_CELL_PROLIFERATION_GO_0008283	1.000	2_MITOSIS	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_REGULATION_OF_CELL_CYCLE	1.000	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	1.000	
RALA	4	0_HALLMARK_G2M_CHECKPOINT	0.750	0_HALLMARK_E2F_TARGETS	0.750	1_KEGG_CELL_CYCLE	0.750	2_CELL_CYCLE_GO_0007049	0.750	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_MELANOMA	0.500	2_MICROTUBULE_CYTOSKELETON	0.500	2_CHROMOSOME	0.500	2_CELL_PROLIFERATION_GO_0008283	0.500	2_REGULATION_OF_CELL_CYCLE	0.500	0_HALLMARK_APOPTOSIS	0.250	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.250	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.250	0_HALLMARK_MYC_TARGETS_V1	0.250	1_KEGG_DNA_REPLICATION	0.250	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.250	1_KEGG_MISMATCH_REPAIR	0.250	1_KEGG_P53_SIGNALING_PATHWAY	0.250	1_KEGG_FOCAL_ADHESION	0.250	1_KEGG_ECM_RECEPTOR_INTERACTION	0.250	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.250	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.250	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.250	1_KEGG_GLIOMA	0.250	
RALGDS	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	2_COLLAGEN	0.500	2_REGULATION_OF_PHOSPHORYLATION	0.500	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.500	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	0.500	2_ENZYME_REGULATOR_ACTIVITY	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	
RAN	1	1_KEGG_GLIOMA	1.000	1_KEGG_MELANOMA	1.000	1_KEGG_BLADDER_CANCER	1.000	2_CELL_CELL_SIGNALING	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_NEUROLOGICAL_SYSTEM_PROCESS	1.000	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
RASA1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_MICROTUBULE_ASSOCIATED_COMPLEX	1.000	2_MICROTUBULE_CYTOSKELETON	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_CONDENSED_CHROMOSOME	1.000	2_COLLAGEN	1.000	2_CHROMOSOME	1.000	2_M_PHASE	1.000	2_CELL_CYCLE_PROCESS	1.000	2_CELL_CYCLE_PHASE	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_REGULATION_OF_CELL_CYCLE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
RASGRF1	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	0_HALLMARK_UV_RESPONSE_DN	0.667	0_HALLMARK_ANGIOGENESIS	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_SMALL_CELL_LUNG_CANCER	0.667	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.667	2_EXTRACELLULAR_MATRIX_PART	0.667	2_EXTRACELLULAR_MATRIX	0.667	2_COLLAGEN	0.667	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_APOPTOSIS	0.333	0_HALLMARK_COMPLEMENT	0.333	0_HALLMARK_E2F_TARGETS	0.333	1_KEGG_CELL_CYCLE	0.333	1_KEGG_PATHWAYS_IN_CANCER	0.333	1_KEGG_MELANOMA	0.333	2_CELL_PROLIFERATION_GO_0008283	0.333	2_CELL_CYCLE_GO_0007049	0.333	
RASSF5	1	
RB1	22	0_HALLMARK_E2F_TARGETS	0.818	1_KEGG_CELL_CYCLE	0.818	0_HALLMARK_G2M_CHECKPOINT	0.773	2_CELL_CYCLE_GO_0007049	0.682	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.636	1_KEGG_P53_SIGNALING_PATHWAY	0.636	1_KEGG_FOCAL_ADHESION	0.591	2_REGULATION_OF_CELL_CYCLE	0.591	1_KEGG_ECM_RECEPTOR_INTERACTION	0.545	2_GABA_RECEPTOR_ACTIVITY	0.545	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	0_HALLMARK_UV_RESPONSE_DN	0.455	2_EXTRACELLULAR_MATRIX_PART	0.409	1_KEGG_DNA_REPLICATION	0.364	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.364	1_KEGG_MELANOMA	0.364	1_KEGG_ALLOGRAFT_REJECTION	0.364	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.364	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.364	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.364	0_HALLMARK_MYC_TARGETS_V1	0.318	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.318	1_KEGG_ASTHMA	0.318	1_KEGG_VIRAL_MYOCARDITIS	0.318	
RBBP4	1	
RBMX	1	
RECQL	1	
RECQL5	2	2_DNA_METABOLIC_PROCESS	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_ENDOMETRIAL_CANCER	0.500	1_KEGG_GLIOMA	0.500	1_KEGG_BLADDER_CANCER	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	0.500	2_ORGANELLE_PART	0.500	2_NUCLEAR_CHROMOSOME	0.500	2_NUCLEAR_PART	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_NUCLEUS	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_INTRACELLULAR_ORGANELLE_PART	0.500	2_CHROMOSOMAL_PART	0.500	2_CONDENSED_CHROMOSOME	0.500	2_CHROMOSOME	0.500	
RELN	9	1_KEGG_CELL_CYCLE	0.556	2_GABA_RECEPTOR_ACTIVITY	0.556	0_HALLMARK_E2F_TARGETS	0.444	1_KEGG_FOCAL_ADHESION	0.444	1_KEGG_ECM_RECEPTOR_INTERACTION	0.444	1_KEGG_PATHWAYS_IN_CANCER	0.444	1_KEGG_MELANOMA	0.444	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	0_HALLMARK_ANGIOGENESIS	0.333	1_KEGG_DNA_REPLICATION	0.333	2_COLLAGEN	0.333	2_REGULATION_OF_PHOSPHORYLATION	0.333	2_CELL_CELL_SIGNALING	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.222	1_KEGG_GLIOMA	0.222	1_KEGG_SMALL_CELL_LUNG_CANCER	0.222	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.222	2_EXTRACELLULAR_MATRIX_PART	0.222	2_NON_MEMBRANE_BOUND_ORGANELLE	0.222	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.222	2_EXTRACELLULAR_MATRIX	0.222	2_CHROMOSOME	0.222	2_DNA_METABOLIC_PROCESS	0.222	2_INTERPHASE	0.222	
RERE	6	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.667	2_EXTRACELLULAR_MATRIX_PART	0.667	2_EXTRACELLULAR_MATRIX	0.667	1_KEGG_CELL_CYCLE	0.500	1_KEGG_MELANOMA	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	0_HALLMARK_APOPTOSIS	0.333	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	0_HALLMARK_ANGIOGENESIS	0.333	0_HALLMARK_ALLOGRAFT_REJECTION	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	1_KEGG_LEISHMANIA_INFECTION	0.333	1_KEGG_ASTHMA	0.333	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.333	1_KEGG_ALLOGRAFT_REJECTION	0.333	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.333	1_KEGG_VIRAL_MYOCARDITIS	0.333	2_EXTRACELLULAR_REGION	0.333	
RFC4	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_COMPLEMENT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	0_HALLMARK_COAGULATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	1_KEGG_ASTHMA	0.500	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.500	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.500	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.500	1_KEGG_VIRAL_MYOCARDITIS	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_COLLAGEN	0.500	
RIMS2	11	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.909	1_KEGG_FOCAL_ADHESION	0.818	1_KEGG_ECM_RECEPTOR_INTERACTION	0.818	2_COLLAGEN	0.727	2_GABA_RECEPTOR_ACTIVITY	0.727	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.636	0_HALLMARK_E2F_TARGETS	0.545	0_HALLMARK_UV_RESPONSE_DN	0.545	1_KEGG_CELL_CYCLE	0.545	2_EXTRACELLULAR_MATRIX_PART	0.545	2_CELL_CELL_SIGNALING	0.545	0_HALLMARK_G2M_CHECKPOINT	0.455	0_HALLMARK_ANGIOGENESIS	0.455	1_KEGG_MELANOMA	0.455	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.455	2_EXTRACELLULAR_MATRIX	0.455	2_EXTRACELLULAR_REGION	0.364	2_EXTRACELLULAR_REGION_PART	0.364	2_SYNAPTIC_TRANSMISSION	0.364	2_CELL_CYCLE_GO_0007049	0.364	2_TRANSMISSION_OF_NERVE_IMPULSE	0.364	1_KEGG_P53_SIGNALING_PATHWAY	0.273	1_KEGG_PATHWAYS_IN_CANCER	0.273	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.273	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.182	
RNF8	2	0_HALLMARK_MITOTIC_SPINDLE	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	2_ORGANELLE_PART	0.500	2_MICROTUBULE_CYTOSKELETON	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_CYTOSKELETAL_PART	0.500	2_NUCLEUS	0.500	2_SPINDLE	0.500	2_CYTOSKELETON	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_INTRACELLULAR_ORGANELLE_PART	0.500	2_CHROMOSOMAL_PART	0.500	2_CHROMOSOME	0.500	2_M_PHASE	0.500	2_MICROTUBULE_CYTOSKELETON_ORGANIZATION_AND_BIOGENESIS	0.500	2_INTERPHASE	0.500	2_CELL_CYCLE_PROCESS	0.500	2_MITOTIC_CELL_CYCLE	0.500	2_CELL_CYCLE_PHASE	0.500	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.500	2_REGULATION_OF_CATALYTIC_ACTIVITY	0.500	
ROCK2	2	2_SYNAPTIC_TRANSMISSION	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	2_REPLICATION_FORK	0.500	2_CHROMOSOME	0.500	2_DNA_METABOLIC_PROCESS	0.500	2_INTERPHASE	0.500	2_CELL_CYCLE_PROCESS	0.500	2_MITOTIC_CELL_CYCLE	0.500	2_REGULATION_OF_PHOSPHORYLATION	0.500	2_CELL_CYCLE_PHASE	0.500	2_CELL_CELL_SIGNALING	0.500	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.500	2_DNA_REPLICATION	0.500	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.500	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.500	2_CELL_CYCLE_GO_0007049	0.500	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	0.500	2_REGULATION_OF_CELL_CYCLE	0.500	2_REGULATION_OF_CELL_PROLIFERATION	0.500	
RPA2	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_HOMOLOGOUS_RECOMBINATION	0.500	1_KEGG_CELL_CYCLE	0.500	2_AXON	0.500	2_MICROTUBULE_CYTOSKELETON	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_NEURON_PROJECTION	0.500	2_DNA_METABOLIC_PROCESS	0.500	
RPN1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	1.000	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_LEISHMANIA_INFECTION	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	1.000	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	1.000	1_KEGG_VIRAL_MYOCARDITIS	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_AXON	1.000	2_EXTRACELLULAR_REGION	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_EXTRACELLULAR_REGION_PART	1.000	
RRM2	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	2_REPLICATION_FORK	0.500	2_CHROMOSOME	0.500	2_DNA_METABOLIC_PROCESS	0.500	2_INTERPHASE	0.500	2_CELL_CYCLE_PROCESS	0.500	2_MITOTIC_CELL_CYCLE	0.500	2_REGULATION_OF_PHOSPHORYLATION	0.500	2_CELL_CYCLE_PHASE	0.500	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.500	2_SYNAPTIC_TRANSMISSION	0.500	2_DNA_REPLICATION	0.500	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.500	2_CELL_CYCLE_GO_0007049	0.500	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	0.500	2_TRANSMISSION_OF_NERVE_IMPULSE	0.500	2_REGULATION_OF_CELL_CYCLE	0.500	2_REGULATION_OF_CELL_PROLIFERATION	0.500	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	
RUVBL2	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	
RYR1	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	2_GABA_RECEPTOR_ACTIVITY	0.750	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_MELANOMA	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_CELL_CELL_SIGNALING	0.500	2_TRANSMISSION_OF_NERVE_IMPULSE	0.500	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.250	0_HALLMARK_G2M_CHECKPOINT	0.250	0_HALLMARK_COMPLEMENT	0.250	0_HALLMARK_E2F_TARGETS	0.250	1_KEGG_CALCIUM_SIGNALING_PATHWAY	0.250	1_KEGG_CELL_CYCLE	0.250	1_KEGG_P53_SIGNALING_PATHWAY	0.250	1_KEGG_PANCREATIC_CANCER	0.250	1_KEGG_ASTHMA	0.250	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.250	2_EXTRACELLULAR_MATRIX	0.250	2_COLLAGEN	0.250	2_REGULATION_OF_PHOSPHORYLATION	0.250	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.250	2_SYNAPTIC_TRANSMISSION	0.250	
RYR2	17	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.412	1_KEGG_ECM_RECEPTOR_INTERACTION	0.412	2_GABA_RECEPTOR_ACTIVITY	0.412	0_HALLMARK_E2F_TARGETS	0.353	1_KEGG_FOCAL_ADHESION	0.353	2_CELL_CELL_SIGNALING	0.353	0_HALLMARK_G2M_CHECKPOINT	0.294	1_KEGG_CELL_CYCLE	0.294	2_SYNAPTIC_TRANSMISSION	0.294	1_KEGG_P53_SIGNALING_PATHWAY	0.235	1_KEGG_MELANOMA	0.235	2_TRANSMISSION_OF_NERVE_IMPULSE	0.235	0_HALLMARK_UV_RESPONSE_DN	0.176	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.176	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.176	1_KEGG_ALLOGRAFT_REJECTION	0.176	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.176	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.176	2_EXTRACELLULAR_MATRIX_PART	0.176	2_NON_MEMBRANE_BOUND_ORGANELLE	0.176	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.176	2_EXTRACELLULAR_MATRIX	0.176	2_COLLAGEN	0.176	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.176	2_GLUTAMATE_RECEPTOR_ACTIVITY	0.176	
RYR3	13	1_KEGG_CALCIUM_SIGNALING_PATHWAY	0.308	2_CALCIUM_CHANNEL_ACTIVITY	0.308	2_LIGAND_GATED_CHANNEL_ACTIVITY	0.231	1_KEGG_MELANOMA	0.154	2_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	0.154	2_SUBSTRATE_SPECIFIC_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	0.154	2_SUBSTRATE_SPECIFIC_TRANSPORTER_ACTIVITY	0.154	2_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	0.154	2_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	0.154	2_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	0.154	0_HALLMARK_G2M_CHECKPOINT	0.077	0_HALLMARK_E2F_TARGETS	0.077	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.077	1_KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	0.077	1_KEGG_CELL_CYCLE	0.077	1_KEGG_OOCYTE_MEIOSIS	0.077	1_KEGG_P53_SIGNALING_PATHWAY	0.077	1_KEGG_FOCAL_ADHESION	0.077	1_KEGG_ECM_RECEPTOR_INTERACTION	0.077	1_KEGG_PATHWAYS_IN_CANCER	0.077	1_KEGG_GLIOMA	0.077	1_KEGG_PROSTATE_CANCER	0.077	1_KEGG_BLADDER_CANCER	0.077	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	0.077	1_KEGG_SMALL_CELL_LUNG_CANCER	0.077	
S100A8	2	
SCML2	2	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_ASTHMA	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_COLLAGEN	0.500	2_CELL_CELL_SIGNALING	0.500	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.500	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	0.500	2_ENZYME_REGULATOR_ACTIVITY	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	
SDC2	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_GLIOMA	1.000	1_KEGG_MELANOMA	1.000	1_KEGG_BLADDER_CANCER	1.000	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_NUCLEUS	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_CHROMOSOMAL_PART	1.000	2_COLLAGEN	1.000	
SDCCAG8	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	1_KEGG_FOCAL_ADHESION	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_GLIOMA	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	2_COLLAGEN	0.500	2_CELL_CYCLE_GO_0007049	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	0_HALLMARK_UV_RESPONSE_DN	0.250	1_KEGG_DNA_REPLICATION	0.250	1_KEGG_PANCREATIC_CANCER	0.250	1_KEGG_ENDOMETRIAL_CANCER	0.250	1_KEGG_PROSTATE_CANCER	0.250	1_KEGG_BLADDER_CANCER	0.250	2_EXTRACELLULAR_MATRIX_PART	0.250	2_CHROMOSOMAL_PART	0.250	2_CHROMOSOME	0.250	2_CELL_CELL_SIGNALING	0.250	2_SYNAPTIC_TRANSMISSION	0.250	
SEC61G	53	1_KEGG_CELL_CYCLE	0.377	0_HALLMARK_E2F_TARGETS	0.358	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.358	1_KEGG_ECM_RECEPTOR_INTERACTION	0.321	0_HALLMARK_G2M_CHECKPOINT	0.283	1_KEGG_P53_SIGNALING_PATHWAY	0.264	1_KEGG_FOCAL_ADHESION	0.264	2_GABA_RECEPTOR_ACTIVITY	0.264	1_KEGG_DNA_REPLICATION	0.208	0_HALLMARK_ANGIOGENESIS	0.189	1_KEGG_PROTEIN_EXPORT	0.189	2_CELL_CYCLE_GO_0007049	0.189	1_KEGG_MELANOMA	0.170	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.170	2_EXTRACELLULAR_MATRIX	0.170	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.151	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.151	1_KEGG_ALLOGRAFT_REJECTION	0.151	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.151	2_EXTRACELLULAR_MATRIX_PART	0.151	2_NON_MEMBRANE_BOUND_ORGANELLE	0.151	2_EXTRACELLULAR_REGION_PART	0.151	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.151	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.132	1_KEGG_ASTHMA	0.132	
SFI1	2	
SFN	1	0_HALLMARK_HYPOXIA	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_ESTROGEN_RESPONSE_LATE	1.000	0_HALLMARK_COMPLEMENT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_COAGULATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_GLIOMA	1.000	2_INTERMEDIATE_FILAMENT_CYTOSKELETON	1.000	2_CORNIFIED_ENVELOPE	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_CYTOSKELETAL_PART	1.000	2_CYTOSKELETON	1.000	2_INTERMEDIATE_FILAMENT	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_TISSUE_DEVELOPMENT	1.000	2_EPIDERMIS_DEVELOPMENT	1.000	2_ECTODERM_DEVELOPMENT	1.000	2_CATION_BINDING	1.000	2_CALCIUM_ION_BINDING	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
SGCB	1	
SGOL1	1	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	1.000	2_AXON	1.000	2_MICROTUBULE_ASSOCIATED_COMPLEX	1.000	2_NEURON_PROJECTION	1.000	2_CELL_CELL_SIGNALING	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
SGOL2	3	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_COMPLEMENT	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	0_HALLMARK_ANGIOGENESIS	0.333	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	0.333	1_KEGG_CELL_CYCLE	0.333	1_KEGG_OOCYTE_MEIOSIS	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_ECM_RECEPTOR_INTERACTION	0.333	1_KEGG_SMALL_CELL_LUNG_CANCER	0.333	1_KEGG_ASTHMA	0.333	1_KEGG_ALLOGRAFT_REJECTION	0.333	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.333	2_EXTRACELLULAR_MATRIX_PART	0.333	2_EXTRACELLULAR_MATRIX	0.333	2_COLLAGEN	0.333	2_CELL_CELL_SIGNALING	0.333	2_SYNAPTIC_TRANSMISSION	0.333	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.333	2_TRANSMISSION_OF_NERVE_IMPULSE	0.333	2_RECEPTOR_ACTIVITY	0.333	
SH3GL3	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	0_HALLMARK_COMPLEMENT	0.500	0_HALLMARK_ANGIOGENESIS	0.500	0_HALLMARK_COAGULATION	0.500	0_HALLMARK_ALLOGRAFT_REJECTION	0.500	0_HALLMARK_KRAS_SIGNALING_UP	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	1_KEGG_ASTHMA	0.500	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_EXTRACELLULAR_REGION	0.500	2_EXTRACELLULAR_REGION_PART	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_COLLAGEN	0.500	2_CELL_CELL_SIGNALING	0.500	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.500	2_RESPONSE_TO_EXTERNAL_STIMULUS	0.500	2_RESPONSE_TO_WOUNDING	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	
SHANK3	2	
SHB	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_CELL_CYCLE	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	0_HALLMARK_G2M_CHECKPOINT	0.250	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.250	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.250	0_HALLMARK_COMPLEMENT	0.250	0_HALLMARK_INFLAMMATORY_RESPONSE	0.250	0_HALLMARK_ANGIOGENESIS	0.250	0_HALLMARK_COAGULATION	0.250	0_HALLMARK_ALLOGRAFT_REJECTION	0.250	0_HALLMARK_KRAS_SIGNALING_UP	0.250	1_KEGG_P53_SIGNALING_PATHWAY	0.250	1_KEGG_FOCAL_ADHESION	0.250	1_KEGG_ECM_RECEPTOR_INTERACTION	0.250	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.250	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	0.250	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.250	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.250	1_KEGG_LEISHMANIA_INFECTION	0.250	1_KEGG_PATHWAYS_IN_CANCER	0.250	1_KEGG_MELANOMA	0.250	1_KEGG_ASTHMA	0.250	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.250	
SLC18A2	6	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	2_CELL_CYCLE_GO_0007049	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_GLIOMA	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_BLADDER_CANCER	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_CHROMOSOMAL_PART	0.500	2_CHROMOSOME	0.500	2_M_PHASE	0.500	2_CELL_CYCLE_PROCESS	0.500	2_MITOTIC_CELL_CYCLE	0.500	2_CELL_CYCLE_PHASE	0.500	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.500	2_CELL_PROLIFERATION_GO_0008283	0.500	2_MITOSIS	0.500	
SLC26A8	4	0_HALLMARK_MITOTIC_SPINDLE	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_CELL_CYCLE	0.500	2_INTERPHASE	0.500	2_CELL_CYCLE_PROCESS	0.500	2_CELL_CYCLE_PHASE	0.500	2_CELL_CYCLE_GO_0007049	0.500	0_HALLMARK_MYC_TARGETS_V1	0.250	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.250	0_HALLMARK_ANGIOGENESIS	0.250	1_KEGG_P53_SIGNALING_PATHWAY	0.250	1_KEGG_FOCAL_ADHESION	0.250	1_KEGG_ECM_RECEPTOR_INTERACTION	0.250	1_KEGG_MELANOMA	0.250	2_ORGANELLE_PART	0.250	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.250	2_EXTRACELLULAR_MATRIX_PART	0.250	2_MICROTUBULE_CYTOSKELETON	0.250	2_NON_MEMBRANE_BOUND_ORGANELLE	0.250	2_CYTOSKELETAL_PART	0.250	2_NUCLEUS	0.250	2_SPINDLE	0.250	2_CYTOSKELETON	0.250	2_SPINDLE_MICROTUBULE	0.250	
SLC6A3	6	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.333	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	1_KEGG_ASTHMA	0.333	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.333	1_KEGG_ALLOGRAFT_REJECTION	0.333	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.333	1_KEGG_VIRAL_MYOCARDITIS	0.333	2_EXTRACELLULAR_MATRIX_PART	0.333	2_CELL_CELL_SIGNALING	0.333	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.333	2_SYNAPTIC_TRANSMISSION	0.333	2_CELL_CYCLE_GO_0007049	0.333	2_TRANSMISSION_OF_NERVE_IMPULSE	0.333	2_GABA_RECEPTOR_ACTIVITY	0.333	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.167	0_HALLMARK_P53_PATHWAY	0.167	0_HALLMARK_ANGIOGENESIS	0.167	0_HALLMARK_ALLOGRAFT_REJECTION	0.167	
SLIT3	2	
SMAD4	2	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	1.000	0_HALLMARK_COMPLEMENT	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1.000	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_LEISHMANIA_INFECTION	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	1.000	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	1.000	1_KEGG_VIRAL_MYOCARDITIS	1.000	2_AXON	1.000	2_NEURON_PROJECTION	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	0_HALLMARK_COAGULATION	0.500	0_HALLMARK_ALLOGRAFT_REJECTION	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	0.500	
SMARCA2	5	0_HALLMARK_G2M_CHECKPOINT	0.800	0_HALLMARK_E2F_TARGETS	0.800	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.800	1_KEGG_CELL_CYCLE	0.800	1_KEGG_P53_SIGNALING_PATHWAY	0.800	2_CELL_CYCLE_GO_0007049	0.800	1_KEGG_FOCAL_ADHESION	0.600	1_KEGG_ECM_RECEPTOR_INTERACTION	0.600	2_EXTRACELLULAR_MATRIX_PART	0.600	2_CELL_CYCLE_PROCESS	0.600	2_CELL_CYCLE_PHASE	0.600	2_REGULATION_OF_CELL_CYCLE	0.600	2_GABA_RECEPTOR_ACTIVITY	0.600	0_HALLMARK_UV_RESPONSE_DN	0.400	1_KEGG_PATHWAYS_IN_CANCER	0.400	1_KEGG_SMALL_CELL_LUNG_CANCER	0.400	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.400	2_EXTRACELLULAR_MATRIX	0.400	2_COLLAGEN	0.400	2_CHROMOSOME	0.400	2_MITOTIC_CELL_CYCLE	0.400	2_REGULATION_OF_PHOSPHORYLATION	0.400	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.400	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.200	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.200	
SMARCA4	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1.000	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	1.000	1_KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION	1.000	1_KEGG_LEISHMANIA_INFECTION	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	1.000	1_KEGG_VIRAL_MYOCARDITIS	1.000	2_AXON	1.000	2_MICROTUBULE_ASSOCIATED_COMPLEX	1.000	2_MICROTUBULE_CYTOSKELETON	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_CYTOSKELETAL_PART	1.000	2_CYTOSKELETON	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_NEURON_PROJECTION	1.000	2_CELL_DEVELOPMENT	1.000	
SMARCC2	5	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	0.800	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.800	1_KEGG_LEISHMANIA_INFECTION	0.800	1_KEGG_ASTHMA	0.800	1_KEGG_ALLOGRAFT_REJECTION	0.800	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.800	0_HALLMARK_E2F_TARGETS	0.600	0_HALLMARK_UV_RESPONSE_DN	0.600	1_KEGG_CELL_CYCLE	0.600	1_KEGG_FOCAL_ADHESION	0.600	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.600	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.600	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.600	1_KEGG_BLADDER_CANCER	0.600	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.600	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.600	1_KEGG_VIRAL_MYOCARDITIS	0.600	2_EXTRACELLULAR_MATRIX_PART	0.600	2_CELL_CELL_SIGNALING	0.600	2_GABA_RECEPTOR_ACTIVITY	0.600	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.400	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	0.400	0_HALLMARK_G2M_CHECKPOINT	0.400	0_HALLMARK_APOPTOSIS	0.400	
SMC1A	4	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	0_HALLMARK_G2M_CHECKPOINT	0.750	1_KEGG_P53_SIGNALING_PATHWAY	0.750	2_DNA_METABOLIC_PROCESS	0.750	2_CELL_CYCLE_PROCESS	0.750	2_MITOTIC_CELL_CYCLE	0.750	2_CELL_CYCLE_PHASE	0.750	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.750	2_CELL_CYCLE_GO_0007049	0.750	2_REGULATION_OF_CELL_CYCLE	0.750	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	1_KEGG_GLIOMA	0.500	1_KEGG_BLADDER_CANCER	0.500	1_KEGG_ASTHMA	0.500	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.500	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.500	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.500	1_KEGG_VIRAL_MYOCARDITIS	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	
SMC3	5	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	2_CELL_CYCLE_GO_0007049	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	0.800	1_KEGG_PATHWAYS_IN_CANCER	0.800	1_KEGG_BLADDER_CANCER	0.800	2_NON_MEMBRANE_BOUND_ORGANELLE	0.800	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.800	2_CHROMOSOMAL_PART	0.800	2_CHROMOSOME	0.800	2_M_PHASE	0.800	2_CELL_CYCLE_PROCESS	0.800	2_MITOTIC_CELL_CYCLE	0.800	2_CELL_CYCLE_PHASE	0.800	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.800	2_CELL_PROLIFERATION_GO_0008283	0.800	2_MITOSIS	0.800	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	0.800	2_REGULATION_OF_CELL_CYCLE	0.800	2_M_PHASE_OF_MITOTIC_CELL_CYCLE	0.800	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	0.800	
SMO	3	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_MELANOMA	0.667	1_KEGG_SMALL_CELL_LUNG_CANCER	0.667	2_CELL_PROLIFERATION_GO_0008283	0.667	2_CELL_CYCLE_GO_0007049	0.667	0_HALLMARK_APOPTOSIS	0.333	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.333	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.333	0_HALLMARK_COMPLEMENT	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	0_HALLMARK_ANGIOGENESIS	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.333	1_KEGG_MISMATCH_REPAIR	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.333	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.333	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	
SOS1	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_REGION	1.000	2_EXTRACELLULAR_REGION_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_COLLAGEN	1.000	2_MULTICELLULAR_ORGANISMAL_DEVELOPMENT	1.000	
SP1	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
SPN	1	0_HALLMARK_APICAL_JUNCTION	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_CELL_CELL_SIGNALING	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
SRC	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.500	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_ASTHMA	0.500	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.500	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.500	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.500	1_KEGG_VIRAL_MYOCARDITIS	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_EXTRACELLULAR_REGION	0.500	2_EXTRACELLULAR_REGION_PART	0.500	
SREBF1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	1.000	0_HALLMARK_COMPLEMENT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ANGIOGENESIS	1.000	0_HALLMARK_COAGULATION	1.000	0_HALLMARK_ALLOGRAFT_REJECTION	1.000	0_HALLMARK_KRAS_SIGNALING_UP	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	1.000	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_MELANOMA	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	1.000	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	
SRI	5	2_CELL_CELL_SIGNALING	0.400	2_SYNAPTIC_TRANSMISSION	0.400	2_REGULATION_OF_HEART_CONTRACTION	0.400	2_NEUROLOGICAL_SYSTEM_PROCESS	0.400	2_TRANSMISSION_OF_NERVE_IMPULSE	0.400	2_SYSTEM_PROCESS	0.400	2_GABA_RECEPTOR_ACTIVITY	0.400	1_KEGG_FOCAL_ADHESION	0.200	1_KEGG_ECM_RECEPTOR_INTERACTION	0.200	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.200	
SRPK1	3	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_MYC_TARGETS_V1	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	0_HALLMARK_ANGIOGENESIS	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	2_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_NUCLEUS	0.667	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_CHROMOSOMAL_PART	0.667	2_CHROMOSOME	0.667	2_INTERPHASE	0.667	2_CELL_CYCLE_PROCESS	0.667	2_MITOTIC_CELL_CYCLE	0.667	2_CELL_CYCLE_PHASE	0.667	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.667	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.667	2_CELL_PROLIFERATION_GO_0008283	0.667	2_CELL_CYCLE_GO_0007049	0.667	2_REGULATION_OF_CELL_CYCLE	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_MITOTIC_SPINDLE	0.333	
SRPR	1	1_KEGG_PROTEIN_EXPORT	1.000	
SSRP1	1	
STAT1	2	1_KEGG_CELL_CYCLE	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_ALLOGRAFT_REJECTION	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.500	1_KEGG_MISMATCH_REPAIR	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	0.500	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_ASTHMA	0.500	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.500	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.500	1_KEGG_VIRAL_MYOCARDITIS	0.500	
STAT3	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_INTERPHASE	1.000	2_CELL_CYCLE_PROCESS	1.000	2_REGULATION_OF_PHOSPHORYLATION	1.000	2_CELL_CYCLE_PHASE	1.000	2_CELL_CELL_SIGNALING	1.000	2_CELL_CYCLE_CHECKPOINT_GO_0000075	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_NEGATIVE_REGULATION_OF_CATALYTIC_ACTIVITY	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	2_REGULATION_OF_CELL_CYCLE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
STAT6	7	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.857	0_HALLMARK_E2F_TARGETS	0.714	1_KEGG_CELL_CYCLE	0.714	1_KEGG_ECM_RECEPTOR_INTERACTION	0.714	0_HALLMARK_G2M_CHECKPOINT	0.571	1_KEGG_P53_SIGNALING_PATHWAY	0.571	1_KEGG_FOCAL_ADHESION	0.571	1_KEGG_BLADDER_CANCER	0.571	2_EXTRACELLULAR_MATRIX_PART	0.571	2_CELL_CYCLE_GO_0007049	0.571	0_HALLMARK_UV_RESPONSE_DN	0.429	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.429	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.429	1_KEGG_LEISHMANIA_INFECTION	0.429	1_KEGG_PATHWAYS_IN_CANCER	0.429	1_KEGG_ASTHMA	0.429	1_KEGG_ALLOGRAFT_REJECTION	0.429	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.429	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.429	2_EXTRACELLULAR_MATRIX	0.429	2_REGULATION_OF_CELL_CYCLE	0.429	2_GABA_RECEPTOR_ACTIVITY	0.429	0_HALLMARK_APOPTOSIS	0.286	0_HALLMARK_ANGIOGENESIS	0.286	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.286	
STX1A	5	0_HALLMARK_G2M_CHECKPOINT	0.600	0_HALLMARK_E2F_TARGETS	0.600	1_KEGG_CELL_CYCLE	0.600	1_KEGG_ECM_RECEPTOR_INTERACTION	0.600	1_KEGG_MELANOMA	0.600	2_CELL_CYCLE_GO_0007049	0.600	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.400	0_HALLMARK_COMPLEMENT	0.400	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.400	0_HALLMARK_ANGIOGENESIS	0.400	1_KEGG_DNA_REPLICATION	0.400	1_KEGG_FOCAL_ADHESION	0.400	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.400	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.400	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.400	1_KEGG_PATHWAYS_IN_CANCER	0.400	1_KEGG_SMALL_CELL_LUNG_CANCER	0.400	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.400	1_KEGG_ALLOGRAFT_REJECTION	0.400	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.400	1_KEGG_VIRAL_MYOCARDITIS	0.400	2_CELL_CYCLE_PROCESS	0.400	2_CELL_PROLIFERATION_GO_0008283	0.400	0_HALLMARK_APOPTOSIS	0.200	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.200	
STXBP1	2	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.500	0_HALLMARK_HYPOXIA	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_COMPLEMENT	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_INFLAMMATORY_RESPONSE	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	0_HALLMARK_COAGULATION	0.500	0_HALLMARK_ALLOGRAFT_REJECTION	0.500	0_HALLMARK_KRAS_SIGNALING_UP	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	1_KEGG_ASTHMA	0.500	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.500	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.500	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.500	
SVEP1	4	
SYNJ1	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	1.000	1_KEGG_VIRAL_MYOCARDITIS	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_COLLAGEN	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	1_KEGG_MELANOMA	0.500	
SYNJ2	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_COLLAGEN	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_ENDOCYTOSIS	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	1_KEGG_ASTHMA	0.500	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.500	
SYT1	2	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	1_KEGG_BLADDER_CANCER	0.500	1_KEGG_ASTHMA	0.500	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.500	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.500	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.500	1_KEGG_VIRAL_MYOCARDITIS	0.500	2_HORMONE_SECRETION	0.500	2_REGULATION_OF_HORMONE_SECRETION	0.500	2_CELL_CELL_SIGNALING	0.500	2_SYNAPTIC_TRANSMISSION	0.500	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.500	2_REGULATION_OF_TRANSPORT	0.500	2_TRANSMISSION_OF_NERVE_IMPULSE	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	
TAP1	1	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	1.000	1_KEGG_VIRAL_MYOCARDITIS	1.000	2_CELL_CELL_SIGNALING	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
TARDBP	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	0_HALLMARK_COAGULATION	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_OOCYTE_MEIOSIS	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_GLIOMA	0.500	1_KEGG_PROSTATE_CANCER	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_BLADDER_CANCER	0.500	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	0.500	2_AXON	0.500	2_MICROTUBULE_CYTOSKELETON	0.500	2_SPINDLE	0.500	2_CYTOSKELETON	0.500	2_CELL_PROJECTION	0.500	2_CHROMOSOMAL_PART	0.500	
TBL1Y	22	1_KEGG_CELL_CYCLE	0.818	0_HALLMARK_E2F_TARGETS	0.727	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.727	0_HALLMARK_G2M_CHECKPOINT	0.636	1_KEGG_P53_SIGNALING_PATHWAY	0.636	2_GABA_RECEPTOR_ACTIVITY	0.591	1_KEGG_ECM_RECEPTOR_INTERACTION	0.545	2_CELL_CYCLE_GO_0007049	0.545	2_REGULATION_OF_CELL_CYCLE	0.455	1_KEGG_FOCAL_ADHESION	0.409	1_KEGG_ASTHMA	0.409	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.364	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.318	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.318	1_KEGG_ALLOGRAFT_REJECTION	0.318	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.318	1_KEGG_VIRAL_MYOCARDITIS	0.318	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.318	2_EXTRACELLULAR_MATRIX_PART	0.318	2_NON_MEMBRANE_BOUND_ORGANELLE	0.318	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.318	2_EXTRACELLULAR_MATRIX	0.318	2_COLLAGEN	0.318	2_REGULATION_OF_PHOSPHORYLATION	0.318	1_KEGG_DNA_REPLICATION	0.273	
TCF12	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	0_HALLMARK_ANGIOGENESIS	0.333	1_KEGG_CELL_CYCLE	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	0.333	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.333	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.333	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	1_KEGG_LEISHMANIA_INFECTION	0.333	1_KEGG_MELANOMA	0.333	1_KEGG_BLADDER_CANCER	0.333	1_KEGG_ASTHMA	0.333	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.333	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.333	1_KEGG_ALLOGRAFT_REJECTION	0.333	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.333	1_KEGG_VIRAL_MYOCARDITIS	0.333	2_COLLAGEN	0.333	2_NEGATIVE_REGULATION_OF_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	0.333	2_CELL_CELL_SIGNALING	0.333	
TCF7L2	7	0_HALLMARK_E2F_TARGETS	0.857	1_KEGG_CELL_CYCLE	0.857	0_HALLMARK_G2M_CHECKPOINT	0.714	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.714	1_KEGG_P53_SIGNALING_PATHWAY	0.714	1_KEGG_FOCAL_ADHESION	0.714	2_CELL_CYCLE_GO_0007049	0.714	1_KEGG_ECM_RECEPTOR_INTERACTION	0.571	1_KEGG_PATHWAYS_IN_CANCER	0.571	1_KEGG_GLIOMA	0.571	1_KEGG_MELANOMA	0.571	1_KEGG_BLADDER_CANCER	0.571	2_NON_MEMBRANE_BOUND_ORGANELLE	0.571	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.571	2_CHROMOSOMAL_PART	0.571	2_CHROMOSOME	0.571	2_M_PHASE	0.571	2_CELL_CYCLE_PROCESS	0.571	2_MITOTIC_CELL_CYCLE	0.571	2_CELL_CYCLE_PHASE	0.571	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.571	2_CELL_PROLIFERATION_GO_0008283	0.571	2_MITOSIS	0.571	2_INTERPHASE_OF_MITOTIC_CELL_CYCLE	0.571	2_REGULATION_OF_CELL_CYCLE	0.571	
TEK	11	0_HALLMARK_E2F_TARGETS	0.727	1_KEGG_CELL_CYCLE	0.727	2_GABA_RECEPTOR_ACTIVITY	0.636	0_HALLMARK_G2M_CHECKPOINT	0.545	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.545	1_KEGG_ECM_RECEPTOR_INTERACTION	0.545	1_KEGG_P53_SIGNALING_PATHWAY	0.455	2_CELL_CYCLE_GO_0007049	0.455	0_HALLMARK_APOPTOSIS	0.364	1_KEGG_FOCAL_ADHESION	0.364	1_KEGG_BLADDER_CANCER	0.364	2_REGULATION_OF_PHOSPHORYLATION	0.364	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.364	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.364	2_REGULATION_OF_CELL_CYCLE	0.364	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	0.364	0_HALLMARK_UV_RESPONSE_DN	0.273	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.273	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.273	2_EXTRACELLULAR_MATRIX_PART	0.273	2_EXTRACELLULAR_MATRIX	0.273	2_CELL_CELL_SIGNALING	0.273	2_TRANSMISSION_OF_NERVE_IMPULSE	0.273	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.182	0_HALLMARK_COMPLEMENT	0.182	
TES	3	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.333	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.333	1_KEGG_MISMATCH_REPAIR	0.333	1_KEGG_CELL_CYCLE	0.333	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_ECM_RECEPTOR_INTERACTION	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.333	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.333	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	1_KEGG_PATHWAYS_IN_CANCER	0.333	1_KEGG_MELANOMA	0.333	1_KEGG_SMALL_CELL_LUNG_CANCER	0.333	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.333	1_KEGG_ALLOGRAFT_REJECTION	0.333	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.333	1_KEGG_VIRAL_MYOCARDITIS	0.333	2_ORGANELLE_PART	0.333	2_MICROTUBULE_CYTOSKELETON	0.333	2_NON_MEMBRANE_BOUND_ORGANELLE	0.333	
TFAP2B	1	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	1.000	2_AXON	1.000	2_MICROTUBULE_ASSOCIATED_COMPLEX	1.000	2_NEURON_PROJECTION	1.000	2_CELL_CELL_SIGNALING	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
TGFBI	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_GLYCOLYSIS	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_PANCREATIC_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_GLIOMA	1.000	1_KEGG_PROSTATE_CANCER	1.000	1_KEGG_MELANOMA	1.000	1_KEGG_BLADDER_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_REGION	1.000	2_EXTRACELLULAR_REGION_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_COLLAGEN	1.000	
TGFBR1	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_GLIOMA	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_BLADDER_CANCER	0.500	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	0.500	1_KEGG_ACUTE_MYELOID_LEUKEMIA	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_CHROMOSOMAL_PART	0.500	2_CHROMOSOME	0.500	2_DNA_METABOLIC_PROCESS	0.500	2_CELL_CYCLE_PHASE	0.500	2_DNA_REPLICATION	0.500	2_CELL_CYCLE_GO_0007049	0.500	
TJP1	3	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	1_KEGG_CELL_CYCLE	0.333	1_KEGG_OOCYTE_MEIOSIS	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_ECM_RECEPTOR_INTERACTION	0.333	1_KEGG_PATHWAYS_IN_CANCER	0.333	1_KEGG_GLIOMA	0.333	1_KEGG_PROSTATE_CANCER	0.333	1_KEGG_MELANOMA	0.333	1_KEGG_BLADDER_CANCER	0.333	1_KEGG_CHRONIC_MYELOID_LEUKEMIA	0.333	1_KEGG_SMALL_CELL_LUNG_CANCER	0.333	2_MICROTUBULE_CYTOSKELETON	0.333	2_NON_MEMBRANE_BOUND_ORGANELLE	0.333	2_SPINDLE	0.333	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.333	2_CHROMOSOMAL_PART	0.333	2_CHROMOSOME	0.333	2_M_PHASE	0.333	2_INTERPHASE	0.333	2_CELL_CYCLE_PROCESS	0.333	2_MITOTIC_CELL_CYCLE	0.333	
TLE2	1	
TNC	4	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	2_CELL_CYCLE_GO_0007049	1.000	0_HALLMARK_G2M_CHECKPOINT	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	1_KEGG_PATHWAYS_IN_CANCER	0.750	1_KEGG_BLADDER_CANCER	0.750	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_MELANOMA	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_COLLAGEN	0.500	2_REGULATION_OF_PHOSPHORYLATION	0.500	2_CELL_CYCLE_PHASE	0.500	2_SYNAPTIC_TRANSMISSION	0.500	2_DNA_REPLICATION	0.500	2_REGULATION_OF_CELL_CYCLE	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	0_HALLMARK_ANGIOGENESIS	0.250	
TP53	93	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.785	0_HALLMARK_E2F_TARGETS	0.774	1_KEGG_CELL_CYCLE	0.763	1_KEGG_P53_SIGNALING_PATHWAY	0.763	0_HALLMARK_G2M_CHECKPOINT	0.677	2_CELL_CYCLE_GO_0007049	0.538	1_KEGG_FOCAL_ADHESION	0.505	1_KEGG_ECM_RECEPTOR_INTERACTION	0.505	2_GABA_RECEPTOR_ACTIVITY	0.505	2_NON_MEMBRANE_BOUND_ORGANELLE	0.462	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.462	2_REGULATION_OF_CELL_CYCLE	0.419	0_HALLMARK_UV_RESPONSE_DN	0.387	1_KEGG_DNA_REPLICATION	0.323	2_EXTRACELLULAR_MATRIX_PART	0.312	1_KEGG_PATHWAYS_IN_CANCER	0.301	1_KEGG_SMALL_CELL_LUNG_CANCER	0.301	2_CHROMOSOME	0.301	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.301	2_COLLAGEN	0.290	2_CELL_CYCLE_PHASE	0.290	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.280	2_EXTRACELLULAR_MATRIX	0.269	1_KEGG_BLADDER_CANCER	0.258	2_DNA_METABOLIC_PROCESS	0.258	
TPX2	1	
TRPV6	3	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.333	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.333	1_KEGG_MISMATCH_REPAIR	0.333	1_KEGG_CELL_CYCLE	0.333	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_ECM_RECEPTOR_INTERACTION	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.333	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.333	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	1_KEGG_PATHWAYS_IN_CANCER	0.333	1_KEGG_MELANOMA	0.333	1_KEGG_SMALL_CELL_LUNG_CANCER	0.333	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.333	1_KEGG_ALLOGRAFT_REJECTION	0.333	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.333	1_KEGG_VIRAL_MYOCARDITIS	0.333	2_ORGANELLE_PART	0.333	2_MICROTUBULE_CYTOSKELETON	0.333	2_NON_MEMBRANE_BOUND_ORGANELLE	0.333	
TSC2	4	0_HALLMARK_E2F_TARGETS	0.750	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	0_HALLMARK_UV_RESPONSE_DN	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_FOCAL_ADHESION	0.750	1_KEGG_PATHWAYS_IN_CANCER	0.750	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.500	2_CELL_CYCLE_GO_0007049	0.500	2_REGULATION_OF_CELL_CYCLE	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	0_HALLMARK_G2M_CHECKPOINT	0.250	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.250	0_HALLMARK_ANGIOGENESIS	0.250	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.250	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.250	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.250	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.250	1_KEGG_LEISHMANIA_INFECTION	0.250	1_KEGG_MELANOMA	0.250	1_KEGG_BLADDER_CANCER	0.250	1_KEGG_SMALL_CELL_LUNG_CANCER	0.250	1_KEGG_ASTHMA	0.250	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.250	
TTN	17	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.824	1_KEGG_ECM_RECEPTOR_INTERACTION	0.706	1_KEGG_FOCAL_ADHESION	0.647	2_GABA_RECEPTOR_ACTIVITY	0.647	1_KEGG_CELL_CYCLE	0.588	2_EXTRACELLULAR_MATRIX_PART	0.588	0_HALLMARK_E2F_TARGETS	0.529	0_HALLMARK_UV_RESPONSE_DN	0.529	2_COLLAGEN	0.529	0_HALLMARK_G2M_CHECKPOINT	0.471	0_HALLMARK_ANGIOGENESIS	0.471	1_KEGG_P53_SIGNALING_PATHWAY	0.471	1_KEGG_ALLOGRAFT_REJECTION	0.471	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.471	2_EXTRACELLULAR_MATRIX	0.471	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.412	0_HALLMARK_COMPLEMENT	0.412	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.412	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.412	1_KEGG_ASTHMA	0.412	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.412	2_NON_MEMBRANE_BOUND_ORGANELLE	0.412	2_EXTRACELLULAR_REGION_PART	0.412	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.412	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.353	
TUBA3C	2	0_HALLMARK_HYPOXIA	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_GAP_JUNCTION	0.500	1_KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_MELANOMA	0.500	2_KINESIN_COMPLEX	0.500	2_EXTRACELLULAR_REGION_PART	0.500	2_CELL_DEVELOPMENT	0.500	2_CELL_CELL_SIGNALING	0.500	2_SYNAPTIC_TRANSMISSION	0.500	2_CELL_PROLIFERATION_GO_0008283	0.500	2_KINASE_REGULATOR_ACTIVITY	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	
TUBA4B	1	1_KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION	1.000	2_MICROTUBULE_ASSOCIATED_COMPLEX	1.000	2_MICROTUBULE_CYTOSKELETON	1.000	2_KINESIN_COMPLEX	1.000	2_CYTOSKELETAL_PART	1.000	
TUBG1	2	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_BLADDER_CANCER	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	1_KEGG_ASTHMA	0.500	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.500	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.500	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.500	1_KEGG_VIRAL_MYOCARDITIS	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_NUCLEUS	0.500	
TUBG2	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_MICROTUBULE_ASSOCIATED_COMPLEX	1.000	2_MICROTUBULE_CYTOSKELETON	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_CONDENSED_CHROMOSOME	1.000	2_COLLAGEN	1.000	2_CHROMOSOME	1.000	2_M_PHASE	1.000	2_CELL_CYCLE_PROCESS	1.000	2_CELL_CYCLE_PHASE	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_REGULATION_OF_CELL_CYCLE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
TUBGCP5	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_COLLAGEN	1.000	2_REGULATION_OF_PHOSPHORYLATION	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_BLADDER_CANCER	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_CHROMOSOME	0.500	2_DNA_METABOLIC_PROCESS	0.500	2_INTERPHASE	0.500	2_CELL_CYCLE_PROCESS	0.500	2_CELL_CYCLE_PHASE	0.500	
TYK2	4	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_CELL_CYCLE	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.250	1_KEGG_DNA_REPLICATION	0.250	1_KEGG_P53_SIGNALING_PATHWAY	0.250	1_KEGG_FOCAL_ADHESION	0.250	1_KEGG_ECM_RECEPTOR_INTERACTION	0.250	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	0.250	1_KEGG_BLADDER_CANCER	0.250	1_KEGG_ASTHMA	0.250	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.250	2_EXTRACELLULAR_MATRIX_PART	0.250	2_MICROTUBULE_CYTOSKELETON	0.250	2_NON_MEMBRANE_BOUND_ORGANELLE	0.250	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.250	2_EXTRACELLULAR_MATRIX	0.250	2_CHROMOSOMAL_PART	0.250	2_CHROMOSOME	0.250	2_DNA_METABOLIC_PROCESS	0.250	2_M_PHASE	0.250	2_INTERPHASE	0.250	2_CELL_CYCLE_PROCESS	0.250	2_MITOTIC_CELL_CYCLE	0.250	2_CELL_CYCLE_PHASE	0.250	
VAMP1	2	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	1_KEGG_BLADDER_CANCER	0.500	1_KEGG_ASTHMA	0.500	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.500	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.500	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.500	1_KEGG_VIRAL_MYOCARDITIS	0.500	2_CELL_CELL_SIGNALING	0.500	2_SYNAPTIC_TRANSMISSION	0.500	2_TRANSMISSION_OF_NERVE_IMPULSE	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	
VAMP3	4	0_HALLMARK_E2F_TARGETS	0.750	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_P53_SIGNALING_PATHWAY	0.750	1_KEGG_MELANOMA	0.750	2_GABA_RECEPTOR_ACTIVITY	0.750	0_HALLMARK_G2M_CHECKPOINT	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	2_CELL_CELL_SIGNALING	0.500	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.500	2_SYNAPTIC_TRANSMISSION	0.500	2_CELL_CYCLE_GO_0007049	0.500	2_TRANSMISSION_OF_NERVE_IMPULSE	0.500	2_SYSTEM_PROCESS	0.500	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	0.500	0_HALLMARK_APOPTOSIS	0.250	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.250	0_HALLMARK_ALLOGRAFT_REJECTION	0.250	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	0.250	1_KEGG_OOCYTE_MEIOSIS	0.250	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.250	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.250	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.250	
VAMP7	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_BLADDER_CANCER	0.667	1_KEGG_SMALL_CELL_LUNG_CANCER	0.667	2_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.333	0_HALLMARK_HYPOXIA	0.333	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	0.333	0_HALLMARK_DNA_REPAIR	0.333	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_APOPTOSIS	0.333	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.333	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.333	0_HALLMARK_COMPLEMENT	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	0_HALLMARK_INFLAMMATORY_RESPONSE	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	0_HALLMARK_ANGIOGENESIS	0.333	0_HALLMARK_COAGULATION	0.333	0_HALLMARK_ALLOGRAFT_REJECTION	0.333	0_HALLMARK_KRAS_SIGNALING_UP	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.333	1_KEGG_MISMATCH_REPAIR	0.333	
VASP	1	
VAV1	3	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_MELANOMA	1.000	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	1.000	2_CELL_CYCLE_PROCESS	1.000	2_CELL_CYCLE_GO_0007049	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_VIRAL_MYOCARDITIS	0.667	2_EXTRACELLULAR_MATRIX_PART	0.667	2_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_DNA_METABOLIC_PROCESS	0.667	2_REGULATION_OF_PHOSPHORYLATION	0.667	2_CELL_CYCLE_PHASE	0.667	
VAV2	3	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_GLIOMA	0.667	1_KEGG_MELANOMA	0.667	1_KEGG_BLADDER_CANCER	0.667	1_KEGG_SMALL_CELL_LUNG_CANCER	0.667	2_CELL_CYCLE_PROCESS	0.667	2_MITOTIC_CELL_CYCLE	0.667	2_REGULATION_OF_PHOSPHORYLATION	0.667	2_CELL_CYCLE_PHASE	0.667	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.667	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.667	2_CELL_CYCLE_GO_0007049	0.667	2_REGULATION_OF_CELL_CYCLE	0.667	2_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE	0.667	0_HALLMARK_MITOTIC_SPINDLE	0.333	1_KEGG_OOCYTE_MEIOSIS	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	
VCAN	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	2_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_COLLAGEN	0.667	2_CELL_CYCLE_GO_0007049	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_MYC_TARGETS_V1	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	0_HALLMARK_ANGIOGENESIS	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_PATHWAYS_IN_CANCER	0.333	1_KEGG_BLADDER_CANCER	0.333	1_KEGG_SMALL_CELL_LUNG_CANCER	0.333	2_MICROTUBULE_ASSOCIATED_COMPLEX	0.333	2_MICROTUBULE_CYTOSKELETON	0.333	2_EXTRACELLULAR_REGION	0.333	
VEGFA	4	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_ASTHMA	0.500	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.500	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.500	1_KEGG_VIRAL_MYOCARDITIS	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_CELL_CELL_SIGNALING	0.500	2_SYNAPTIC_TRANSMISSION	0.500	2_CELL_CYCLE_GO_0007049	0.500	2_TRANSMISSION_OF_NERVE_IMPULSE	0.500	0_HALLMARK_APOPTOSIS	0.250	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.250	0_HALLMARK_UV_RESPONSE_DN	0.250	
VLDLR	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_MELANOMA	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_COLLAGEN	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_PANCREATIC_CANCER	0.500	1_KEGG_ENDOMETRIAL_CANCER	0.500	1_KEGG_GLIOMA	0.500	1_KEGG_PROSTATE_CANCER	0.500	1_KEGG_BLADDER_CANCER	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_REGULATION_OF_PHOSPHORYLATION	0.500	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.500	2_CELL_CYCLE_GO_0007049	0.500	
WEE2	4	0_HALLMARK_G2M_CHECKPOINT	0.750	0_HALLMARK_E2F_TARGETS	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_FOCAL_ADHESION	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	2_CELL_CYCLE_GO_0007049	0.750	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_COMPLEMENT	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.500	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.500	1_KEGG_VIRAL_MYOCARDITIS	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	
XIAP	1	1_KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY	1.000	2_CASPASE_REGULATOR_ACTIVITY	1.000	
XRCC2	5	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.800	1_KEGG_FOCAL_ADHESION	0.800	1_KEGG_ECM_RECEPTOR_INTERACTION	0.800	2_CELL_CYCLE_GO_0007049	0.800	0_HALLMARK_ANGIOGENESIS	0.600	1_KEGG_DNA_REPLICATION	0.600	1_KEGG_PATHWAYS_IN_CANCER	0.600	1_KEGG_MELANOMA	0.600	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.600	2_EXTRACELLULAR_MATRIX_PART	0.600	2_NON_MEMBRANE_BOUND_ORGANELLE	0.600	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.600	2_EXTRACELLULAR_MATRIX	0.600	2_COLLAGEN	0.600	2_DNA_METABOLIC_PROCESS	0.600	2_DNA_REPLICATION	0.600	0_HALLMARK_MYC_TARGETS_V1	0.400	0_HALLMARK_UV_RESPONSE_DN	0.400	1_KEGG_P53_SIGNALING_PATHWAY	0.400	1_KEGG_SMALL_CELL_LUNG_CANCER	0.400	2_MICROTUBULE_CYTOSKELETON	0.400	2_CHROMOSOME	0.400	
YWHAH	1	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_REGULATION_OF_PHOSPHORYLATION	1.000	2_CELL_CELL_SIGNALING	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
ZNF212	4	0_HALLMARK_G2M_CHECKPOINT	0.250	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.250	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.250	0_HALLMARK_E2F_TARGETS	0.250	0_HALLMARK_MYC_TARGETS_V1	0.250	1_KEGG_DNA_REPLICATION	0.250	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.250	1_KEGG_MISMATCH_REPAIR	0.250	1_KEGG_CELL_CYCLE	0.250	1_KEGG_FOCAL_ADHESION	0.250	1_KEGG_ECM_RECEPTOR_INTERACTION	0.250	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.250	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.250	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.250	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.250	1_KEGG_PATHWAYS_IN_CANCER	0.250	1_KEGG_MELANOMA	0.250	1_KEGG_SMALL_CELL_LUNG_CANCER	0.250	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.250	1_KEGG_ALLOGRAFT_REJECTION	0.250	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.250	1_KEGG_VIRAL_MYOCARDITIS	0.250	2_ORGANELLE_PART	0.250	2_MICROTUBULE_CYTOSKELETON	0.250	2_NON_MEMBRANE_BOUND_ORGANELLE	0.250	
ZNF274	1	
ZNF3	3	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.667	0_HALLMARK_COMPLEMENT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	0_HALLMARK_UV_RESPONSE_DN	0.667	0_HALLMARK_ANGIOGENESIS	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.667	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.667	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_MELANOMA	0.667	1_KEGG_SMALL_CELL_LUNG_CANCER	0.667	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.667	1_KEGG_ALLOGRAFT_REJECTION	0.667	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.667	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.667	2_EXTRACELLULAR_MATRIX_PART	0.667	2_EXTRACELLULAR_MATRIX	0.667	2_COLLAGEN	0.667	2_CELL_PROLIFERATION_GO_0008283	0.667	2_CELL_CYCLE_GO_0007049	0.667	
ZWINT	4	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_MICROTUBULE_CYTOSKELETON	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_CHROMOSOME	1.000	2_M_PHASE	1.000	2_CELL_CYCLE_PROCESS	1.000	2_CELL_CYCLE_PHASE	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_REGULATION_OF_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	0.750	1_KEGG_BLADDER_CANCER	0.750	2_SPINDLE	0.750	2_CHROMOSOMAL_PART	0.750	2_MITOTIC_CELL_CYCLE	0.750	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.750	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.750	2_CELL_PROLIFERATION_GO_0008283	0.750	2_MITOSIS	0.750	
